Dr. Gymbro

Gel ɗin Bicarbonate a Tsakiyar Hawan Keke: Ƙaruwa da 12 W Bayan Awanni 3

Dr. Gymbro — Sat, 31 Oct 2026 08:11:57 GMT

# Kowa ya san an iya ɗaukar "baking‑soda" (sodium bicarbonate) **kafin** wani ƙoƙari mai ƙarfi. Kusan babu wanda ya gwada abin da ke faruwa idan an sha shi **a tsakiyar** dogon tseren. Wani sabon gwajin ɗan adam na *crossover* a kan masu keke da suka horar ya yi daidai da haka, kuma sakamakon da aka samu bayan awanni uku na hawan ba za a watsar da shi ba: **+12 W a gwajin minti 12**. Abin damuwa shine, gudu‑gudun sprint na minti 2 ba su nuna wani tashi ba, kuma adadin mahalarta ƙanana ne. Wannan shi ne gwajin ɗan adam a kan masu keke 11 da suka horar, ba gwajin dabbobi ko sel‑sel a dakin gwaje‑gwaje ba. Ga abin da aka gano a zahiri. ## Me Ya Sa Wannan Binciken Ke Da Muhimmanci Sodium bicarbonate (SB) ya sha fama da amfani wajen ƙoƙari mai ƙarfi na tsawon mintuna 1 zuwa 60. Har zuwa yanzu, bincike ya mayar da hankali kan shan sa **kafin** motsa jiki. Kamar yadda marubutan suka nuna, ba a taɓa gwada SB *a lokacin* motsa jiki ba, ko kuma ko zai iya rage raguwar ƙarfin da ke faruwa a kan **durability** – wato yawan ƙarfin da ka rage bayan dogon aiki. Binciken, da aka wallafa a *Scandinavian Journal of Medicine & Science in Sports* (Norte et al., 2026), ya gwada bicarbonate da carbohydrate a cikin **sabuwar hanyar gel**. ## Yadda Aka Aiwar da Gwajin Masu keke 11 da suka horar sun kammala tsarin bazuwar *crossover*. Matakan sun kasance: - **Ziyarar farko (baseline):** an auna ƙarfin a yanayin da ba a gaji ba – sprint na dakiku 6 uku, gwajin minti 2, da gwajin minti 12. - **Gwaje‑gwaje guda biyu:** awanni 3 na hawan keke a **95 % na gas‑exchange threshold**, tare da carbohydrate **80 g/h**. - **Yanayi biyu:** carbohydrate kaɗai (CHO), ko carbohydrate da bicarbonate (CHO + BI), inda aka yi amfani da **18 g sodium bicarbonate da 2 g potassium bicarbonate** gaba ɗaya. - **Gwajin ƙarshe:** an maimaita ainihin jerin gwaje‑gwajen da aka yi bayan awanni 3 na hawan, don auna a yanayin gaji. ## Sakamakon Da Ke Bayyana **Gwajin minti 12:** ƙarfin ya ƙaru da **12 W** a yanayin CHO + BI fiye da CHO kaɗai (p = 0.01, Hedges’ g = 1.07). Wannan tasiri ne mai girma kuma shine kawai sakamakon da ya fita da muhimmanci a ƙididdiga. **Sauran gwaje‑gwajen ba su samu tasiri ba:** - Sprint na dakiku 6: +12 W (p = 1.00, g = 0.18) – ba mu samu muhimmanci ba. - Gwajin minti 2: +6 W (p = 0.888, g = 0.32) – ba mu samu muhimmanci ba. Banbancin sprint ya yi daidai da na minti 12 a ma’aunin wutan lantarki, amma tasirin ya yi ƙasa da mahimmanci, don haka ba za a iya ɗauka a matsayin haɓaka na zahiri ba. Amfanin yana bayyane ne a aikin da ke buƙatar ci gaba da ƙarfin (threshold‑ish), ba a ƙoƙarin gajeren, mai fashe‑fashe ba. ## Matsalar Ciki (GI) Ba Ta Tasiri Ba Matsalar ciki ita ce dalilin da ya fi sa mutane su daina amfani da bicarbonate. A nan, **ba a samu bambanci a alamar gastrointestinal tsakanin yanayi biyu ba**. Marubutan sun bayyana ciwon kamar ƙarami ne. Shigar da adadin a cikin gel na carbohydrate, a rarraba shi tsawon tseren, ya kasance mai sauƙi a cikin wannan ƙungiyar. ## Muhimmancin Sa Ga Wasannin Dogon Lokaci Idan kana yin triathlon, gran fondo ko dogon tseren hanya, lokutan da ke da tasiri sau da yawa sukan zo ne a ƙarshe, lokacin da ka gaji kuma kana bukatar ƙara ƙarfin. Wannan bincike na nuni da cewa taimakon buffering a tsakiyar tseren, ba kawai kafin farawa ba, na iya taimaka wa wajen riƙe ƙarfin da ake buƙata a wannan lokacin. Marubutan sun fassara shi a matsayin yiwuwar rage raguwar ƙarfin da gajiya ke haifarwa, ko da yake gwajin minti 12 guda ba zai iya tabbatar da wannan tsarin **durability** da kansa ba. ## Yadda Za Ka Iya Amfani Da Shi **Matsakaicin da aka yi amfani da shi a binciken:** 18 g sodium bicarbonate + 2 g potassium bicarbonate a tsawon awanni 3, tare da carbohydrate **80 g/h** a cikin gel. Idan an raba shi daidai, hakan zai zama kusan 6 g SB a kowace awa (lissafin mu, ba a ciro daga takarda ba). Hakanan yana bayar da kimanin 5 g sodium daga SB kaɗai. **Lokaci:** An ciye shi a lokacin motsa jiki, a matsayin ɓangare na shirin ciyarwa, ba a matsayin ƙwanƙolin da ake sha **kafin tseren** ba. Takaitaccen bayanin ba ya ba da takamaiman jadawalin ciyarwa, don haka kada ku yi tunanin an yi shi a wasu lokuta banda "a duk tsawon awanni 3". **Waɗanda Zasu Iya Amfana Da Shi:** - Masu keke, triathletes, da masu dogon tseren da ke riga suna amfani da adadin carbohydrate mai yawa. - ‘Yan wasa da ke ƙare wasanni da wani ƙoƙari mai tsawo na mintuna 10 zuwa 15. - Mutanen da suke son gwada wannan a horo kafin su ɗauki shi a gasar. **Waɗanda Ya Kamata Su Guje Shi Ko Su Yi Cikakken Sa‑ido:** - Duk wanda aka ba da shawarar rage sodium, ko wanda ke da matsalar hawan jini, ko cutar zuciya – ku tattauna da ƙwararren likita. - Masu fama da matsalolin GI da ba su taɓa gwada tsarin bicarbonate a horo ba. - Masu ƙwararren sprint ko ƙananan tseren – ba a samu wani tasiri a sprint ko minti 2 ba. - Duk wanda ke tsammanin “mabuɗin sihiri”. Wannan gwaji ƙanana ne kuma ɗaya ne kawai. ## Iyakokin Da Ya Kamata Ku San Su - **Karamin misali:** mutane 11 kacal – dole ne a maimaita a cikin manyan ƙungiyoyi, ciki har da mata da manyan matakan aiki. - **Fa’idar da aka ga:** ta bayyana ne kawai a gwajin minti 12. Sprint da minti 2 ba su inganta ba. - **Tsarin guda:** awanni 3 a 95 % na gas‑exchange threshold tare da 80 g/h carbohydrate wataƙila ba ya kama da yanayin gasar ku. - **Kayan samfuri:** kamfanin MNSTRY ya samar da kayan abinci, Siemens Healthineers ya ba da na’urar nazarin jini. Marubutan sun bayyana cewa babu wani tasiri daga waɗannan kamfanoni a ƙirƙira, tattara bayanai, nazari, fassarar ko yanke shawarar wallafa. Wani marubuci yana da alaƙa da Precision Fuel & Hydration. - **Dakin gwaje‑gwaje, ba gasar ba:** gwajin minti bayan dogon hawan da aka sarrafa ba su da yanayi irin na gasar da ta cika da canje‑canje. ## Kammalawa Wannan shi ne nazari na farko da ya duba sha bicarbonate *a lokacin* dogon hawan keke, kuma ya gano ƙaruwa mai ma’ana na **12 W** a ƙarshen awanni 3 a gwajin minti 12, ba tare da ƙarin alamar GI ba. Alƙawarin yana da kyau, amma ƙanƙanta ne kuma akwai iyaka. Ku ɗauke shi a matsayin dalili mai ƙarfi na ƙarin bincike, da kuma wani gwaji da ‘yan wasa masu juriya za su iya tattaunawa da ƙwararren masani, ba a matsayin tabbacin haɓaka ba.

Creatine a Cikin Gurasar (Cast) Ba Zai Ceton Tsokoki Ba, Amma Amfaninsa A Lokacin Dawowa Na Banbanta

Dr. Gymbro — Sat, 31 Oct 2026 08:11:03 GMT

# Creatine a Cikin Gurasar (Cast) – Ba Zai Ceton Tsokoki Ba, Amma Amfanin Sa A Lokacin Dawowa Na Banbanta Idan ka fasa ƙasusuwa, ka tari ligaman, ko ka yi tiyata, tsokoki na fara raguwar girma kusan nan da nan. To shin creatine – wanda shine mafi binciken kari a fannin abincin wasanni – zai iya dakatar da wannan raguwa? Binciken tsarin sabo da aka wallafa a *Experimental Physiology* ya ba da amsa mai sassaƙa. **Lokacin da aka ɗaure tsoka (immobilisation), hujjojin suna da ruɓaɓewa kuma ba su da karfi. A lokacin dawowa, akwai alamu cewa creatine na iya taimakawa sauri wajen sake gina tsoka.** Amma waɗannan alamu sun fito ne daga ƙananan gwaje‑gwaje kaɗan. Wannan bincike yana magana ne akan mutane, amma ɓangaren ƙarami ne kawai na dukan al'amari. Ga abin da aka gano a cikin wannan nazari da kuma abin da ba za a iya faɗi ba. --- ## Menene Masana Suka Yi Ainihi? Ƙungiyar da Pratt ya jagoranta – tare da Candow, Rawson, Forbes da Prokopidis – sun bincika manyan ɗakunan adana bayanai na PubMed, Scopus, Web of Science da Cochrane Library daga farkon su har zuwa Maris 2026. Sun bi ƙa’idar PRISMA wadda take jagorantar nazarin tsarin bincike. Sakamakon bincikensu ya ƙunshi **gwaje‑gwaje shida na ƙididdiga, da aka raba zuwa rukuni na placebo, tare da mahalarta 118 gaba ɗaya**. Shekarun mahalarta sun yi tsakanin **15 zuwa 24 shekara**. Duk gwaje‑gwajen sun yi amfani da **makonni 1‑2 na ɗaurin wani ɓangaren jiki** a matsayin yanayin rashin amfani. Sun auna girman tsoka, nauyin ƙoshi (lean mass), da kuma aikace‑aikacen ƙarfi (strength), ƙarfin wuta (power) da juriya (endurance) a lokacin da ba a motsa ba, da kuma a lokacin dawowa idan an samu. Wannan ba sabon gwaji ba ne, a’a – nazari ne da ya tattara hujjojin da ke akwai. Gwaje‑gwajen kanana ne kuma daban‑daban, wanda ke iyakance yawan abin da za a iya fitarwa daga su. --- ## Gama Na Daya: Shin Creatine Na Hana Raguwa? A halin yanzu ba a iya tabbatar da hakan ba. Sakamakon gwaje‑gwajen suna jayayya da juna. ### Girman Tsoka (Quadriceps cross‑sectional area, an auna ta CT ko NMR) - Bincike biyu sun nuna creatine ba ta yi wani tasiri ba. A daya, raguwar girman ta kasance **‑5.6 %** da creatine vs **‑5.5 %** da placebo; a dayan kuma **‑11.0 %** vs **‑9.4 %**. ### Nauyin ƙoshi (lean mass, an auna ta BIA ko DXA) - Gwanon ƙasa na ƙafafu ya fadi **5.6 %** da creatine vs **8.9 %** da placebo. - Gwanon ƙasa na hannuwa ya **kare (+0.9 %)** da creatine vs **‑3.7 %** da placebo. Wannan na iya bayyana a matsayin nasara, sai dai idan muka kalli yadda aka auna. --- ## Matsalar Ruwa Masu nazarin sun yi gargadi cewa bambancin da aka gani a BIA da DXA na iya kasancewa sakamakon canjin ruwa a jiki, **ba ainihin adadin tsoka ba**. Creatine na jawo ruwa ya shiga cikin ƙwayoyin tsoka. Saboda haka, yadda BIA da DXA ke karanta ƙarin ruwa a matsayin lean mass na iya haifar da ra'ayin “ƙarin tsoka” da ba gaskiya ba. Hanyoyin hoto (CT da NMR) da ke auna ainihin girman tsoka ba su nuna wani bambanci ba. Nazarin ba ya cewa creatine ba ta da amfani a wannan lokaci; kawai yana nuna cewa alamar lean mass ba za a iya dogara da ita don tabbatar da ceto na tsoka ba. --- ## Ƙarfi da Power A Lokacin Da Ba A Motsa Jiki Ba Sakamakon aiki ba su da daidaito. Creatine ta nuna fa’ida a **gwaje‑gwajen ƙafafu ne amma ba a ƙananan hannuwa ba**. Me ya sa aka samu wannan rabuwa? Binciken bai fayyace ba. Da gwaje‑gwajen da suka yi ƙanana ne, kowanne bayani na iya zama tunanin ƙirƙira. Masu binciken sun kammala da cewa **bayanan da ake da su a yanzu ba su goyi bayan creatine a matsayin hanyar kariya daga raguwar tsoka, asarar lean mass, ko raguwar aiki**. --- ## Gama Na Biyu: Dawowa (Recovery) Anan ne aka samu abin da ya fi jan hankali. Daga cikin gwaje‑gwaje shida, **hudu sun haɗa da matakin dawowa**, kuma **uku ɗin su sun yi amfani da horon ƙarfi na juriya**. Biyu daga cikinsu sun ba da rahoton ƙaruwa mai girma tare da creatine: - **Quadriceps CSA:** **+21.3 %** da creatine vs **+14.3 %** da placebo - **Lean mass na ƙafafu:** **+5.6 %** vs **+3.8 %** - **Power:** **+52.2 %** vs **+35.2 %** - **Strength:** **+28.7 %** vs **+22.8 %** Wadannan lambobi suna nuni da bambanci mai ma’ana a takarda, amma an samo su ne daga gwaje‑gwaje biyu kawai, mahalarta su matasa ne, kuma lambar lean mass har yanzu tana da alamar ruwa. Don haka, ɗauki wannan a matsayin alamar alkawari, ba a matsayin tsari da aka tabbatar ba. --- ## Ƙuntatawa Da Ya Kamata Ka Sani - **Bayanan da ke ƙasa:** gwaje‑gwaje shida, mutane 118. - **Mahalarta matasa ne kawai:** shekaru 15‑24. Manyan mutane da marasa lafiya da ke fuskantar raguwar tsoka ba a gwada su ba – su ne mafi buƙatar kulawa. - **Lokacin ɗaurin da ya ƙanƙanta:** makonni 1‑2, maimakon watannin da ake ɗora cast a zahiri. - **Matsalolin auna:** BIA da DXA na iya ɓata tare da ruwa. - **Ƙarancin gwaje‑gwaje:** kawai biyu ne suka nuna fa’ida a lokacin dawowa. - **Rikicin sha’anin kudi:** wasu marubuta sun bayyana cewa suna da alaƙa da masana’antar creatine (ta hanyar tallafi, gudummawar kayan, ko aikin shaidu). Wannan ba ya rushe binciken, amma yana nuni da buƙatar fahimtar wannan ɓangare. --- ## Abubuwan Da Za Ka Iya Aiwatar Da Su **Kimanin adadi:** Babu wani adadi da aka ba da shawara a takaitaccen binciken, amma tsarin da aka yarda da shi na **creatine monohydrate** shi ne **3‑5 g a kowace rana**. Wasu gwaje‑gwaje sun fara da matakin “loading” – 20 g a rana na ‘yan ranaku – amma wannan ba dole ba ne; abin da yafi muhimmanci shi ne ci gaba da shan a kowace rana. **Lokaci:** Fara shan creatine a lokacin da aka sanya cast (ko a farkon ɗaurin) kuma ci gaba har zuwa lokacin horon juriya. Kada ka yi tsammanin zai hana raguwa a rana ta farko bayan cire cast. **Waɗanda za su amfana:** Mutanen da ke da lafiya, masu motsa jiki, kuma suka fuskanci ɗaurin ƙafa ko hannu na ‘yan makonni kaɗan, kuma za su yi horon ƙarfi na juriya bayan an saki su. Creatine na da tsada mai sauƙi, kuma idan an riga an san yana da amfaninsa a motsa jiki, ƙara shi ba shi da haɗari mai yawa. **Waɗanda za su guje shi ko su tambayi likita:** Duk wanda ke da cutar ƙoda, wasu cututtuka masu alaƙa da ƙoda, masu shan magungunan da ke tasiri kan ƙoda, mata masu dauke da ciki ko masu shayarwa – su tuntuɓi likita kafin su fara. Manyan mutane da marasa lafiya da ke cikin masana’antar jinyar suna bukatar a yi nazari a kansu kafin a ɗauka cewa sakamakon nan ya shafe su. **Muhimmanci sosai:** Creatine na ƙara wa horo karfi, ba ya maye gurbin horo. Fa’idar dawowa da aka gani a bincike na faruwa ne a cikin **horon juriya na ƙarfi**. Ku bi shawarwarin likitan ilimin motsa jiki (physio) kuma ku ƙara nauyi a hankali da zarar an amince da hakan. --- ## Kammalawa Creatine ba wani garkuwa bane da zai kare tsokoki yayin da suke cikin cast. Bayanai na girman tsoka sun nuna ƙarancin kariya, kuma ribar lean mass na iya zama ruwa ne kawai. Amma a matakin dawowa, alamu suna nuni da yiyuwar ƙaruwar girma, ƙarfi da power a cikin wasu gwaje‑gwaje biyu. Don matasa masu lafiya da ke yin horon juriya na ƙarfi, creatine na iya zama ƙarin ƙarfin da zai taimaka. Amma har yanzu ana bukatar ƙarin gwaje‑gwaje da suka fi tsawo, a manyan shekaru da kuma a marasa lafiya, kafin a iya kiran shi **tabbataccen magani**.

Whey Kafin Barci Ya Rage Rabi Lokacin Faduwa Barci; Casein Ba Ta Yi

Dr. Gymbro — Sat, 31 Oct 2026 08:10:04 GMT

# Shekaru da dama, dokar motsa jiki ta ce: idan kana son samun protein a dare, ka sha casein – wacce ake kira “mai zuba a hankali”. Sabon gwaji kan mutane ya jefa wannan ra'ayi cikin rudani. A wani ƙaramin gwaji (n = 9) **gram 40 na whey protein da aka sha minti 30 kafin kwanciya bayan horon ƙarfi** ya rage lokacin faduwa barci, inganta barci, da rage ciwon tsoka fiye da abin sha na carbohydrate da aka daidaita da adadin kalori. Casein, wacce aka ɗauka a matsayin zakarar dare, ba ta kai wannan matakin ba. Kafin kowanne ya watsar da buhun casein, dole ne a fahimci cikakkun bayanai. Wannan **binciken kan mutane ne, amma ƙanana sosai**, kuma whey *ba ta* kayi nasara a kan casein a gwajin kai tsaye. ## Binciken: Abin Da Masana Sukayi Aikin ya fito ne daga ƙungiyar Jami'ar Fasaha ta Munich (Technical University of Munich) tare da haɗin gwiwa a Jamus da Netherlands, kuma an wallafa a *International Journal of Sport Nutrition and Exercise Metabolism* (2026). Gwajin ya kasance **randomized, double‑blind, crossover trial**, wato kowanne mahalarta ya gwada dukkan yanayi uku. Mata da maza 9 masu lafiya, masu horon jiki, sun halarta: maza biyar da mata huɗu, shekarunsu matsakaici 24 ± 2, BMI 24.4 ± 2.9 kg/m². A lokuta uku daban‑daban, sun yi horon motsa jiki, sannan a minti 30 kafin su kwanta suka sha ɗayan zabin uku: - **WHEY:** gram 40 whey protein - **CASEIN:** gram 40 casein protein - **CON:** isocaloric maltodextrin (carbohydrate) control Barci an auna shi da **actigraphy** (na’urar motsi da ake saka a wuyan hannu), **heart‑rate variability (HRV)**, da **tambayar ra'ayin barci**. Haka kuma an bi sawun alamun hanji, aikin horo na gobe, da delayed onset muscle soreness (DOMS). ## Lambobi: Whey vs Control Sakamakon an gabatar da su a matsayin median, tare da tazara a cikin inter‑quartile range. Whey ta wuce control a kowane muhimmin ma’aunin barci (duk p < .05): | Ma’auni | WHEY | CASEIN | CON | |---|---|---|---| | Lokacin faduwa barci (min) | 9.0 | 16.0 | 19.0 | | Ingancin barci | 96% | 96% | 93% | | Jimillar lokacin barci (min) | 400 | 390 | 363 | | Kimar barci daga mahalarta (1‑10) | 8.0 | 7.0 | 6.0 | Babban labari shi ne lokacin faduwa barci: median kusan mintuna 9 bayan whey, yayinda carbohydrate control ke ba da mintuna 19. Jimillar lokacin barci ma ya nuna kusan mintuna 37 mafi tsawo a yanayin whey. Whey ma ta **rage DOMS a sa’o’i 12 da 24 bayan horo** idan aka kwatanta da control (p < .05). ## Jerin Mummunan: Casein Ba Ta Wuce Control Medians na casein sun tsaya tsakanin whey da control a mafi yawan ma’aunin (mintuna 16 don faduwa barci, mintuna 390 na barci, kimar 7). Amma **casein ba ta inganta barci sosai idan aka kwatanta da control**. Wannan shi ne bambanci da ke sa labarin ya zama abu don tattaunawa, ba hukunci ba. Takardar ta nuna cewa ribar whey ta kasance mai muhimmanci a kan control, **amma ba a kan casein ba (duk p > .05)**. Don haka binciken *ba* ya nuna cewa whey ta fi casein ba. Ya nuna kawai whey ta wuce statistically a kan carbohydrate, yayin da casein ba ta yi hakan ba. Da mutane tara kawai, wannan bambanci na iya zama sakamakon hayaniya da ƙarancin ƙarfi. ## Abubuwan Da Ba Su Canza Ba Wannan ba sihiri bane ga kowa da kowa. Ba a samu **bambanci tsakanin rukunin** a: - Ma’aunin heart‑rate variability - Alamun hanji - Aikace‑aikacen horo na gobe Wannan na ƙarshe yana da mahimmanci. Kyakkyawan barci da ƙarancin ciwo ba su haifar da ƙaruwa a aikin gobe a wannan gwajin. A bangaren alheri, gram 40 na protein a kusa da lokacin kwanciya ba su ƙara matsalolin ciki fiye da control. ## Me Ya Sa Whey Zai Iya Taimakawa Barci? Abstrakt ba ya ƙayyade hanyoyin da ke faruwa, don haka duk wani bayani yana kan tunani ne kawai. Wasu ra’ayoyi sun haɗa da: 1. **Amino acid da ke fitowa daga whey** – suna iya tasiri kan hanyoyin da suka shafi barci. 2. **Saurin narkewa da shige** – whey yana narkewa da sauri, wanda zai iya kawo rise a serotonin da melatonin. 3. **Rage ciwon tsoka** – ciwon tsoka da aka rage yana sa mutum ya fi sauƙin yin barci. Babu ɗayansu da aka gwada a wannan bincike. A ɗauki su a matsayin tunanin bincike na gaba, ba sakamakon da aka tabbatar ba. ## Iyakokin Da Ya Kamata Ka San - **Samfurin ƙanana:** mutane 9. Gwaje‑gwajen crossover kan ƙanana su kan rasa babbar ƙarfi ko su nuna bambancin bazuwar. - **Whey vs casein ba a warware ba:** babu bambanci mai ƙarfi a gwajin kai tsaye. - **Actigraphy ba dakin gwajin barci ba ne:** yana kimanta barci daga motsi, ba kamar polysomnography ba, musamman ga lokacin faduwa barci. - **Kimantawa daga zuciya** na iya shafar yadda mahalarta ke amsa tambayoyi. - **Rukunin mutane ƙuntata:** matasa masu lafiya, masu horon ƙarfi. Ba a iya fassara ga manya, masu matsalar barci, ko wadanda ba su yin ƙarfi ba. - **Control shine carbohydrate:** ba a kwatanta whey da babu kari ba. - **Tsarin gwaji guda‑guda:** ba ya ba da bayani game da tasirin dogon lokaci kan barci, farfadowa ko girman tsoka. ## Abubuwan Da Za Ka Iya Amfani Da Su **Matsakaicin kashi da lokaci da aka yi amfani da su a gwaji:** gram 40 na whey protein, a sha minti 30 kafin kwanciya, bayan horon ƙarfi. **Waɗanda za su iya gwadawa:** - Masu ɗaga nauyi da ke horar da dare kuma suka kasa cika buƙatar protein a kullum. - Mutane da ke neman protein a lokacin kwanciya kuma suna sha’awar ganin tasirin kan barci da ciwo. **Waɗanda yakamata su guje shi ko su tuntuɓi likita da farko:** - Duk wanda ke da rashin lafiyar madara ko lactose mai tsanani. - Masu cutar koda ko wasu yanayi da ke buƙatar takaita protein, su tattauna da likita. - Wadanda ke barci lafiya kuma suna horar da safe, domin babu shaida da ke nuna musu fa'ida. - Duk wanda ke tsammanin samun ƙaruwa a aikin gobe, domin ba a ga hakan ba. **Hanyar hankali:** idan kana son gwadawa, ɗauke shi a matsayin gwaji na kanka. Ka riƙa daidaita sauran al'amuran maraice, ka rubuta yawan mintuna da ka ɗauka ka kwanta da yadda kake jin ciwo, sannan ka kwatanta da dare da ba ka sha shake. ## Kammalawa Ra'ayin “casein ita ce kawai protein da za a ci kafin kwanciya” bai samu tabbataccen **knockout** a nan ba, haka kuma whey ba ta samu cikakken nasara ba. Abin da wannan gwaji ya nuna shi ne: whey da aka sha kafin barci bayan ɗaga nauyi yana da alaƙa da saurin faduwa barci, ingantaccen barci, da ƙananan ciwo idan aka kwatanta da carbohydrate control, yayin da casein ba ta fito daban ba. Don tabbatar da wannan za a buƙaci manyan gwaje‑gwaje da suka ƙunshi gwaji kai‑tsaye na whey da casein tare da auna barci ta hanyoyin kimiyya masu inganci.

Masu Cin Ganyayyaki Sun Sha Creatine na Mako Hudu: Tsallake Sun Inganta, Amma Gudun Ba su Sauya

Dr. Gymbro — Sat, 31 Oct 2026 08:09:03 GMT

# Masu Cin Ganyayyaki Sun Sha Creatine na Mako Hudu: Tsallake Sun Inganta, Amma Gudun Ba su Sauya Masu cin ganyayyaki an yi imanin za su amfana da creatine fiye da sauran jama'a, domin abincin su ba ya ƙunshe da wannan sinadari. Wani sabon gwajin bazuwar, mai ɓoye‑uku, da aka yi kan mutane 20 ya gwada wannan ra'ayi. Sakamakon ya kasance ɗaya‑doi: **aikin tsalle ya inganta, amma gwaje‑gwajen gudu da ƙarfi ba su nuna wani tasiri ba**. Gwajin ya ɗauki makonni huɗu kacal. Wannan bincike an wallafa shi a *European Journal of Applied Physiology* (López‑Moreno et al., 2026; PMID 42390589; rajista NCT06483321). Ga abin da aka gano da abin da ba a iya faɗi ba. --- ## Me Yasa Masu Cin Ganyayyaki Suke Zama Abun Bincike na Creatine? Creatine yana samuwa a nama da kifin teku, don haka mutane masu bin tsarin abincin tsirrai (vegan) yawanci ba su samu isasshen adadi daga abinci ba. Jiki na iya ƙirƙirar wani ɓangare na creatine, amma aƙalla ma'adinan da ke cikin tsokoki na masu cin ganyayyaki kan kasance ƙasa da na waɗanda ke cin nama. Wannan na nufin akwai yiyuwar su samu faɗi idan an ƙara musu creatine ta hanyar ƙwaya. Sai dai wannan gwajin bai kwatanta masu cin ganyayyaki da masu cin nama ba, kuma ba a auna matakin creatine a cikin tsokoki ba. Saboda haka ba za a iya fitar da hukunci cewa creatine "yana fi tasiri" a masu cin ganyayyaki fiye da masu cin nama ba. --- ## Yadda Aka Gudanar da Gwajin - **Masu shiga:** Maza da mata masu cin ganyayyaki, masu ƙoshin lafiya, shekaru 18‑45, jimillar 20. - **Rukuni:** Rukuni 10 (5 maza, 5 mata) suka samu creatine monohydrate; sauran 10 (5 maza, 5 mata) suka samu placebo. - **Kudade:** 0.1 g a kowane kilogram na nauyin jiki a kowace rana (misali, gram 7 ga wanda ke da kilo 70). - **Tsawon lokaci:** Mako 4, a kan tsarin abincin vegan mai adadin kalori daidai. - **Abubuwan da aka auna kafin da bayan gwaji:** yanayin jiki, *counter‑movement jump* (CMJ), gudu, *repeated jumps*, ƙarfin riƙe hannu, *isometric mid‑thigh pull* (IMTP), da alamu na ƙoda. --- ## Abubuwan da suka Inganta Mafi ƙarfi ci gaba ya zo a aikin fashe‑fashe na ƙafafu. Rukunin da aka ba da creatine ya ƙara ƙimar CMJ, tsayin tsalle, da lokacin tashi a lokutan tsalle‑tsalle da aka maimaita (p < 0.001‑0.04). Yanayin jiki ma ya bambanta idan aka kwatanta da placebo (p < 0.05): - **Matsakaicin sinadarin tsoka:** +0.3 kg - **Jimillar ruwan jiki:** +1.4 kg - **BMI:** +0.3 kg/m² - **Kitse a jiki:** ‑1.4 kg Serum creatine da creatinine suma sun ƙaru sosai a rukunin creatine (p < 0.001‑0.03), alamar da ake sa ran lokacin da ake ƙara creatine. --- ## Abubuwan da Ba su Canza ba A cikin gwaje‑gwajen ƙarfi, **gudu, riƙe hannun, da IMTP ba su sami wani bambanci ba**. Marubutan sun kammala da cewa creatine "yana ƙara ƙarfin fashe‑fashe na ƙafafu", amma gwaje‑gwajen ƙarfi da aka bayar ba su tabbatar da hakan ba. Saƙon da ya fi dacewa shi ne: creatine na inganta fashe‑fashe da ya dogara da tsalle, ba sai ya haifar da ƙaruwa a gudu ko ƙarfi ba. --- ## Game da +1.4 kg na Ruwan Jiki Creatine yana jawo ruwa zuwa cikin sel na tsoka, don haka ƙaruwa da kilogram 1.4 a ruwan jiki ya yi daidai da wannan. Sinadarin tsoka ya ƙaru da kilogram 0.3 kacal, ma’ana mafi yawan ƙaruwa a jimillar nauyi ruwan ne, ba ƙarin tsoka ba. Rashin kitse da kilogram 1.4 da aka gani yana da ban sha'awa, amma a cikin mutane 20 da suka yi gwajin tsawon makonni huɗu, ya kamata a ɗauke shi a matsayin alamar farko, ba alƙawarin rage kitse ba. Takaitaccen ba ya ba da dalilin da ya haifar da wannan ragin kitse. --- ## Me Ya Faru da Koda? Alamomin ƙoda an auna su, kuma serum creatinine ya tashi a rukunin creatine — alamar da ake tsammani idan creatine ya ƙaru. Creatinine ba alamar lalacewar ƙoda ba ne, sai dai samfurin da ke fitowa daga rushewar creatine a jiki. Sai dai takaitaccen ba ya ba da cikakken rahoto kan aikin ƙoda, kuma marubutan sun ba da shawarar a yi ƙarin bincike na dogon lokaci don tantance tsaro da inganci a wannan ɓangare. Mako huɗu ba su isa ba don tantance tasirin dogon lokaci. --- ## Ƙuntatawa da Dole a San Su 1. **Ƙaramin misali:** Mutane 10 a kowane rukuni ba su ba da damar fitar da sakamako ga al’umma da yawa ba, kuma yana ƙara yiwuwar samun sakamako maras ƙarfi. 2. **Ƙarancin lokaci:** Mako huɗu kawai ba su ba da haske kan tasirin dogon lokaci ba. 3. **Babu ƙungiyar masu cin nama:** Ra'ayin "masu cin ganyayyaki su fi amfana" ba a gwada shi a wannan bincike ba. 4. **Bambancin sakamakon aiki:** An samu ci gaba a tsalle‑tsalle, amma ba a gani a gudu, riƙe hannu ko IMTP ba. 5. **Rikicin sha'awa:** Wani marubuci ya bayyana cewa ya karɓi kuɗin shawara daga Danone da Foods For Tomorrow, wani kuma mashawarcin kimiyya ga kamfanin gummies na creatine ya karɓi samfur kyauta. Duk da haka gwajin ya kasance ɓoye‑uku da placebo‑controlled. --- ## Amfani a Aiki - **Kudade:** 0.1 g/kg/rana – misali gram 7 ga mutum mai kilo 70, ko gram 8 ga mai kilo 80. An ba shi a kowace rana ba tare da wani lodin farko ba. - **Lokaci:** Takaitaccen ba ya fayyace ko akwai wani lokaci na musamman da ya fi tasiri. Hanya mafi sauƙi ita ce a sha a kowace rana, har da ranakun hutu, don ci gaba da cika ajiyar creatine. - **Samfur:** Creatine monohydrate yawanci ana sarrafa shi da sinadarai, don haka ya dace da masu cin ganyayyaki. Ka tabbata kwandunan ba su ƙunshi gelatin ba, kuma ka zaɓi samfurin da aka gwada ta ɓangare na uku. - **Wanda zai amfana:** Masu cin ganyayyaki masu aiki waɗanda ke son ƙara ƙarfi a tsalle, plyometrics, ko wasu ayyukan fashe‑fashe na ƙafafu, da kuma waɗanda ke son cike gibi da creatine da ba su samu a abincinsu. - **Wanda ya kamata ya guje shi ko ya tuntuɓi likita da farko:** Mutanen da ke da matsalar ƙoda ko cutar ƙoda, masu shan magungunan da ke tasiri kan ƙoda, mata masu juna biyu ko masu shayarwa, da duk wanda ke da wata cuta. Hakanan a san cewa ƙaruwa da ruwa a jiki na faruwa da wuri, kuma zai iya shafar masu gasa a rukunin nauyi. - **Sa ran abin da zai faru:** Ka sa ran ƙaramin ci gaba a fashe‑fashe na ƙafafu, ba tabbacin ƙaruwa a gudu ko ƙarfin duka ba. --- ## Gabaɗaya Sakamako A cikin masu cin ganyayyaki 20 masu aiki, makonni huɗu na creatine monohydrate sun inganta aikin tsalle da sauyin yanayin jiki, ba tare da wani tasiri a kan gudu, riƙe hannun ko IMTP ba. Wannan yana nuna alamar farko mai kyau ga 'yan wasa masu bin abincin tsirrai, amma ba hujja ce da ke tabbatar da fa’ida ta musamman ga masu cin ganyayyaki ba. Ana buƙatar gwaje‑gwajen manya‑manya, masu dogon lokaci, tare da kwatanta masu cin nama da auna matakin creatine a tsokoki don ƙara haske.

Paraxanthine da Caffeine: Haɗin da Ya Yi Nasara, da Mai Ceton Barci

Dr. Gymbro — Sat, 31 Oct 2026 08:08:05 GMT

# Paraxanthine da Caffeine: Haɗin da Ya Yi Nasara, da Mai Ceton Barci **Paraxanthine**, babban metabolite na caffeine, an gwada shi kai tsaye da caffeine a kan maza 14 masu horon rowing. Haɗin 200 mg na kowannensu ya doke placebo a tseren mita 2000, amma tasirinsa ƙanana ne (d = 0.30). Babu ɗayan sinadaran da ya nuna ƙaruwa a aikin su kai kaɗai. Paraxanthine kaɗai, duk da haka, ya fi daɗaɗɗa ga barcin da ake samu bayan horo. Ga lambobin, iyakoki, da waɗanda za su iya amfana da wannan. ## Menene Paraxanthine, Kuma Me Ya Sa Ya Mahimmanci? Lokacin da ka sha kofi, hanta na sauya yawancin caffeine zuwa paraxanthine. Wannan shine babban metabolite, kuma ana tunanin yana ba da gudunmawa ga tasirin ƙarfafa da kake ji. Ana kuma sayar da shi a matsayin kari, wadda ake tallatawa a matsayin "mai laushi" ga caffeine. Tallan ba ya bi da hujjojin kimiyya da suka dace. Masu binciken da suka jagoranci aikin, Bingol Diedhiou da tawagarsa, sun nuna cewa ba a tantance tasirin paraxanthine a kan aikin motsa jiki da barci a cikin ‘yan wasa ba yadda ya kamata. Wannan shine gwaji na farko da ke ƙoƙarin cike wannan gibi. ## Yadda Gwajin Ya Gudana Gwajin an tsara shi ne a matsayin **randomized, double‑blind, crossover** – tsarin da ke ba da ƙarfi a binciken ƙananan ƙungiyoyi, tunda kowanne ɗan wasa ya zama kansa a matsayin maganin kansa. - **Masu shiga:** maza 14 masu horon rowing a matakin jami’a, matsakaicin shekaru 21.6 ± 1.9, da kusan shekaru 2.2 ± 1 na ƙwarewa a wasan. - **Gwaji:** tseren mita 2000 a kan ergometer. - **Yanayi huɗu:** caffeine + paraxanthine, caffeine + placebo, paraxanthine + placebo, da placebo kaɗai. An ba da kowane sinadari 200 mg. - **Abubuwan da aka auna:** lokacin ƙarewa, matsakaicin ƙarfin aiki, yawan bugun zuciya, da ƙimar barci da gajiya a ranar horon. - **Bincike:** repeated‑measures ANOVA tare da Bonferroni post‑hoc tests. ## Sakamakon Babba: Haɗin Ya Yi Nasara Idan aka kwatanta da placebo, haɗin 200 mg caffeine + 200 mg paraxanthine ya haifar da saurin kammala tseren mita 2000 tare da ƙarfin matsakaici mafi girma (p = 0.044; Cohen’s d = 0.30). Wannan sakamakon na da ma’ana ta ƙididdiga, amma ba zai juya wasan ba – d = 0.30 ƙanana ne. Ba a bayyana adadin dakikokin da aka ƙara ba, don haka kada ka ɗauki wannan a matsayin tabbacin ƙara lokaci ga ka. ## Abin Mamaki: Babu Sinadari da Ya Nuna Nasara Da Kansa Wannan shi ne ɓangaren da jaridu ke yawan watsawa. Caffeine kaɗai da paraxanthine kaɗai **ba su nuna hujjar ingantaccen ƙara aiki** a wannan samfurin. Sakamakon ya kusanto placebo, amma ba shi da ƙarfi da zai sa a kira su nasara. Masu binciken sun kammala da cewa paraxanthine kaɗai bai ba da ƙwarewar ergogenic a 200 mg ba. Haɗin ne ya fito fili. Tunda ‘yan wasa 14 ne kawai, ƙila ƙididdiga ba su da ƙarfin da zai gano tasiri ƙanana daga kowane sinadari. “Ba mu da muhimmanci” ba yana nufin “ba ya aiki”. ## Juyin Barci Yanayin da ke ɗauke da caffeine ya haifar da raɗaɗi a barci. Paraxanthine kaɗai ya nuna sakamakon da ya fi alheri a bangaren barci. Masu binciken sun bayyana paraxanthine a matsayin **ƙarin jurewa (tolerance) fiye da ƙara aiki**. Wannan na da muhimmanci ga masu horo da dare, inda stimulant na gaba zai iya rushe barcin da ke biyo baya. Gwajin bai nuna cewa paraxanthine yana inganta barci ba; ya nuna kawai ba ya cutar da barci kamar yadda caffeine ke yi. ## Iyakoki Da Ba Za a Iya Watsarwa Ba - **Ƙananan samfur:** mutane 14, duk maza matasa masu horon rowing. Ba lallai sakamakon ya shafi mata, tsofaffi, ko wasanni daban‑daban ba. - **Tasiri ƙanana:** d = 0.30 ƙanana ne, p = 0.044 yana kan iyaka. - **Kashi na sinadari ɗaya ba su da muhimmanci:** babu hujja a kan ko ɗayan zai yi aiki shi kaɗai a wannan kima. - **Matsayin barci:** ba a yi amfani da na’urorin auna ainihin barci kamar polysomnography ba, don haka ba a tantance ainihin tsarin barci ba. - **Kima ɗaya kawai:** masu bincike sun bukaci ƙarin gwaje‑gwaje na dose‑response. - **Tsawon lokaci ƙanƙanta:** ba a tattauna amfanin dogon lokaci ko tsaron lafiya ba. Masu binciken sun bayyana babu wani rikicin sha’awa (adverse events). ## Abubuwan Da Za a Iya Amfani Da Su A Aiki **Kima:** Gwajin ya yi amfani da 200 mg na kowane sinadari. Kada ka ɗauki wannan a matsayin shawarar ƙara fiye da abin da kake sha yanzu. Haɗa 200 mg caffeine da 200 mg paraxanthine na ƙara yawan stimulant, don haka ka tabbatar da juriya da kake da shi kafin ka yi amfani. **Lokaci:** Takaitaccen labarin bai fayyace lokacin da ake ba da maganin ba kafin motsa jiki, don haka ka bi umarnin samfur kuma ka gwada a horo, ba a ranar gasar ba. Idan kana horo da daddare, ka tuna cewa paraxanthine kaɗai yana ba da fifiko a bangaren barci fiye da waɗanda ke ɗauke da caffeine. **Wadanda Zasu Amfana:** - ‘Yan wasa da ke horo da yamma kuma suke son rage tasirin caffeine a barci. - Mutanen da ke da hauhawar jin caffeine sosai (sensitivity) kuma ke samun jijjiga ko barci mara kyau daga kima na al’ada. - ‘Yan wasa masu jurewa dogon lokaci da ke son gwada haɗin, muddin sun fahimci cewa hujja na kan farawa. **Wadanda Ya Kamata Su Guje Ko Su Yi Hankali:** - Mutanen da ke da cutar zuciya, hawan jini mai ƙarfi, damuwa, ko ciki, sai likita ya amince. - Mutanen da ke riga suna amfani da sinadaran stimulant da dama. - Duk wanda ke tsammanin samun babban ƙara a aiki; tasirin nan ya kasance ƙanana. ## Kammalawa Karanta sakamakon a matsayin rabo biyu. Caffeine da paraxanthine suna ba da mafi kyawun aikin rowing idan aka kwatanta da placebo, yayin da paraxanthine kaɗai ya nuna zaɓi mafi alheri ga barci. Babu sinadari guda ɗaya da ya tabbatar da ƙara aiki a kan kansa. Wannan jagora ne mai alƙawari, ba amsa ta ƙarshe ba, don haka ana buƙatar manyan gwaje‑gwaje da ke bin diddigin barci na zahiri.

Ruwan Ketone a Zafi: Ƙara Ƙarfi da Inganta Kwarewa?

Dr. Gymbro — Fri, 30 Oct 2026 08:14:46 GMT

# Ruwan Ketone a Zafi: Ƙara Ƙarfi da Inganta Kwarewa? **Taƙaitaccen Bayani:** Ruwan ketone ana ɗauka a matsayin abincin da ke ƙone kitse, amma wani gwaji a yanayin zafi ya nuna zai iya ƙara wa jiki juriya da ƙarfafa tunani. A maza 17 da suka yi horon guje‑guje, ketone monoester da caffeine sun tsawaita lokacin gajiya zuwa minti **8.9** idan aka kwatanta da minti **7.0** a lokacin da aka sha carbohydrate da caffeine, bayan minti 90 na treadmill a 34 °C. Aikin tunani a gwajin **1‑back** ma ya inganta, yayin da bugun zuciya da zafin jiki ba su nuna bambanci mai ma’ana ba. A gefe guda, a gwajin **2‑back**, lokutan amsawa da aikin “hit‑and‑avoid” ba su nuna fa’ida ba. Gwajin ƙarami ne, maza kawai, kuma an yi shi a zaman guda ɗaya. Ga abin da bayanan ke nuna, da abin da ba su nuna ba. --- ## Menene Masu Binciken Suka Yi? Wata ƙungiya da **Lints** da **Arent** ke jagoranta a Jami’ar South Carolina ta gwada maza 17 masu horon guje‑guje (shekaru 23.8 a matsakaici, VO₂max **58.6 ml/kg/min**). Tsarin gwajin ya kasance mai ƙyalli‑ƙyalli kuma ba tare da sani ba, don haka kowane mahalarta ya ji gwaji a yanayi biyu: **ketone + caffeine** da **carbohydrate + caffeine**. A kowanne zaman, ‘yan wasa sun sha **4 mg/kg** na caffeine tare da ɗayan abubuwan biyu: - **KET:** ketone monoester, (R)-3‑hydroxybutyl‑(R)-3‑hydroxybutyrate. - **CHO:** carbohydrate control – **Cluster Dextrin**. Bayan haka, sun yi minti 90 na treadmill a 34 °C da 45 % yanayin ɗumi, sannan suka ci gaba da gwajin ƙarfin lokaci‑zuwa‑gajiya (**TTE**) mai ƙarfi. Manufar shi ne tantance yadda sojoji da ‘yan wasan ƙwararru ke iya kasancewa masu faɗakarwa da ƙarfi a yanayi mai zafi, inda jini zuwa kwakwalwa, samun man fetur, da juriya ga zafi ke raguwa. --- ## Abinda aka Samu: Kusan Mintuna Biyu na Ƙara a Gajiya Lokacin gajiya ya tsawaita tare da ketone: **8.9 ± 4.6** minti idan aka kwatanta da **7.0 ± 2.1** minti (*p* = 0.04). Wannan ya ninka minti **1.9**, wato kusan **¼** na ƙarin lokacin a ƙarshen taron zafi. A irin wannan gwaji, bambancin minti biyu na da ma’ana ga ƙarshe‑ƙarfi ko tsere‑zuwa‑gama. Ko da yake ƙimar *p* ta ƙasa da 0.05, bambancin da aka samu a cikin ƙungiyar ketone ya bambanta sosai (daidaiton **± 4.6** minti), ma’ana mutane daban‑daban sun amsa daban‑daban. Don haka, a kalla ketone na iya haifar da ƙaruwa, amma ba tabbataccen sakamako ba ne ga kowa. --- ## Sakamakon Kwarewar Ƙwaƙwalwa: Inganta 1‑Back, Ba Duka Ba A gwajin tunani, ketone ya haifar da: - **Ingantaccen sakamako a 1‑back gaba ɗaya:** **+2.8 %** (*p* = 0.001). - **Ingantaccen sakamako a 1‑back na manufa:** **+8.9 %** (*p* < 0.001). - **Kara bambancin manufa (d’):** **+0.3** (*p* = 0.001). Wadannan canje‑canje sun kasance a duk lokacin da aka auna. Sai dai ba a sami tasiri a gwajin **2‑back** mai ƙalubale, a lokutan amsawa na **Dynavision**, ko a aikin “hit‑and‑avoid”, inda babu bambanci tsakanin yanayi biyu. Don haka, ketone ba ya ƙara wa mahalarta kwarewar tunani a kowane fanni, sai ga wasu ayyuka na ƙwaƙwalwa da ke buƙatar saurin tunani. --- ## Bayanin Metabolism Bayanan jini sun nuna ketone na yin abin da ake tsammani. **Beta‑hydroxybutyrate (BHB)** ya tashi daga **1.7 mmol/L** a tsakiyar aikin zuwa **3.5 mmol/L** bayan kammala (*p* < 0.001). A lokaci guda, **glukos** a jini ya ragu, daga **14.7 mg/dL** a tsakiyar aikin zuwa **27.6 mg/dL** bayan aiki (*p* < 0.001). Wannan yana nuni da cewa an sami ingantaccen amfani da ketone ko da glucose ya ƙasa a jini – wani yanayi mai ban sha’awa, domin a mafi yawan lokuta ana ɗaukar carbohydrate a matsayin abincin da ya fi dacewa da ƙoƙarin ƙarfin jiki. --- ## Abin Da Ba Ya Canjawa: Bugun Zuciya da Zafin Jiki Masu binciken sun jaddada abubuwan da ketone ba su yi ba. Matsakaicin bugun zuciya ya nuna yanayin **lokaci** (ya ragu a zagaye na minti 45 na farko), amma ba ya nuna **yanayi** (*p* = 0.453). Bugun zuciya mafi girma a gwajin TTE bai bambanta ba (*p* = 0.112). Zafin jiki na ciki ya tashi da lokaci a duka yanayi biyu, amma bambancin ba shi da ma’ana (*p* = 0.065). Ko da yake ƙimar *p* na zafin jiki ta kusan iyaka, gwaji mafi girma zai iya fayyace ko akwai wani tasiri na ainihi. A halin yanzu, ketone ba su ƙara wa zuciya ko zafin jiki wani ƙarin matsi ba, kuma ƙarin aikin da aka samu ba su zo da ƙarin zafi ba. --- ## Iyakoki Da Ya Kamata Ka Sani - **Ƙaramin yawan mahalarta:** mutane **17** kawai. - **Maza kawai:** matasa maza masu horon guje‑guje; ba a gwada mata, tsofaffi ko marasa horo ba. - **Zama guda ɗaya a kowanne yanayi:** babu maimaituwar gwaji, don haka ba a san ko sakamakon zai maimaitu ba. - **Caffeine a duka rukuni:** an kwatanta **ketone + caffeine** da **carbohydrate + caffeine**; ba a san tasirin ketone ba tare da caffeine ba. - **Sakamakon ƙwaƙwalwa marasa daidaito:** fa’ida ta bayyana a **1‑back** kawai, ba a **2‑back**, lokutan amsawa, ko “hit‑and‑avoid”. - **Bambancin amsawa a TTE:** yawan bambanci a ƙungiyar ketone yana nuna cewa mutane na amsa daban‑daban. Masu binciken sun bayyana cewa babu rikice‑rikice na ƙididdiga (no statistical interaction). --- ## Abubuwan Aiki Da Za Su Taimaka **Matsaka:** Takaitaccen bayanin ya fayyace caffeine **4 mg/kg** a duka yanayi, amma ba ya ba da adadin ketone monoester. Don haka, dole ne a duba takardar asali (PMCID: PMC13378723) don cikakken bayanin ƙayyadaddun ƙima. **Lokaci:** Takaitaccen ba ya bayyana ainihin lokacin shan ketone. An sha ketone tare da caffeine kafin zaman minti 90 na zafi da ƙoƙarin ƙarshe. **Wanda zai amfana:** ‘Yan wasa masu horo da ma’aikatan soja da ke aiki a yanayin zafi, waɗanda ke son kiyaye ƙwaƙwalwar aiki da ƙarfin ƙarshe. A ɗauke shi a matsayin ƙari da za a gwada a horo, ba a ranar gasar ba. **Wanda ya kamata ya guje ko ya yi hankali:** - Mutanen da ke da rashin jituwa da caffeine, domin **4 mg/kg** babban adadi ne. - Kowa da ke da wata cuta, mace mai juna biyu, ko wanda ke shan magunguna masu tasiri a kan glucose. Nemi shawarar likita, musamman saboda ketone na rage glucose a wannan gwaji. - Masu neman fa’ida a duk fannoni na tunani; bayanan ba su goyi bayan hakan ba. - ‘Yan wasa da ke fama da matsalar ciki; ketone na iya haifar da matsaloli a hanji, ko da yake takaitaccen ba ya tabo su. --- ## Gabaɗaya A cikin wannan ƙananan gwaji mai sarrafa sosai, **ketone monoester + caffeine** ya fi **carbohydrate + caffeine** wajen tsawaita lokacin gajiya da inganta aikin ƙwaƙwalwa guda ɗaya bayan dogon aiki a zafi, ba tare da bambanci a bugun zuciya ko zafin jiki ba. Alama ce mai ban sha’awa ga ayyukan a yanayi mai zafi, amma yana buƙatar ƙara gwaje‑gwaje a ƙungiyoyi masu yawa, tare da haɗa mata da mutane masu ƙarni daban‑daban, kafin a ɗauke shi a matsayin hujja tabbatacciya.

SlimSEB: Haɗin Probiotic da Enzyme Ya Lashe Placebo—Amma Akwai Matsala

Dr. Gymbro — Fri, 30 Oct 2026 08:13:51 GMT

# SlimSEB: Haɗin Probiotic da Enzyme Ya Lashe Placebo—Amma Akwai Matsala **Takaitawa:** Wani haɗin probiotic, enzyme da ganyen shuke‑shuke da ake kira **SlimSEB** ya doke placebo a gwajin bazuwar makonni 12 da ya kunshi mutane 87 da ke cikin haɗarin cutar sukari ta nau’i II. Mutanen da suka yi kiba sun rasa kilogram 4.5 fiye da placebo, suka rage da'irar ƙirjinsu da santimita 11, yayin da kolesterol da alamun rashin amincewar insulin ma suka inganta. Sai dai samfurin an samar da shi daga kamfanin da ya ƙirƙira shi, gwajin ƙarami ne kuma gajere, kuma haɗin sinadarai da yawa yana nufin babu wani abu guda ɗaya da za a iya ɗauka a matsayin babban dalilin sakamakon. Ga abin da bayanan suka nuna, yadda yake kwatanta da magungunan GLP‑1, da kuma abin da ya kamata mu yi la’akari da shi sau biyu. ## Menene Gwajin Ya Gano Da Gaske? Takardar da aka wallafa a *Frontiers in Nutrition* a shekarar 2026 (Rathi et al., DOI 10.3389/fnut.2026.1956865) ta tantance kari mai suna **SlimSEB**. Wannan haɗin ya ƙunshi: - **Probiotics** – 1.5 biliyan CFU - **Enzymes** na narkewa, ciki har da **SucroSEB** – da masana suka ce yana canza sukari na abinci zuwa prebiotic fiber - **Furen mulberry** - **Green tea** - **Cinnamon** (kirfa) da aka niƙa - **Chromium picolinate** Tsarin gwajin ya kasance: gaba‑gaba, bazuwar, biyu‑mai‑shiru, rukuni‑mai‑daidai, tare da placebo a matsayin ma’auni. An ba mutane 87 da ke cikin haɗarin cutar sukari ta nau’i II SlimSEB ko placebo a kowace rana tsawon kwanaki 84 (makonni 12). Daga ciki, 43 an ayyana su a matsayin masu nauyi (BMI ≥ 25) kuma 44 a matsayin masu kiba (BMI ≥ 30). Gwajin ya samu rijista a matsayin **CTRI/2023/11/059798**. ## Sakamakon Da Ya Fi Fice Idan aka kwatanta da placebo, SlimSEB ya haifar da raguwar da ta zama **statistically significant**: - **Matsayin nauyi:** -2.60 kg a rukuni masu nauyi (p = 0.0045) da -4.51 kg a rukuni masu kiba (p < 0.0001) - **BMI:** -0.92 da -1.80 kg/m² - **Da'irar ƙirji:** -3.86 cm a masu nauyi (p = 0.0169) da -11.03 cm a masu kiba (p = 0.0014) Raguwar da'irar ƙirji a rukuni masu kiba – santimita 11 cikin makonni 12 – tana da tasiri sosai, amma dole ne a yi hankali wajen fassara wannan sakamako. ## Canjin Alamun Metabolism Takardar ta kuma nuna ci gaba a alamun sukari a jini: - **Fasting plasma glucose** ya sauka 0.45 mmol/L a duka rukunan - **HbA1c** ya sauka 0.65 % da 0.67 % - **HOMA‑IR** (kimar rashin amincewar insulin) ya sauka 0.47 da 0.69, wato raguwar kashi 21.5 % a masu nauyi da 24.8 % a masu kiba, alhali a placebo raguwar kawai kashi 9.0 % da 4.3 % bi da bi. **Kolesterol** ne ya nuna bambanci mafi girma: - **Total cholesterol** ya ragu 14.21 % da 16 % da SlimSEB, yayin da a placebo ya ragu 3.85 % a masu nauyi amma ya tashi 8.65 % a masu kiba. - **LDL‑C** ya ragu 11.61 % da 14.63 % da SlimSEB, alhali a placebo ya ragu 0.88 % a masu nauyi amma ya tashi 13.39 % a masu kiba. - **C‑reactive protein (CRP)**, alamar kumburi, ya ragu 13.6 % da 17.3 %, amma bambancin ya kasance ƙarfi ne kawai a rukuni masu kiba. Lura: a rukuni na placebo, matakan lipids sun *tabarbare* a cikin masu kiba, wanda ya sa bambancin ya zama mafi girma fiye da yadda raguwar SlimSEB kadai zai nuna. ## Tsaro Da Rahusa An samu abubuwa 8 da suka faru a sauƙaƙe, babu ɗaya da aka danganta da samfurin, kuma ba a sami wani yanayi mai tsanani ba. Wannan alama ce ta kyau, amma gwajin mutane 87 na tsawon makonni 12 ba zai iya gano matsaloli masu tsanani ko na dogon lokaci ba. ## Ƙalubale Da Sauran Ƙuntatawa 1. **Zama tare da masana’anta.** SlimSEB an samar da shi daga **Specialty Enzymes and Probiotics (USA)** – kamfanin da ya ƙirƙira shi. Wannan na iya haifar da gurbata sakamakon, don haka ana bukatar gwaje‑gwajen da masu zaman kansu suka gudanar. 2. **Samfur ƙanana ne kuma a ƙasa guda.** Gwajin ya gudana a Indiya tare da mutum 87 kacal. Saboda haka ba lallai ne sakamakon ya shafi al'ummomi, abinci, ko yanayin rayuwa daban‑daban ba. 3. **Lokaci gajere.** Makonni 12 ba su ba da haske kan ko raguwar nauyi za ta ci gaba da kasancewa ko ko fa’idodin za su dawwama ba. 4. **Haɗin sinadarai da yawa.** Probiotics, enzymes, mulberry, green tea, cinnamon da chromium na ƙunshe a cikin samfur guda; babu wani abu ɗaya da za a iya ɗauka a matsayin babban dalilin tasirin. 5. **Ba a fayyace ƙimar ba.** Ba a bayar da cikakken adadin kowanne sinadari da ake shan kullum ba, don haka ba mu da isasshen bayani don tantance ingancin kowane ɓangare. ## Tasirin Raguwar Nauyi – Ta yaya yake kwatantawa? Raguwar nauyi tsakanin kilogram 2.6 zuwa 4.5 da aka samu bayan cire tasirin placebo ba ta kai matakin magungunan GLP‑1 ba. A gwajin **STEP 1**, **semaglutide** ya haifar da raguwar nauyi kusan **15 %** na nauyin jiki a tsawon makonni 68. SlimSEB bai kai wannan matakin ba, kuma yanzu ba mu da alamu da ke nuna zai iya maye gurbin waɗannan magunguna. Wataƙila ya zama ƙarin taimako ga waɗanda ke neman rage nauyi a mataki na farko. ## Yadda Za a Amfani Da Shi a Rayuwa **Adadin da lokacin amfani:** Gwajin ya ba da shawarar shan kari ɗaya a kowace rana tsawon kwanaki 84, amma ba a fayyace girman ƙwayar ba. Abu guda da muka tabbatar da shi shine **1.5 biliyan CFU** na probiotic. **Wanda zai amfana:** Shaidu sun shafi manya masu nauyi ko masu kiba da ke cikin haɗarin cutar sukari ta nau’i II. Ba su shafi masu cutar sukari ta tsananta, yara, ko masu nauyi kaɗan ba. **Wadanda ya kamata su guje ko su tuntuɓi likita kafin su fara (ba cikakken jerin daga wannan takarda ba):** - Mutanen da ke kan maganin sukari, saboda haɗin da ke iya rage matakan sukari. - Matan da ke cikin ciki ko masu shayarwa. - Mutanen da suke da raunin garkuwar jiki – probiotics na rayuwa na bukatar tsaro. - Wadanda ke da matsalar rashin jure caffeine ko abubuwan da ke cikin green tea. - Wadanda suke neman ragin nauyi mai tsanani kamar na GLP‑1. ## Kammalawa Sakamakon SlimSEB na da alƙawari, amma har yanzu a matakin farko ne, kuma an samo shi ne daga kamfanin da ya ƙirƙira samfurin. Abincin da ya fi inganci, motsa jiki, da barci na har yanzu su ne tubalan da suka fi tasiri. Gwaje‑gwajen da masu zaman kansu suka gudanar, tare da tsawon lokaci da yawan mahalarta, za su taimaka mana mu tantance ko wannan haɗin ya cancanci a saka shi a matsayin ƙarin hanya ga waɗanda ke neman rage kiba da inganta alamar metabolism.

Bitamin C Mai Araha da ke Taimakawa Ƙarfi a Ƙafafu Yayin Tsufa

Dr. Gymbro — Fri, 30 Oct 2026 08:12:55 GMT

# Kowa na taƙama da furotin da creatine don ƙara ƙarfi a tsufa. Wani sabon bincike daga Birtaniya ya nuna wani abu mai araha da ba shi da wata ƙima: matakin bitamin C a cikin jinin ku. A cikin sama da mutane 5,000 masu shekaru tsakanin 48 zuwa 92, waɗanda ke da "matsakaicin" bitamin C a plasma sun fi sauri tafiya da kuma tashi daga kujera da sauri fiye da waɗanda ke da ƙananan matakai. Wannan dangantaka ce, ba hujja ba, amma yana da amfani a san adadin ku. ## Abin da masu binciken suka yi a zahiri Takardar da aka wallafa a *Calcified Tissue International* ta Scott, Cameron, Yates da Welch ta yi nazari kan bayanai daga rukunin EPIC‑Norfolk. Wannan babbar binciken jama'a na Birtaniya ne da ke tattara mutane masu shekaru 48 zuwa 92. Tsarin binciken **cross‑sectional** ne, wato hoto guda a wani lokaci. Ba ya bi diddigin mutane a gaba don ganin wanene zai rasa ƙashi. Yawancin binciken da suka gabata kan bitamin C da ƙashi sun dogara ne kan abin da mutane *suka ce sun ci*. Wannan ƙungiya ta kuma yi amfani da **plasma vitamin C**, ma'aunin jini na ainihi. Sun raba mahalarta zuwa rukuni uku: - **Low (ƙasa):** ƙasa da 25 µmol/L - **Suboptimal (ba a kai ba):** 25 zuwa ƙasa da 50 µmol/L - **Optimal (mafi kyau):** 50 µmol/L ko sama Sa’an nan suka kwatanta ƙarfi na riƙon hannu (da aka daidaita da tsawo), saurin tafiya, da lokacin da aka ɗauka don kammala tafkin kujeru biyar. Sun daidaita da yanayin rayuwa, na biolojikal, na likita da na abinci. ## Lambobin da suka fito a kan taken **Mata** da ke da plasma vitamin C mai kyau idan aka kwatanta da ƙasa sun samu: - Ƙarin ƙarfi na riƙon hannu da aka daidaita da tsawo (+0.54 kg/m², p = 0.009) - Saurewar tafiya mafi girma (+0.11 m/s, p < 0.001) - Lokaci na tafkin kujeru biyar mafi sauri (kimanin 1.03 s ƙasa, p = 0.028) **Maza** da ke da plasma vitamin C mai kyau idan aka kwatanta da ƙasa sun samu: - Saurewar tafiya mafi girma (+0.05 m/s, p = 0.01) - Lokaci na tafkin kujeru biyar mafi sauri (kimanin 0.71 s ƙasa, p = 0.026) Abin lura, maza ba su nuna **wani alaƙa da ƙarfi na riƙon hannu** ba a cikin binciken plasma. Don haka taken “ƙafafu masu ƙarfi” ya fi dacewa ga jinsi biyu fiye da “komai ya ƙarfi”. ## Menene game da bitamin C daga abinci? Bayanan abincin ba su zama tsari ba. Wasu mata a cikin rukuni mafi yawan cin abinci sun fi waɗanda ke cin ƙasa. Kashi na 2 da 5 na alƙaluma (quintiles) sun samu sauri tafiya (+0.04 m/s), kuma kashi na 4 da 5 sun samu lokutan kujeru biyar masu sauri (kimanin 0.67 s da 0.57 s ƙasa). Ba a sami tsarin da ya tashi a tsaye ba da kowane mataki. A maza, masu binciken ba su sami **kowane alaƙa** ba game da vitamin C na abinci. Wannan bambanci tsakanin sakamakon tambayar abinci da na jini yana da mahimmanci. Matakan jini suna nuna adadin da jiki yake da shi a ainihi, yayin da tambayar abinci ke ba da kimanta kawai. Marubutan sun nuna wannan bambanci a matsayin dalilin da ya sa ya fi dacewa a duba *status* maimakon shan abinci kaɗai. ## Me yasa bitamin C zai iya tasiri ga tsoka? Bitamin C na da muhimmanci wajen samar da collagen, wadda ke riƙe da ƙwayoyin tsoka da hana su tsagewa. Hakanan yana cikin tsarin antioxidants na jiki, wanda ke da alaƙa da tsoka a shekarun baya. Wannan shi ne tushen kimiyya na ra'ayin cewa ƙarancin bitamin C zai iya kawo sarcopenia, wato asarar ƙashi da aikin tsoka da ke faruwa da tsufa. Wannan binciken ba ya gwada waɗannan hanyoyi, sai dai ya duba yadda matakin jini ke da alaƙa da gwaje‑gwajen aiki. ## Ƙuntatawa da ya kamata ku sani - **Binciken lura ne kuma cross‑sectional.** Ba zai iya nuna cewa bitamin C ne ya haifar da kyakkyawan aiki ba. Mutane masu lafiyar jiki na iya cin 'ya'yan itãcen marmari da kayan lambu da yawa, kuma plasma vitamin C zai iya zama alamar salon rayuwa mafi lafiya gaba ɗaya. Masu binciken sun daidaita da abubuwa da yawa, amma daidaitawa ba ta kawar da dukkan ƙalubale ba. - **Hanyar ba ta da tabbas.** Mutanen da ba su motsa yawa ko suke jin rauni na iya cin ƙarancin 'ya'yan itãce, wanda zai juyar da alamar. - **Babu gwajin ƙarin magani da aka yi.** Ba a ba kowa bitamin C ba a gwada shi sannan a auna sakamako. - **Tasirin ba shi da girma sosai** kuma ya bambanta tsakanin jinsi da irin sakamakon. Marubutan sun ce sakamakon na nuni da cewa plasma vitamin C mai kyau “na iya zama muhimmi” ga aikin jiki. Sun yi kira a fili ga nazarin dogon lokaci da gwaje‑gwajen shiga. ## Abubuwan da za a iya amfani da su **Manufa:** A wannan binciken, rukunin da ke da alaƙa da fa'ida shine plasma vitamin C na 50 µmol/L ko sama. Idan kana son sanin inda kake, ka tambayi likitanka ko gwajin plasma vitamin C ya dace da kai. **Matsakaicin kashi:** Binciken bai gwada kowane kashi ba, don haka babu ƙima na ƙarin magani da za a iya bayarwa daga gare shi. Abin da yake tallafawa shine ra'ayin cewa *matsayin jini* yana da muhimmanci. 'Ya'yan itãcen marmari da kayan lambu, ko kuma ƙarin magani, na iya zama hanyoyin zuwa ga wannan matakin, amma ana buƙatar gwaje‑gwaje don nuna ko ƙara matakin a jini zai inganta ƙarfi ko motsi. **Lokaci:** Ba a nazarce shi ba. Babu wani abu a nan da ke nuna cewa lokacin shan yana da tasiri. **Wanda zai fi amfana:** Manyan mutane a tsakiyar shekaru da kuma gaba, musamman waɗanda ba su cin 'ya'yan itãce da kayan lambu da yawa ba kuma ke damuwa da saurin tafiya, fita daga kujeru, ko sarcopenia. **Wanda zai yi hankali:** Kowa da ke tunanin ƙara ƙarin magani, musamman masu matsalar ƙoda ko tarihi na dutsen ƙoda, ko waɗanda ke shan magunguna akai‑akai. Waɗannan gargadi sun fito ne daga gwanintar likita gama gari ba daga wannan takarda ba, don haka ka tattauna shirin ƙarin magani da likita. **Abin da ba zai maye gurbin ba:** Horon dage‑dage da isasshen furotin har yanzu su ne manyan hanyoyin da aka tabbatar don kiyaye tsoka. Matsayin bitamin C, a mafi kyau, na iya zama ƙari mai tallafi kawai. ## Gaba ɗaya Sakamakon yana da sauƙi kuma mai ƙarfafa gwiwa: a babban rukunin Birtaniya, manyan manya da ke da plasma vitamin C mai kyau sun fi saurin motsi. Yana da arha a duba, kuma ga mafi yawan mutane, yana da araha a inganta ta hanyar abinci. Amma har sai gwaje‑gwajen da aka yi da tsari sun nuna cewa ƙara bitamin C zai inganta aikin tsoka, ka ɗauki wannan a matsayin alamar alƙaluma mai fata, ba umarni ba.

GAA: Ƙara Basirar Ƙwaƙwalwa? Sakamakon Gwaji na Makonni 6 Ya Bayyana

Dr. Gymbro — Fri, 30 Oct 2026 08:11:37 GMT

# GAA: Ƙara Basirar Ƙwaƙwalwa? Sakamakon Gwaji na Makonni 6 Ya Bayyana **GAA** (guanidinoacetic acid) aƙalla ana sayar da shi a matsayin ƙara basira, amma yanzu ya samu gwajin ɗan adam na farko da ya kai ga ƙarshe. A cikin wani gwaji mai ɗaukar **makonni 6**, an yi nazari a kan matasa **58** masu lafiya. An ga ɗan saurin amsawa a wasu lokuta da alamun saukaka damuwa, amma kusan dukkan sauran gwaje‑gwajen kwakwalwa ba su nuna tasiri ba. Alamar aminci ta yi kyau, amma gwajin ya ƙunshi mutane kaɗan, an yi shi a matsayin bincike na farko, kuma babu rukuni da ya karɓi **creatine** kaɗai. Ga abin da aka gano a zahiri, wanene zai iya amfana da shi, da dalilin da ya sa hukuncin ke da ruɗani. ## Menene GAA, kuma me ya sa ake yawaita yabansa? GAA shi ne ɗan matakin da ke cikin hanyar samar da **creatine** a jikinmu. A cikin ɓangaren gabatarwa na binciken an ambaci wasu karatu da suka nuna cewa GAA na iya ƙara yawan creatine a kwakwalwa fiye da **creatine monohydrate (CrM)**. Wannan ikirari ne da ke ƙarfafa talla a matsayin *brain booster*. Amma yana da mahimmanci a fahimci cewa ƙaruwa a matakin creatine ba lallai ne ya haifar da ƙarin tunani ba, kuma marubuta sun bayyana a sarari cewa tasirin sa a kan aikin kwakwalwa har yanzu ba a san shi ba. Wannan gwaji an shirya shi ne domin fara amsa wannan tambaya. ## Yadda aka gudanar da binciken Ƙungiyar masu bincike, ƙarƙashin jagorancin **Richard Kreider** a **Laboratory of Exercise & Sport Nutrition**, Jami'ar Texas A&M, ta shirya gwaji mai **randomized, double‑blind, parallel‑group**. An zaɓi mutane **58** masu lafiya (mata 33, matsakaicin shekaru 35.5). A tsawon makonni 6, mahalarta sun sha ɗayan ɗayan abubuwa uku: - **Placebo** – maltodextrin, sau biyu × 6 g a rana - **GAA** – sau biyu × 1 g a rana (jimlar 2 g) da kuma sau biyu × 5 g placebo - **GAA + creatine monohydrate** – 2 g GAA + sau biyu × 5 g CrM a rana (jimlar 10 g) Kafin da bayan ƙara, an ɗauki samfurin jini a zaman azumi, sannan an yi gwaje‑gwajen tunani da tambayoyi kan yanayin zuciya, damuwa, barci, da ingancin rayuwa. An riga an yi rijistar gwajin da lambar **ISRCTN68542582**. ## Sakamakon da ya fi jan hankali: saurin amsawa Abin da ya zamanto mafi burgewa shi ne **saurin amsawa**. GAA kadai ya nuna alamar haɓaka a gabaɗayan **reaction time** da kusan **242 ms**, amma bambancin ba shi da ƙarfi sosai (‑533 zuwa 50 ms, p = 0.10). A matsayin alamar kididdiga, wannan kawai alama ce, ba tabbacin tasiri ba. A nazarin **interaction effect** – wato bambanci tsakanin rukuni da lokaci idan aka kwatanta da placebo – an samu **tasiri mai mahimmanci** a kan gabaɗayan saurin amsawa (**‑330 ms**, p = 0.031) da kuma saurin amsawar “YES” (**‑290 ms**, p = 0.004). Wasu muhimman sassa biyu – **reaction time** da **YES accuracy** a kan *recalled‑correct* – sun kusan kai ga mahimmanci (p = 0.078 da p = 0.084). Marubuta sun kammala da cewa an ga ci gaba a ƙwaƙwalwar tuna labaran magana da saurin dawo da su. ## Kariya: yawancin gwaje‑gwajen ba su nuna wani tasiri ba A sauran gwaje‑gwajen ba a sami bambanci ba. Baya ga **Delayed Picture Recognition Task**, **Digit Vigilance Task**, **Corsi Block Task**, da **Stroop Color‑Word Task**, ba a ga wani tasiri na GAA ba. Wadannan gwaje‑gwajen suna auna ƙwaƙwalwar gani, kulawa mai ɗorewa, tunani sarari, da ikon sarrafa kansa. Marubuta sun amince da rashin daidaito a sakamakon idan aka kwatanta GAA da placebo kai tsaye. Saboda haka GAA ba ya ƙara basira a fannin tunani gabaɗaya; abin da ya faru shi ne ɗan tasiri a wasu gwaje‑gwajen saurin amsawa. ## Yanayin zuciya, damuwa, barci, da ingancin rayuwa Sakamakon na biyu ya kasance ɗan **mixed bag**, kuma mafi yawan su suna cikin “na kusan mahimmanci” (p tsakanin 0.05‑0.10): - **Motsi na jiki** – rukuni na GAA ya ba da rahoton ƙarin lokaci a motsa jiki idan aka kwatanta da placebo. - **Damuwa** – GAA ya rage darajar **Perceived Stress Scale** (p = 0.036) da kuma tunanin cewa matsaloli na ƙaruwa (p = 0.053). Marubuta sun ɗauki wannan a matsayin ƙaruwa a lafiyar tunani. - **Barci** – an ambaci “tasiri masu kyau da kuma waɗanda ka iya zama marasa so” a kan ingancin barci, ba tare da cikakken bayani ba. - **Ingancin rayuwa** – GAA ya rage gajiya (p = 0.068) kuma ya ba da ƙimar lafiyar rayuwa a matsayin “mai kyau” (p = 0.092). Rukuni na **GAA + CrM** ya ba da rahoton ƙarin matsaloli kamar ɓarnatar ƙafa (p = 0.053), amma kuma ya ba da ƙarin farin ciki a rayuwa (p = 0.081) da ƙasa da damuwa ko baƙin ciki (p = 0.066). A takaice, wasu ɗan ƙaramin nasara na bazuwar lokaci na iya fitowa, amma ba za a iya ɗaukar waɗannan sakamako na biyu a matsayin tabbatattu ba. ## Binciken aminci A bangaren aminci, gwajin bai nuna wata alamar cuta ba. Babu bambanci a cikin alamomin jini ko a cikin rahoton kurakurai da mahalarta suka bayar a tsakanin rukuni a tsawon makonni 6. ## Iyakoki da abubuwan da ya kamata a sani Wannan karamar kafa ce ta bincike. Da mutane **58** da aka raba zuwa rukuni uku, ƙarfin ƙididdiga ya kasance ƙanƙanta, kuma yawan gwaje‑gwajen da aka yi ya ƙara haɗarin samun sakamakon ƙarya. Wasu manyan sakamako dai alamu ne kawai. Mahalarta matasa ne masu lafiya da motsa jiki, don haka ba za a iya faɗi cewa sakamakon zai aiki ga tsofaffi, masu cutar tunani, ko marasa lafiya ba. Gwajin ya ɗauki makonni 6 kacal. Game da tallafi, an sami goyon bayan **WoodNext Foundation**, ƙungiya da ba ta sayar da kayan gina jiki ko creatine ba. Babban marubuci **Richard Kreider** ya dade yana binciken creatine kuma yana zama memba a **Scientific Advisory Board** na **AlzChem**, kamfanin da ke kera creatine monohydrate da GAA. Takardar ta sanar da wannan dangantaka, kuma an ce an samu cikakken bincike daga jami’an jami’a. Sai a lura da irin wannan yanayi. ## Abubuwan aiki na gaskiya - **Matsakaicin ƙima da aka gwada**: 2 g GAA a rana (ana raba zuwa guda biyu na 1 g), ko tare da 10 g creatine monohydrate (guda biyu na 5 g), tsawon makonni 6. Takaitaccen labari ba ya ba da shawarar tsawon lokacin amfani. - **Waɗanda za su iya sha'awa**: matasa masu lafiya da motsa jiki da ke son gwada sabbin ƙari, idan sun fahimci cewa shaida tana cikin matakin farko. - **Waɗanda ya kamata su guje ko su tuntuɓi likita**: ba a bayar da bayanai kan yara, mata masu ciki ko masu shayarwa, manya masu tsufa, ko masu cutar koda/wasu yanayi na lafiya ba; don haka ba a ba da izini ga waɗannan rukunin ba. Kowane mutum da ke ɗauke da wasu magunguna ko yanayi na lafiya ya kamata ya tuntuɓi likita kafin ya fara amfani da GAA. - **Saitin tsammani**: kada a yi zato za a ga ƙaruwa a kowane fanni na tunani. Sakamakon na iya nuna ƙaramin haɓaka a saurin amsawa da wasu alamu na jin daɗi, ba a haɓaka ƙwaƙwalwar tuna ko mai da hankali ba. - **Zabin araha**: gwajin ba ya ba da damar kwatanta GAA da creatine monohydrate kai‑kawai, saboda babu rukuni na creatine kai‑kawai. Rukuni na **GAA + CrM** ya sanya wahala a bambanta tasirin kowanne sinadari. ## Hukunci GAA ba a tabbatar da shi a matsayin ƙara basira ba. Binciken ya nuna alamar yiwuwar haɓaka a saurin amsawa, ya tabbatar da aminci a gajeren lokaci, kuma ya ga wasu alamu na rage damuwa da ingancin rayuwa. Amma ya kuma nuna cewa mafi yawan gwaje‑gwajen tunani ba su motsa ba. Kamar yadda marubuta suka yi nuni, akwai buƙatar ƙarin bincike kafin a yanke hukunci ƙarshe. A halin yanzu, GAA ƙari ne da ake tunani da shi, ba cikakken **brain booster** ba.

Extract ɗin Girbin Kofi: 200 mg Caffeine Ya Ƙara Aikin Keke da Kashi 4.6 %

Dr. Gymbro — Fri, 30 Oct 2026 08:10:27 GMT

# Extract ɗin Girbin Kofi: 200 mg Caffeine Ya Ƙara Aikin Keke da Kashi 4.6 % Miligran **200 mg** na caffeine da aka samu daga cikakken extract ɗin ‘coffee cherry’ ya sa ‘yan wasan keke masu horo su ƙara aikin su a gwajin minti 15 mai ƙarfi. Sai dai ba a ga wannan extract ya sa tsokoki su sake cika glycogen da sauri ba. Wannan sakamakon ya fito ne daga sabon gwaji da aka gudanar a mujallar *Journal of the International Society of Sports Nutrition* (Pavis da abokan aiki, 2026), kuma yana da amfani ga masu neman sabon “superfruit” na pre‑workout da kuma ga waɗanda suka ji labarin cewa coffee cherry na taimakawa wajen cika glycogen. ## Menene Coffee Cherry Extract a Gaskiya? “Coffee bean” ita ce ƙwaƙwalwar ‘seed’ na ‘fruit’. ‘Fruit’ ɗin da ke kewaye da ita, wato coffee cherry, a mafi yawan lokuta ana watsar da shi yayin sarrafa kofi. Extract da aka gwada a nan an samo shi daga cikakken *Coffea arabica* cherry, inda aka tsarkake shi don caffeine da polyphenols, ciki har da chlorogenic acids. Kowane ƙwaro ya ƙunshi **200 mg caffeine** da **15 mg polyphenols**. Wannan adadin caffeine ya kasance ƙasa da na yau‑da‑kullum a fannin gina jiki. Masu binciken suna son sanin ko samfurin da ke ɗauke da sinadarai da dama, wanda aka samo daga ‘whole‑fruit’, zai iya yin abubuwa biyu: **(i)** ƙara aikin jiki, da **(ii)** saurin sake cika glycogen a tsokoki. ## Yadda Aka Gudanar da Binciken Tsarin gwajin ya ƙunshi ƙarfi, amma ƙungiyar ‘participants’ ta kasance ƙanana. - **Tsari:** gwaji na **randomized, double‑blind, placebo‑controlled crossover** - **Masu halarta:** ‘trained cyclists’ 12 (maza 11, mace 1) da ke da V̇O₂max na **55 ± 2 mL·kg⁻¹·min⁻¹** - **Gwajin motsa jiki 1:** minti 30 a kan cycle ergometer a kimanin **79 % V̇O₂max**, sannan a bi da gwajin minti 15 na sauri (TT1) - **Sake dawowa:** an ba su ƙarin abinci mai gina jiki (1 g/kg nauyin jiki na carbohydrates) tare da ɗaukar ƙarin kwaya, sannan a gudanar da gwajin minti 15 na ƙarshe (TT2) a safiyar gobe - **Ma’auni:** samfurin jini a duk lokacin gwaji, da biopsies na tsoka bayan TT1 (0 h), sannan a sa’o’i 4 da 24 Saboda kowane ɗan ƙwallon ya sha ƙwaya biyu – ɗaya da extract, ɗaya da placebo – kowanne mutum ya kasance a matsayin kulawar kansa. Wannan shi ne babban ƙarfin gwajin a wannan ƙaramin ƙungiya. ## Sakamakon Babba: Ƙarin Aiki, Ƙarancin Jin Ƙoƙari Gwajin jini ya tabbatar cewa an shaƙa supplement ɗin. Matakan plasma na caffeine da chlorogenic acid sun tashi sosai idan aka kwatanta da placebo yayin motsa jiki da kuma dawowa (p < 0.001). Lambobin aikin sun bi sahu. A gwajin minti 15, ‘yan wasan keke sun samar da **4.6 % ± 1.5 %** ƙarin aikin jimla tare da extract: **3.14 ± 0.15 kJ/kg** vs. **3.02 ± 0.17 kJ/kg** a placebo. Girman tasiri (Hedge’s g) ya kai **0.8** (95 % CI 0.2 zuwa 1.4), wanda ke nuni da tasiri mai girma, duk da cewa fadin interval ɗin na nuna ƙuncin ƙididdiga saboda ƙaramin adadi. Banbancin ya kasance statistically significant (p < 0.05). Haka kuma, **perceived exertion** ya ragu a lokacin da ake yin aikin daidaito da extract – wato aikin da ya fi sauƙi a zuciya. Matsakaicin **respiratory exchange ratio** bai bambanta ba, don haka ba a sami alamar canjin hanyar amfani da makamashi ba. ## Gaskiyar Gaskiya: Babu Ƙara Saurin Cika Glycogen Rabin sauran zato bai cika ba. Glycogen a tsoka ya ƙaru sosai a duka rukuni biyu yayin dawowa, kamar yadda ake tsammani idan ‘yan wasa suka ci carbohydrates. Daga awa 0 zuwa 4, glycogen ya tashi da **64 ± 13 mmol/kg dw** a placebo, yayin da a extract ya tashi da **44 ± 10 mmol/kg dw**. Daga awa 4 zuwa 24, ƙaruwa ta kasance **53 ± 8** da **45 ± 10 mmol/kg dw** bi da bi. Marubutan sun bayyana cewa bambancin ba shi da ma’ana, kuma babu wani shaidar da ke nuna cewa extract ya hanzarta sake cika glycogen. A takaitaccen kalma, **caffeine alone** tare da carbohydrate na iya ƙara adadin glycogen a wasu bincike‑bincike, amma a wannan gwaji da aka yi da **1 g/kg carbohydrate**, ba a ga wani ƙarin tasiri ba. Hakanan takaitaccen (abstract) bai ba da sakamakon TT2 ba, don haka ba za mu iya cewa abin ya shafi aikin safiyar gobe ba. ## Me Ya Sa Ya Kamata Ka Yi Kulawa? - **Karamin samfur:** Mutane 12 ne kawai, mace ɗaya a ciki – wannan na rage yanda za a iya amfani da sakamakon ga al’umma. - **Babu rukuni na caffeine kai tsaye:** An kwatanta extract da placebo ne kawai, ba da caffeine na 200 mg ba. Don haka ba mu san ko ribar ta samo ne daga caffeine ne, polyphenols ne, ko haɗa su ba. - **Samfur guda, ƙima guda:** Sakamakon ya shafi wannan takamaiman extract ɗin, ba dukkan kayayyakin coffee‑fruit ba. - **Tallafin masana’anta:** An samu kuɗi daga FutureCeuticals, kuma ma’aikata uku na kamfanin sun kasance co‑authors. Marubutan daga Jami’ar Exeter sun ce sun ci gaba da cin gashin kansu a fassara sakamakon. Gwajin an riga aka yi rijista (NCT05404841), wanda ke da fa’ida. - **Gwajin ƙanƙara:** Gwajin minti 15 ba lallai ya wakilci tsere na sa’o’i da dama ko horon ƙarfi ba. ## Abubuwan Da Za Ka Iya Amfani Da Su - **Ƙwaro:** An gwada **200 mg caffeine** da **15 mg polyphenols** daga extract, an sha shi kafin motsa jiki. Wannan caffeine yana daidai da kusan kofin kofi biyu (musamman idan an yi kofi mai ƙarfi). - **Lokaci:** A wannan bincike, aka sha supplement ɗin **kafin** fara motsa jiki. Ba a fayyace ainihin lokacin da aka ɗauka ba, don haka a bi umarnin alamar kayayyaki da kuma abin da ya taɓa aiki a gare ku. - **Wanda zai fi amfana:** ’Yan wasa masu juriya da ke son ƙarin aiki da adadi ƙananan caffeine, ko wadanda ke son samfurin “whole‑fruit” maimakon ƙwayoyin caffeine kaɗai. Ya dace a gwada shi a horo, ba a ranar gasa ba. - **Wanda ya kamata ya guje shi:** Mutanen da ke da **caffeine‑sensitivity**, matsalolin damuwa, matsalolin barci, matsalolin bugun zuciya ko hawan jini, masu ciki, ko waɗanda ke horo a daren zafi su yi shawara da likita ko su guji. - **Abin da ba zai yi ba:** Kada ku yi tsammanin zai hanzarta cika glycogen. Don farfadowa da sauri, carbohydrates ne ke da muhimmanci, ba wannan extract ba. ## Takaitaccen Bayani A wannan gwajin crossover ƙanana, amma mai ƙarfi, **whole coffee cherry extract** da ke ɗauke da caffeine kaɗan ya ƙara aikin minti 15 na tseren keke da **4.6 %**, kuma ya rage jin ƙoƙari a yayin aikin daidaito. Da’awar "yana taimakawa cika glycogen" ba a samu goyon baya ba. Akwai buƙatar manyan gwaje‑gwaje da aka kwatanta da caffeine kaɗai don tantance ko fruit‑product na coffee cherry yana da wani fa’ida da caffeine ke rasa.

Vitamin D da Saurin Dawowar Ƙarfi a Maza Masu Cikakken Matakin Vitamin D

Dr. Gymbro — Thu, 29 Oct 2026 08:18:54 GMT

# Vitamin D da Saurin Dawowar Ƙarfi a Maza Masu Cikakken Matakin Vitamin D Maza da ke da matakin vitamin D na al'ada na iya dawo da ƙarfi cikin sauri bayan wani horo mai tsanani a ƙafafu idan suka sha **4000 IU** a kowace rana. A gwajin da aka gudanar tare da raba bazuwar da placebo, ƙarfin isometric ya ƙaru kusan **kashi 8 cikin ɗari** bayan awanni 24. Alamomin lalacewar tsoka kamar **ALT** da **AST** suma sun dan ragu. Sai dai abin mamaki, radadin ciwo ba ya raguwa kwata‑kwata. Ga abin da binciken ya nuna, iyakokinsa, da kuma wanene zai iya amfana da shi. ## Abin da Binciken Ya Nuna Da Gaske Binciken da **Tyler Barker** da abokansa suka jagoranta ya kasance gwaji na raba bazuwar da placebo. Sun zaɓi matasa maza masu lafiya, masu motsa jiki kaɗan, masu shekaru kusan **30**. “Motsa jiki kaɗan” an ayyana a nan a matsayin **aƙalla minti 30 na aikin jiki a rana uku a mako**. Wadannan ba manyan masu nauyi ba ne. A ƙungiyoyi biyu, an ba da placebo (n = 13) ko **4000 IU na cholecalciferol (vitamin D₃; n = 15)** a kowace rana tsawon **kwana 35**. Matakin serum **25‑hydroxyvitamin D** a farkon gwajin ya kasance kusan **30‑31 ng/mL** a duka ƙungiyoyin, wato matakin da ake ɗauka ya isa, don haka ba a yi gwaji a kan masu ƙarancin vitamin D ba. A ranar **28**, an zaɓi ƙafa ɗaya a bazuwar don a yi tsari mai haifar da lalacewa. An yi saituna **10** na tsalle‑tsalle (eccentric‑concentric) a kan horizontal **plyo‑press** da nauyin **75 %** na nauyin jiki, tare da hutu na **sakan 20** tsakanin saituna. Masana sun bi diddigin alamomin cikin jini, ƙarfin isometric na ƙafa ɗaya, da radadin ciwo nan da nan bayan horon, sannan a **awanni 24, 48, 72** da **168**. An kuma ɗauki samfurin jini bayan **sa’a 1**. ## Babban Sakamako: Karfi Ya Dawo Da Sauri Tsarin ƙara sinadarin ya ƙara matakin serum **25(OH)D** da kusan **kashi 70 %**. Muhimmin abu ga masu horo shi ne, ƙungiyar da ta sha vitamin D ta sami dawowar ƙarfin isometric mafi girma bayan lalacewar tsoka. Bambancin ya kai **kashi 8 %** a alamar **awanni 24** (P < 0.05). A matakin aiki, ƙungiyar da ta sha vitamin D ta sami ƙaramin ragin ƙarfin a ranar da ke biyo bayan horon mai tsanani. Ga duk wanda ke yin irin wannan horon akai‑akai, irin wannan bambanci na iya zama da tasiri. Binciken bai tantance ko wannan zai ci gaba da tasiri a dogon lokaci ba. ## Alamomin Lalacewar Tsoka Sun Ragu Masu binciken sun auna **alanine aminotransferase (ALT)** da **aspartate aminotransferase (AST)**. Waɗannan su ne enzymes da ke fitowa a jini idan an sami ɗan damuwa ko lalacewar tsoka. Vitamin D ya rage tashin su a mataki na farko da kuma a lokutan da aka auna (**awanni 48, 72 ko 168**, dangane da alamar). Wannan na nuni da ƙarancin lalacewar tsoka, ko kuma saurin gyarawa. Amma ALT da AST ba su keɓance ga tsoka ba; suna da alaƙa da aikin hanta, don haka ba su ba da cikakken hoton lalacewar tsoka ba. **Creatine kinase**, wani sanannen alamar lalacewar tsoka, ba a ambaci sakamakonsa a wannan rahoton ba. Don haka, a ɗauke wannan a matsayin goyon baya, ba hujja ba. ## Abin Da Ya Ba Da Darasi: Ciwo Bai Ragu Ba Wannan shi ne ɓangaren da ya hana labarin zama mu'ujiza. Vitamin D bai rage radadin ciwo ba (P > 0.05). Masu shan vitamin D sun ji kamar waɗanda ke shan placebo, ko da kuwa ƙarfin su ya dawo da sauri. Wannan ya dace da al'adar bincike a fannin dawowar lafiya: ciwo da asarar ƙarfi su ne abubuwa masu alaka amma ba a kan haka ba. Idan burinka shine “raguwa ciwo,” vitamin D ba ya cika wannan. Idan ka fi damuwa da samun ƙarfi da wuri, zai iya zama da amfani. ## Kuntatawa Da Ya Kamata Ka Sani - **Samfurin ƙanana:** Mutane **28** kacal, an raba su gidauniyar **13** da **15**. - **Maza kawai:** Ba za a iya amfani da sakamakon ga mata ba. - **Yanayin gwaji:** Tsarin **plyo‑press** na ƙafa ɗaya ba shi da kamanceceniya da horon ƙafa na yau da kullum ko na ƙungiyar wasanni. - **Alamomin kai tsaye:** ALT da AST ba su takamaiman ga tsoka ba. - **Lokaci kaɗan:** **Kwana 35** na ƙarin sinadari da yanayi ɗaya na lalacewar tsoka, ba tare da sakamakon dogon lokaci na ƙarfi ko girma ba. - **Matakin farawa:** Binciken bai yi magana kan masu ƙarancin vitamin D ba, duk da cewa marubuta sun bayyana amfanin a cikin waɗanda ke da isasshen matakin. Wannan gwaji ne guda ɗaya da ƙananan adadi, don haka yana ba da alamar da ake buƙata amma ba ya zama shawara ta ƙarshe. ## Abubuwan Da Za Ka Iya Aiwatarwa **Kudadi:** Binciken ya yi amfani da **4000 IU (100 µg)** na vitamin D₃ a kowace rana. Wannan yana kan iyakar da ake yarda da shi a matsayin amintacce ga manya, don haka ba ƙwaya babba ba, amma ba ƙanana ba. **Lokaci:** Masu halarta sun sha shi a kowace rana tsawon **kwana 35**, tare da horon lalacewa a rana 28. Takardar ba ta fayyace wani takamaiman lokaci na yini ba, amma tana nuna muhimmancin shan sinadarin akai‑akai a cikin makonni. Shan shi tare da abinci mai kitse na iya taimakawa, duk da cewa binciken bai gwada haka ba. **Wanda Zai Amfana:** Maza masu lafiya, masu isasshen matakin vitamin D, kuma da ke neman ƙarin hanya don dawo da ƙarfin isometric bayan horon eccentric mai tsanani. Mutanen da ke da ƙarancin ƙayyadaddun rana ko abinci mai ƙarancin vitamin D za su iya duba matakin su da farko. **Wanda Ya Kamata Ya Guje Shi:** Duk wanda ba ya son wuce **4000 IU** ba tare da shawarar likita ba, mutanen da ke da cutar kodan (renal disease), **hypercalcemia** ko **sarcoidosis**, waɗanda ke shan magunguna da ke hulɗa da vitamin D ko calcium, da mata masu juna biyu. Ka tambayi likita, ka yi gwajin **25(OH)D** kafin ka fara a wannan matakin. Hakanan ka guje shi idan babban burinka shine rage ciwo, tunda wannan bincike bai nuna tasiri a kan ciwo ba. ## Kammalawa A wannan ƙaramin gwajin raba bazuwar, **4000 IU** a rana na vitamin D₃ tsawon **kwana 35** ya ƙara matakin serum **25(OH)D** da **kashi 70 %**, ya inganta dawowar ƙarfin isometric bayan **awanni 24** da **kashi 8 %** (P < 0.05), kuma ya rage tashin **ALT/AST** a maza masu isasshen matakin. Bai rage radadin ciwo ba. Sakamakon yana da ban sha'awa kuma ya cancanci a ci gaba da bincike, amma yana buƙatar manyan gwaje‑gwaje da ƙarin rukuni‑rukuni da kuma dogon lokaci kafin a ɗaukaka shi a matsayin mafita ta dindindin ga dawowar lafiya.

Capsule na Cire Gwanda Ya Ɗaga VO₂max da 14.8% — Amma Akwai Babban Matsala

Dr. Gymbro — Thu, 29 Oct 2026 08:17:44 GMT

# Capsule na Cire Gwanda Ya Ɗaga VO₂max da 14.8% — Amma Akwai Babban Matsala **Takaitaccen Bayani:** Capsule na ƙwayar gwanda da aka sha na tsawon kwanaki 40 ya ba da rahoton ƙaruwa na 14.8% a VO₂max. A cikin sabon takardar *Antioxidants* (2026), matasa maza ‘yan wasa 50 da suka sha 320 mg a rana na **beta‑glucan mai yawa** daga *multi‑mushroom extract* sun daga VO₂max daga 46.26 zuwa 53.12 mL/kg/min. Matsalar mafi girma ita ce babu rukuni na placebo, ba a yi bazuwar raba ƙungiyoyi ba, kuma ba a ɓoye (blinding) gwajin ba; a ƙarshe, ‘yan wasan sun ci gaba da horo a tsawon lokacin. Gwaje‑gwajen ƙwayoyin a kan sel na zuciyar bera suna nuni da haɗin kai da **hypoxia**, amma an gwada sinadarai guda uku (beta‑glucan, taurine, L‑arginine), ba capsule ɗin gaba ɗaya ba. Ga abin da binciken ya gano, abin da ba za a iya tabbatarwa ba, da abin da ya kamata a yi tunani biyu akansa. --- ## Lambar Da Ta Ja Hankali Takardar (Kumar, Gill, Verma & Singh, *Antioxidants* 2026; 15(11):1386) ta ba da rahoton cewa matasa maza ‘yan wasa 50 masu shekaru 18‑22 sun sha **320 mg a rana** na **beta‑glucan mai yawa** daga **cire ƙwayar gwanda** (*multi‑mushroom extract*) tsawon kwanaki 40. VO₂max ɗinsu ya tashi daga **46.26** zuwa **53.12 mL/kg/min**, wato ƙaruwa na **14.8%** (p < 0.001). Jimillar VO₂ ya ƙaru da **11.6%**. Rahoton *NutraIngredients* ya kuma nuna cewa lokacin gajiya ya tsawaita. Samfurin da ake magana a kai shi ne **“7‑in‑1 Mushroom Complex Extract”** a cikin kwayar. Takardar ba ta fayyace irin ƙwayoyin gwanda da aka yi amfani da su ba, sai dai ba za a iya yin zato ba. ## Babbar Matsala: Babu Placebo, Babu Randomization, Babu Blinding Wannan gwaji **ba tare da rukunin sarrafawa ba** ya kasance *single‑arm pre‑post pilot*. Ba a yi amfani da placebo, ba a yi randomization, kuma ba a ɓoye gwajin ba. Masu binciken sun bayyana sakamakon a matsayin **hypothesis‑generating**. Abubuwan da ke rufe wannan matsala sune: - **Horon ya ci gaba.** ‘Yan wasan sun ci gaba da yin horon su na yau da kullum a cikin kwanaki 40. Horon na makonni shida kan haifar da ƙaruwa mai yawa a VO₂max ba tare da wani ƙari ba, don haka ba a iya ware tasirin horo daga na capsule ba. - **Tasirin tsammani (expectancy effect).** Kowa ya san cewa suna shan wani kari; wannan na iya ƙara ƙwazo a gwajin ƙarshe. - **Yawan mahalarta kaɗan.** Dukkan mahalarta su ne matasa maza masu lafiya; ba a iya fitar da sakamako ga mata, manya, ko marasa horo. Tsarin gwajin ya kunshi *washout* na capsule na tsawon kwanaki 14‑17 kafin a fara, da kuma abincin da aka daidaita adadin kalori (*isocaloric diet*). Waɗannan matakai suna taimakawa, amma ba su maye gurbin rukuni na placebo ba. ## Canje‑Canje a Jini da Numfashi Sakamakon na biyu sun kasance gauraye kuma suna da wahalar fassara: - **Peak Respiratory Quotient (RQ)** ya ƙaru daga 1.096 zuwa 1.308 – darajar da ta wuce kima, don haka ya kamata a yi taka tsantsan wajen karanta wannan alama. - **Hematocrit** ya ragu daga 44.5 % zuwa 42.1 %, abin da ke tafiya akasin al’adar “ƙarin ƙwayoyin jini, ƙarin oxygen”. - **Mean Corpuscular Volume (MCV)** ya ƙaru. - **White Blood Cell Count** ya ragu daga 7.53 zuwa 6.80 ×10⁹/L; neutrophils sun sauka yayin da lymphocytes suka tashi. Hematocrit mafi ƙasa tare da VO₂max mafi girma abu ne mai ban sha’awa, amma babu rukunin sarrafawa da zai tabbatar da ko wannan yana da asali a kan gani ko wani tasiri na plasma‑volume ko hayaniya kawai. ## Gwaje‑gwajen Kwayoyin: Ban Sha’awa, Amma Tambaya Ta Banbanta Takardar ta kuma ƙunshi wani ɓangare na dakin gwaje‑gwaje. Masu binciken sun yi amfani da **H9c2 rat cardiomyoblasts** (sel na zuciyar bera) sannan suka haifar da **hypoxia** da cobalt chloride (CoCl₂). Sun gwada sinadarai uku: 1. **Beta‑glucan** a 20 µg/mL 2. **Taurine** a 40 µM 3. **L‑arginine** a 50 µM Duk sinadarai uku sun inganta aikin metabolism daga 67.29 % (hypoxia kadai) zuwa 83.65‑97.40 %. Haka kuma, sun rage **Hif1a transcripts**, alamar rage martanin sel ga hypoxia. Gwajin **Seahorse** na aikin mitochondria ya nuna wasu canje‑canje, amma ba su da muhimmanci na ƙididdiga. Akwai tazara tsakanin wannan aikin da gwajin ɗan adam. A sel an gwada sinadarai a yanayin hypoxia, yayin da a mutane aka sha cikakken *multi‑mushroom extract*. Don haka, kodayake sakamakon sel na iya ba da ra'ayi, ba su tabbatar da hanyar da capsule ke aiki a jikin mutum ba. ## Abin Da Za A Iya Tusa da Abin Da Ba Za A Iya Tusa Ba **Abin da za a iya tallafawa:** - Babban canjin pre‑post a cikin mutane 50 tare da p‑value ƙasa da 0.001. - Bayanan sel da ke nuna rage Hif1a da inganta metabolism a yanayin hypoxia. **Abin da ba za a iya tallafawa ba:** - Ikrar cewa *cire gwanda* yana haifar da kusan 15 % ƙaruwa a VO₂max ba tare da la’akari da horo, tasirin tsammani, da yanayin gwaji ba. - Idan an yi gwaji da rukunin placebo, ƙila sakamakon ya kasance ƙasa da haka, ko ma babu tasiri kwata‑kwata. ## Mahimmancin Aiki - **Kaya:** 320 mg a rana na beta‑glucan mai yawa daga *multi‑mushroom extract*. - **Tsawon lokaci:** kwanaki 40. Ba a fayyace lokacin da ake sha a rana ba, don haka ba a samu shawarwarin dawowa ba. - **Waɗanda ya kamata su yi la’akari:** matasa maza masu lafiya da ke horo kuma suke son gwadawa da kansu. A ɗauki shi a matsayin gwaji, ba magani da aka tabbatar ba. Ku bi kididdiga a yanayi mai daidaito. - **Waɗanda ya kamata su guje:** masu ciki, masu shayarwa, marasa lafiya, ko waɗanda ke shan magunguna masu ƙarfafa garkuwar jiki. ‘Yan wasa da suka yi wannan gwaji su duba takardar shaida ta ƙungiyoyin ƙwararru (Third‑Party Certifications) kafin su ci gaba. - **Abin da ba za a yi ba:** kada a maye gurbin horo na yau da kullum (tsarin horo, bacci, abinci) da capsule. ## Gabaɗayan Ƙarshe Ɗaga na 14.8 % a VO₂max wani labari ne da ke yaduwa da sauri, kuma rashin rukunin placebo shi ne babban dalilin da ya sa ya kamata a yi taka tsantsan. Wannan gwaji na farko yana ba da **hypothesis** ga ‘yan bincike, ba ga ‘yan wasa ba. Gwajin da ya dace shine **randomized, placebo‑controlled trial** da ke ba da cikakken bayani kan nau’in gwanda, adadin mahalarta da ke fiye da 50, da tsare‑tsaren ɓoye. Har sai an samu irin wannan gwaji, amsar tambayar “shin capsule na cire gwanda yana ƙara kusan 15 % a VO₂max?” ba ta da tabbas.

Casein Kafin Barci Ba Zai Lalata Barcinka Ba, Bayanai Daga WHOOP Sun Nuna

Dr. Gymbro — Thu, 29 Oct 2026 08:16:44 GMT

# Casein Kafin Barci Ba Zai Lalata Barcinka Ba, Bayanai Daga WHOOP Sun Nuna Kun taɓa jin cewa shan mashin protein mai nauyi a gaban kwanciya zai sa ku "shakalawa, juyawa" a cikin dare, har ku rasa barci mai kyau? Wani sabon bincike na bazuwar da aka yi a kan 'yan wasa mata ƙwararru ya gwada wannan tunani tare da agogo na WHOOP. Sakamakon ya fi ɗan bacin rai fiye da jin amsar “eh” ko “a’a”. Mashin din ba ta lalata barci ba, amma kuma ba ta inganta shi ba. ## Gaskiyar Da Ke Cikin Binciken Ciyar da jiki kafin barci ya zama dabara da ake yawan amfani da ita don dawo da ƙarfi. Protein da ke narkewa a hankali, irin su casein, ana ɗaukar sa a matsayin zaɓi mai kyau, domin yana ba da amino acid a cikin dare. A gefe guda, akwai fargaba cewa cin abinci da daddare zai iya katse barci, ƙara bugun zuciya, ko rage dawowar da ake samu da dare. Masana a Jami'ar Florida State University, tare da abokan aikin su a Jami'ar South Dakota State University, sun yi ƙoƙarin tantance wannan. Takardarsu, da aka wallafa a *Journal of the International Society of Sports Nutrition* (Paterson et al., 2026), ta nuna cewa binciken bazuwar da ke da “double‑blind crossover” kan abincin pre‑sleep a manyan 'yan wasan mata ya yi ƙanƙanta. ## Yadda Binciken Ya Gudana An zaɓi 'yan wasa mata 25 daga NCAA Division I masu shekaru 18 zuwa 25, kuma 21 suka kammala gwajin. Kowanne ɗan wasa ya shiga yanayi huɗu a cikin tsari bazuwar, double‑blind, placebo‑controlled crossover: - **Casein gram 40** (160 kcal) - **Alpha‑lactalbumin gram 40**, wani nau’in protein da aka samo daga whey (160 kcal) - **Carbohydrate gram 40** (160 kcal) - **Placebo gram 40** (kimanin 5 kcal) Kowane yanayi ya ɗauki daren uku a jere, tare da aƙalla kwanaki uku na “washout” tsakanin su. Jimillar tsarin ta kai makonni 4 zuwa 8. 'Yan wasan sun sha ƙarin abincin kimanin sa’o’i 2 bayan abincin dare na ƙarshe, kuma kusan minti 30 kafin su kwanta. Wannan ne adadin ƙarshe na kalori da suka ci a ranarsu. ## Abubuwan Da Aka Auna Bayanan da ba su da kuskure sun fito ne daga agogon WHOOP 4.0: tsawon barci, lokacin farawar barci (sleep onset latency), ingancin barci, bugun zuciya a hutu, da bambancin bugun zuciya (HRV). Kullum safe, 'yan wasan sun cike takardun tambayoyi kan ingancin barci, lokacin da suka ɗauka su kwanta, da yadda suka ji sun dawo da ƙarfi. A cikin ƙananan rukunin 'yan wasa shida, an sanya masu kula da glucose marasa alama (blinded CGM) domin a bi sawun glucose da dare. ## Lambobi: Kamar Babu Tasiri Babu wani tasiri mai ma’ana da aka samu a kan kowanne daga cikin ma’aunin barci ko dawowa (duk p > 0.05). A tsakiyar yanayi huɗu: - **Tsawon barci:** awa 7.47 zuwa 7.62 - **Ingancin barci:** 91.5 % zuwa 92.0 % - **Bugun zuciya a hutu:** 53.5 zuwa 54.1 bpm - **HRV:** 98.2 zuwa 103.9 ms Bayanan da aka samu daga tambayoyin ma’aikata suma sun ba da labari ɗaya. Matsakaicin ƙimar ingancin barci ya kai daga 69 % zuwa 75 %, mintuna 16 zuwa 20 na ɗaukar barci, da ƙimar dawowa daga 61 % zuwa 66 %. Babu bambanci mai ma’ana tsakanin yanayin da aka ba su. A cikin ƙananan binciken glucose, an ga canjin glucose da dare (p = 0.008), kamar yadda ake tsammani. Amma ba a samu bambanci tsakanin yanayi ba (p = 0.187) kuma babu haɗin tasiri tsakanin yanayi da lokaci (p = 0.550). Marubutan sun kammala cewa shan casein, alpha‑lactalbumin ko carbohydrate sau uku a dare ba su hana ko inganta barci ko dawowa idan aka kwatanta da placebo. ## Labarin Da Ba A Sa Ran Sa Ba: Ba Ya Inganta Barci Wannan ba labarin “protein kafin barci yana inganta barci” ba ne. Babu wani yanayi mai aiki da ya zarce placebo a kowanne ma’aunin barci. Idan kana son casein don gina tsoka, ko don cika burin protein na yau da kullum, wannan binciken yana nuna cewa ba za ka damu da barcinka ba. Idan ka yi tunanin zai zama maganin barci, binciken ba ya tallafa wa wannan tunani. Binciken bai auna sakamakon ƙarfi, gina tsoka, ko canjin ƙwayoyin jiki ba. Don haka ba zai iya tabbatar da ko protein kafin barci yana taimakawa wajen dawo da tsoka ba. ## Iyakoki Da Ya Kamata Ka Sani - **Lokacin gwaji gajere:** Kowane yanayi ya ɗauki kwanaki uku kacal. Ba a san tasirin dogon lokaci ba. - **Bayanan barci daga na’ura:** WHOOP yana da sauƙi, amma ba shi daidai da aikin dakin gwaje‑gwaje na polysomnography, wato gwajin mafi inganci. - **Rukunin mutane ƙanana:** Dukkan mahalarta ’yan wasa mata ƙwararru ne masu shekaru ƙanana, waɗanda ke barci kusan awa 7.5 da inganci sama da 91 %. Ba za a iya ɗaukar sakamakon ga waɗanda ba su barci sosai ba, manya, maza, ko waɗanda ba ’yan wasa ba. - **Ƙananan ƙungiyar CGM:** Kawai ’yan wasa shida ne suka samu na’urar glucose, don haka sakamakon ba shi da ƙarfi. - **Yawan samfur:** Mutane 21 da suka kammala ba su isa ba don gano tasiri ƙanana. - **Bayyanawa:** Wani marubuci memba ne na International Protein Board, ba tare da biyan kuɗi ba. ## Abubuwan Da Zasu Amfane Ka - **Kima:** Binciken ya yi amfani da gram 40 na protein ko carbohydrate (160 kcal). Wannan shine adadin da ke da hujja a nan. - **Lokaci:** 'Yan wasan sun sha shi kusan minti 30 kafin kwanciya, kimanin sa’o’i 2 bayan abincin dare na ƙarshe, wato a matsayin kalori na ƙarshe na yini. - **Wanda zai amfane shi:** 'Yan wasa da masu motsa jiki da ke son amfani da ciyar da jiki kafin barci don cika buƙatun protein ko kuzari. A cikin wannan ƙungiyar na matasa masu barci mai kyau, ba a ga wani illa ko ƙara a HRV ko bugun zuciya. - **Wanda ya kamata ya guje shi ko ya yi hankali:** - Mutane da ke da rashin jure nono, ko waɗanda ba sa iya cin protein na madara, domin duka proteins da aka gwada sun fito ne daga madara. - Duk wanda ya lura da kansa cewa cin abinci da daddare yana rikita barcinsa. Waɗannan sakamakon na ƙungiya gaba ɗaya ne, kuma mutum zai iya bambanta. - Mutane da ba sa bukatar ƙarin kalori ko protein. Binciken ya nuna babu fa'idar barci, don haka babu dalili na ƙara shi sai don wasu dalilai na abinci. **Gaba ɗaya:** Ikirarin “protein kafin barci yana lalata barci” bai tsaya a wannan bincike ba. Ka ɗauki mashin kafin kwanciya a matsayin kayan abinci, ba wata dabara ta barci ba, kuma ka kalli bayananka na WHOOP ko na barci idan kana son sanin yadda kake amsa ga shi.

Ruwan Ƙarfi Da Za Ka Iya Amfani Da Shi Kamar Pre‑Workout—Da Ɗaya Ciki

Dr. Gymbro — Thu, 29 Oct 2026 08:15:52 GMT

# Ka Taɓa Ganin Haɗin Caffeine Da Taurine? Ka taɓa ganin kwalban da ke lakabi da **caffeine plus taurine**? Wannan shine tushen dubunnan ruwan ƙarfi da garin pre‑workout. Amma shin haɗin nan yana ƙara maka aiki ne ko kawai tallace‑tallace? Bincike na sabuwar *meta‑analysis* da aka wallafa a mujallar **Nutrients** (He et al., 2026) ya tattara gwaje‑gwaje mafi inganci. Amsar tana da alƙawari, amma akwai wasu muhimman abubuwa da ya kamata a lura da su. ## Menene Masana Suka Bincika? Ƙungiyar ta duba PubMed, Embase, Web of Science, Cochrane Library da sauran kafofin har zuwa 1 Yuni 2026. Sun nemi gwaje‑gwajen da aka gudanar a cikin ƙungiyoyi masu bazuwar (randomized controlled trials) waɗanda suka kwatanta **caffeine plus taurine** da placebo. An zaɓi gwaje‑gwaje **goma sha ɗaya** da suka ƙunshi **mutane 234**. An yi nazari ta amfani da *random‑effects model* kuma an tantance ingancin bayanai da kayan RoB 2.0. Abubuwan da aka auna sun haɗa da: lokacin gajiya, ƙarfin anaerobic mafi girma, darajar jin ƙoƙari (RPE), lokacin amsawa (reaction time) da *heart rate*. Marubutan sun bayyana babu wani ƙiyayya. ## Abubuwan Da Suka Inganta - **Juriya (lokacin gajiya).** Haɗin caffeine‑taurine ya wuce placebo da bambanci mai ma’ana (standardized mean difference – SMD) na **0.54** (95 % CI 0.03–1.05). Wannan matsakaici ne, alamar cewa akwai tasiri, amma ba a iya tabbatar da shi ba tare da kuskure ba. - **Karfin anaerobic.** Wannan shine sakamakon da ya fi bayyanawa: **SMD 0.55** (95 % CI 0.21–0.89). Idan kana son ƙara saurin tsalle, gudu ko wasu ƙananan motsa jiki masu ƙarfi, wannan yana nuni da fa’ida. - **Rashin jin nauyi (RPE).** Jin ƙoƙari ya ragu sosai (**SMD ‑0.44**, 95 % CI ‑0.83 – ‑0.04). A sauƙaƙe, aikin da aka yi ya ji kamar ya fi sauƙi. Wannan na iya zama sakamakon caffeine, yayin da ba a iya ware tasirin taurine ba. ## Abubuwan Da Ba Su Inganta Ko Ba Za A Dogara Da Su Ba - **Heart rate.** Ba a samu wani tasiri mai ma’ana ba. Bambanci na ƙungiya **‑0.11** bugun zuciya a minti, tare da iyaka daga **‑5.8** zuwa **+5.5**. Don haka, haɗin ba ya ƙara ko rage bugun zuciya yayin motsa jiki. - **Lokacin amsawa.** An samu bambanci mafi girma (**SMD ‑1.49**, 95 % CI ‑2.78 – ‑0.20), amma yanayin bambancin tsakanin gwaje‑gwaje ya yi yawa, kuma *prediction interval* ya wuce sifili. Saboda haka ba za a iya jingina ga saurin amsawa ba. ## Tambayar Ruwan Ƙarfi Marubutan sun ƙara nazarin wani samfurin kasuwanci da ke ɗauke da sinadarai da dama. Wannan ya ba da ƙima ta **SMD 0.48** (95 % CI 0.19–0.78). Ruwan kasuwanci kan ƙunshi sukari da ƙarin abubuwa, don haka ba za a iya danganta wannan sakamakon ga **caffeine da taurine** kawai ba. Sun jaddada cewa ya kamata a gwada samfur din a matakin sinadarai, ba a matsayin shaida ga tasirin caffeine‑taurine ba. Don haka, shin ruwan ƙarfinka zai iya zama pre‑workout? Wataƙila zai taimaka, amma takardar ba za ta iya fayyace wane sinadari ne ya haifar da tasirin ba, kuma ba za a iya tabbatar da cewa kwalbar da ke a firij ɗinka ta dace da abin da aka gwada ba. ## Ƙuntatawa Da Ya Kamata Ka Sani - **Ƙaramin tushen hujja.** Gwaje‑gwaje 11 da mutane 234 ba su da yawa; marubuta sun yi nuni da ƙaramin ƙarfi. - **Raba sinadarai ba a yi ba.** An kwatanta haɗin gaba ɗaya da placebo, don haka ba a iya tantance tasirin caffeine kaɗai, taurine kaɗai, ko haɗin su. - **Sakamakon mara daidaito.** Lokacin amsawa ya nuna bambanci tsakanin gwaje‑gwaje. - **Iyakokin ƙima.** Estimatin lokacin gajiya ya kusan barin sifili a iyaka. - **Kalmar kammalawa.** Marubuta sun ce “yiwuwar fa’ida”, ba “tabbatar da fa’ida” ba. ## Shawarwarin Amfani Binciken bai bayar da ƙimar kwayoyin da aka yi amfani da su a gwaje‑gwaje ba; ƙimomin da ke ƙasa an samo su ne daga adabin gaba ɗaya. - **Matsakaicin ƙima.** Tasirin ergogenic na caffeine yawanci yana tsakanin **3–6 mg/kg** na nauyin jiki. Binciken da ya gabata kan taurine (Waldron et al., 2018) ya duba **1–6 g** a kowanne shan. - **Lokacin shan.** Ana ba da shawarar a sha caffeine **minti 30–60** kafin horo – wannan ba sabon abu ba ne, amma yana taimakawa. - **Wanene zai amfana.** Manyan da ke lafiya, masu cin caffeine a kai a kai, kuma suna son ƙara ƙarfin sprint ko ƙananan lokaci, ko waɗanda ke son horo mai wahala ya ji kamar sauƙi. - **Wanene ya kamata ya guji.** Mutanen da suke da tsananin jin caffeine, masu juna biyu, masu matsalar bacci, ko waɗanda ke da matsalolin bugun zuciya ko hawan jini. Duk wanda ke yin horo a maraice ya yi la’akari da yiwuwar caffeine na shafar barci. Ka tuntuɓi likita idan kana da wata cuta. - **Kada ka jira canjin heart‑rate a matsayin alamar aiki.** Bayanai sun nuna babu canji. - **Kulawa da ƙarin abubuwa.** Sukari da sauran sinadarai a cikin ruwan kasuwanci ba su cikin wannan binciken, don haka ba su da tasiri a sakamakon caffeine‑taurine. ## Kammalawa Wannan *meta‑analysis* na nuna cewa **caffeine plus taurine** na iya ƙara ƙarfin anaerobic da tsawon lokacin gajiya kadan‑kadann, tare da rage jin ƙoƙari, ba tare da tasiri a *heart rate* ba. Duk da haka hujjar ta ƙunshi ƙananan gwaje‑gwaje, kuma ba a iya tabbatar da cewa taurine na ƙara wani abu bayan caffeine ba. Idan ruwan ƙarfinka ya dace da buƙatarka, ka ɗauke shi a matsayin hanyar shigar da caffeine da wasu ƙarin abubuwa masu yuwuwa, ba a matsayin pre‑workout da aka tabbatar ba. Ana buƙatar manyan gwaje‑gwaje da za su gwada caffeine kaɗai, taurine kaɗai, da haɗin su don ƙara fayyace gaskiyar lamarin.

Creatine HCl Ya Fi Monohydrate a Ƙwallon Kafa – Kada Ka Manta da Shi Yanzu

Dr. Gymbro — Thu, 29 Oct 2026 08:14:47 GMT

# Creatine HCl Ya Fi Monohydrate a Ƙwallon Kafa – Kada Ka Manta da Shi Yanzu **Kafin ka ƙara ko rage amfani da creatine, ka karanta abin da ke ƙasa; binciken yana da iyakoki masu tsanani, kuma sakamakonsa ya sabawa wasu sakamakon da muka sani tun da farko.** --- ## Menene Masana Suka Gwada a Gaskiya? Wani ƙungiya daga Sashen Kimiyyar Wasanni na Jami'ar Wenzhou Medical University a China, ƙarƙashin jagorancin **Prof. Duan**, ta wallafa wani binciken bazuwar da aka sarrafa da placebo a *Journal of the International Society of Sports Nutrition* (2026). Sun zaɓi ‘yan wasa maza na jami’a **40** kuma suka raba su gida huɗu, kowane rukuni na ‘yan wasa 10: - **Creatine monohydrate** (Cr‑Mon) - **Creatine ethyl‑ester** (Cr‑Ee) - **Creatine hydrochloride** (Cr‑HCl) - **Placebo** Duk ‘yan wasa sun bi shirin horo na makonni **huɗu** wanda ya ƙunshi motsa jiki na gudu a, a kalla sau **uku** a mako (jimillar zama 12). An auna su **kafin** da **bayan** horon ta hanyoyi kamar: - **Countermovement vertical jump (CMVJ)** – tsalle daga tsaye - **Sprint na mita 20** - **L‑run** – gwajin juyawa - **Wingate test** – ƙarfin anaerobic (ƙarfin kololu, matsakaicin ƙarfin, alamun gajiya) - **VO2max** – ƙara‑ƙara na numfashi --- ## Sakamakon Da Ya Fi Ban Sha’awa: Irin Na Zamani Sun Fi Gaba ### Gabaɗaya Kowane rukuni—ko da placebo—ya samu ɗan ci gaba, al’amari da ake sa ran faruwa bayan horo mai tsari na wata guda. Sai dai rukunan da suka karɓi creatine sun haɓaka sosai fiye da placebo wajen **aikin jiki, ƙarfin kololu, da alamun gajiya** (p = 0.001). ### Creatine HCl da Ethyl‑Ester Taƙaitaccen bayani ya nuna cewa **Cr‑Ee** da **Cr‑HCl** sun ba da ƙaruwa a kan **Cr‑Mon** a fannoni uku masu muhimmanci: 1. **CMVJ** (tsalle) 2. **Sprint na mita 20** 3. **L‑run** (juyawa) da **ƙarfin kololu** Wannan yana nufin a cikin wannan gwaji, nau’ukan da suka fi tsada ba kawai sun daidaita da monohydrate ba, har ma sun yi fice a kan al’amuran da suka fi shafar ‘yan wasa na ƙwallon ƙafa. --- ## Inda Babu Banbanci Babu wani bambanci mai ma’ana tsakanin rukunan a kan **matsakaicin ƙarfin (peak power)** ko **VO2max**. Wannan ya dace da fahimtar cewa creatine yana tallafawa ayyukan da ke buƙatar **phosphocreatine**—kamar sprint da tsalle—ba tare da tasiri kai tsaye kan ƙarfin numfashi ba. --- ## Dalilan da Ya Sa Kada Ka Daina Amfani da Monohydrate Yanzu ### 1. Ƙananan Rukunin Bincike Kowane rukuni ya ƙunshi ‘yan wasa **10** kacal. Idan ɗaya ko biyu suka ba da amsa sosai, hakan na iya “sarrafa” matsakaicin rukuni. Saboda haka, sakamakon ba shi da ƙarfi sosai don yanke hukunci na ƙarshe. ### 2. Lokacin Gwaji Ƙarami Makonin **huɗu** ne kawai—ba zai ba mu damar ganin tasirin dogon lokaci ba, kamar *injury risk*, tasirin jiki a kakar wasa, ko kuma yiwuwar samun abubuwan da suka shafi lafiya. ### 3. Samfurin Mutane Maɗaukaki Duk mahalarta matasa ne, maza, ‘yan wasa na jami’a. Ba za mu iya faɗi cewa sakamakon zai yi daidai ga mata, manya, ko ‘yan wasa a wasu wasanni ba. ### 4. Rashin Bayyanar Adadin Creatine a Jiki Takardar ba ta bayyana adadin creatine da aka ba wa kowane rukuni ba, kuma ba a auna **creatine a cikin tsoka** ba. Don haka ba mu san ko **Cr‑HCl** ko **Cr‑Ee** suka ƙara adadin creatine a jiki fiye da monohydrate ba. ### 5. Sabani da Binciken da Aka Yi a Da Binciken da aka yi a 2009 na **Spillane** da ƙungiyarsa ya nuna cewa **creatine ethyl‑ester** ba ya wuce monohydrate a kan mafi yawan alamomi, kuma yana haifar da ƙaruwa a **serum creatinine**. Saboda haka, wannan sabon sakamako ɗaya ba zai iya *gyara* tunanin da aka samu daga manyan bincike da suka gabata ba. ### 6. Monohydrate Har Yanzu Na Da Shaida Monohydrate shine nau’in da aka fi nazari, yana samuwa a ko’ina, kuma yawanci mafi araha. Ko da wani gwaji ƙanana na nuna wani rikice‑rikice, ba za mu iya ɗauka cewa ya zama mafi tasiri ba har sai an tabbatar da shi a manyan gwaje‑gwaje. --- ## Amfani Mai Ma’ana | Abin Da Za Ka Lura Da Shi | Shawara | |--------------------------|---------| | **Adadi** | Binciken bai bayyana adadin da aka ba kowane rukuni ba. Idan za ka yi amfani da monohydrate, bi **umarnin da ke kan samfurin** ko nemi shawarwarin ƙwararren masani a fannin abincin wasanni. Idan za ka gwada HCl ko Ee, ka bi umarnin da masu samar da su suka rubuta. | | **Lokaci** | Binciken ya ba da creatine a kowace rana tsawon makonni huɗu, tare da horon sprint sau uku a mako. Ba a fayyace lokacin shan creatine a rana ba—amma a mafi yawancin nazari, **cigaba da amfani** shine mafi muhimmanci. | | **Wanda Zai Amfana** | ‘Yan wasa da ke neman ƙara saurin sprint, tsalle, da ƙarfin kololu—musamman a lokacin shirin kakar wasa. Masu fama da **ƙalubalen shaƙa** na monohydrate (misali, matsalar koda) na iya la’akari da HCl, amma wannan ba ya nufin HCl zai zama mafi sauƙin sha. | | **Wanda Ya Kamata Ya Yi Caution** | Mutanen da ke da **cutar koda**, masu shan magunguna, da masu ƙasa da **shekara 18** su tattauna da likita kafin farawa. Ethyl‑ester na buƙatar kulawa saboda ƙaruwa a serum creatinine da aka nuna a wasu bincike. | --- ## Kammalawa Gwajin na nuna cewa **creatine HCl** da **creatine ethyl‑ester** na iya ba da ƙarin fa’ida a kan **tsalle, sprint, L‑run, da ƙarfin kololu** a cikin gajeren lokaci na horo. Sai dai, iyakokin rukuni (40 ‘yan wasa), tsawon lokaci (mako huɗu), da rashin bayyanar adadi suna nuni da bukatar ƙarin bincike mai faɗi. Har sai an samu manyan gwaje‑gwaje da suka haɗa da auna **creatine a cikin tsoka**, za a ci gaba da ganin **monohydrate** a matsayin zaɓi mafi tabbatacce, mai araha, kuma mai sauƙin samu. **HCl** da **Ee** suna ci gaba da zama abubuwan da za a kula da su, amma ba su da hujja mai ƙarfi da za ta tilasta a chanja dabarun da ake amfani da su a halin yanzu.

Karin Da Ya Kara Sha Arginine Da Kashi 17% A Wani Gwaji Karami

Dr. Gymbro — Wed, 28 Oct 2026 08:17:08 GMT

# Karin Da Ya Kara Sha Arginine Da Kashi 17% A Wani Gwaji Karami **Arginine** da aka sha kafin motsa jiki na iya rasa wani bangare na fa'ida. Wani gwajin crossover da aka gudanar a 2023 ya gano cewa haɗa gram 5 na arginine da kapsul ɗin Astragalus da *Panax notoginseng* saponins (APS) ya ƙara shakar arginine kuma ya canza wasu alamomin nitric oxide (NO). Alamar **arginine/ADMA** ta ƙaru **167.1 %** – abu da ke nuni da yanayi mafi kyau ga samar da NO. Kafin ka ƙara wani abu a cikin shakar ka, ga abin da binciken ya nuna da abin da ba ya nuna. ## Menene Gaskiyar Binciken Takardar da aka wallafa a *Functional Foods in Health and Disease* (2023; 13(6):307‑319, rajista a matsayin NCT05024123) ta bayyana wannan **randomized, double‑blind, placebo‑controlled crossover pharmacokinetic study**. Mutane masu lafiya tsakanin shekaru 20 zuwa 80 sun sha gram 5 na foda arginine tare da ko dai kapsul ɗin APS ɗaya ko kuma placebo. Kowanne mahalarta ya gwada duka yanayi biyu, tare da lokaci na wankewa a tsakani. Masana sun tattara *plasma* da fitsari don bin diddigin matakin arginine da alamomin da suka shafi NO. Masu rubutun sun ce ba su san wani gwajin ɗan adam da aka yi a baya kan haɗin Astragalus da ginseng a kan matakan NO ba, don haka wannan aiki ne na mataki na farko. ## Lambobin Da Suka Fice Idan aka kwatanta arginine tare da placebo, arginine tare da APS ya haifar da: - **Arginine AUC +17.3 %** (p = 0.041). AUC na nufin jimillar shigarwa, don haka wannan sakamakon na “ƙara shakar arginine”. - **Arginine C_max +11.1 %**. Wannan shine kololuwar matakin a cikin jini. Takaitaccen bai ba da p‑value ba. - **Arg/ADMA ratio +167.1 %** (p = 0.007). ADMA (asymmetric dimethylarginine) yana ƙin enzyme da ke samar da NO, don haka ƙaruwa a wannan alaka na nuni da yanayi mafi kyau ga samar da NO. - **Urinary nitrate +20.8 %** da **urinary cGMP +18.9 %**. Duka biyun alamomi ne a ƙasa da NO. Takaitaccen bai ba da ƙimar muhimmanci ga waɗannan ba. Masu rubutu sun kammala da cewa APS ya inganta shakar arginine, ya rage ADMA, kuma ya ƙara samar da NO. ## Me Ya Sa Masu Motsa Jiki Zasu Damu (Kuma Me Ya Sa Kada Su Yi Wahalhalu) Arginine na daga cikin manyan sinadarai na *pre‑workout* saboda shi ne tushen NO, wanda ke taimakawa wajen sassautar jijiyoyi. Koyaya, wasu sun yi korafi cewa shan arginine daga baki ba koyaushe yake haifar da ƙaruwa a matakin NO ba. Idan wani abu zai iya **ƙara shakar arginine** kuma **ya rage ADMA**, tabbas zai iya zama abin sha’awa ga masu motsa jiki. Masu rubutun sun ba da shawarar APS na iya amfanar da *pre‑workout* da lafiyar zuciya. Amma wannan shawarar ta wuce abin da bayanai suka nuna. **Wannan bincike ya auna alamomin jini da fitsari ne kawai. Ba a gwada aiki a lokacin motsa jiki – kamar ƙarfi, juriya, ko “pump” – ba.** Ba wanda ya sami ƙaruwa a ainihin aiki. Alamomin NO da aka auna ba sa nufin an samu ƙara a ƙarfi ko aiyuka. ## Kuskuren Da Ya Kamata Ka San 1. **An cire mutane shida.** An yi rajista da mutane 30, amma bayan cire waɗanda amsoshin su suka bambanta sosai, an rage zuwa 24 – wato kashi 20 % na samfurin. Cire mutane saboda “bambancin kai‑da‑kai” na iya sanya sakamakon ya zama mai tsafta fiye da ainihi, amma ba a fayyace yadda aka yanke wannan shawara ba. 2. **Samfurin ƙarami.** Mutane 24 ba su da yawa, kuma p‑value na AUC (0.041) yana kan iyakar shigar da ƙa’ida. 3. **Masu lafiya kawai.** Ba a haɗa da masu cutar zuciya, hawan jini, ko waɗanda ke ɗaukar magunguna ba. 4. **Tsarin guda‑daya.** Takaitaccen ya bayyana **gram 5 na arginine + kapsul ɗin APS ɗaya**. Ba a ba da bayanin tsawon lokacin amfani ko maimaitawa ba. 5. **Alamomin wakili ne.** Nitrate a fitsari da cGMP ba su auna aikin jijiyoyi kai tsaye ba; su ne alamomin NO ne kawai. 6. **Bayanai marasa cikawa.** Takaitaccen ba ya ƙunshi adadin saponin a cikin kapsul, farashin samfur, ko wasu muhimman bayanai. Don haka ya kamata ka duba takardar asali idan kana son ƙarin bayani. ## Abubuwan Da Za Su Amfane Ka - **Gwajin da aka yi:** gram 5 na foda arginine tare da kapsul ɗin APS ɗaya. Idan ba a ba da adadin saponin a cikin kapsul ba, ba za a iya maimaita gwajin ba. - **Lokacin ɗauka:** Takaitaccen ba ya fayyace tsawon lokacin da ake jira kafin motsa jiki ko ko an yi wani motsa jiki a lokacin gwajin. Kada ka ɗauka cewa akwai wani “window” na musamman da aka tabbatar da shi. - **Waɗanda za su iya amfani da shi:** Mutane masu lafiya, daga shekaru 20 zuwa 80, da ke riga suna shan arginine kuma suna son ƙara yawan shakar sa. - **Waɗanda ya kamata su guje shi ko su tuntuɓi likita kafin su yi amfani:** - Duk wanda ke da matsalar zuciya, hawan jini, ko ke ɗaukar magungunan zuciya. - Duk wanda ke shan maganin jini ko wasu magunguna masu tasiri a kan jijiyoyi. - Mata masu juna biyu ko masu shayarwa, da kuma kowa da ke da wata cuta mai tsanani. - Duk wanda ke tsammanin zai samu ƙaruwa a aiki, saboda ba a gwada ainihin aiki a wannan bincike ba. Takaitaccen ba ya maganar farashi, don haka kiran shi "karo mai araha" ba shi da tushe. ## Gabaɗaya Wannan ƙaramar, amma an sarrafa sosai, *crossover trial* ya ba da alamar farko mai ƙarfi cewa APS na iya inganta yadda jiki ke sarrafa ƙarin arginine da kuma inganta alamar NO. **Tsallaken 167 % a alaƙar Arg/ADMA** babban abu ne da ya kamata a lura da shi. Sai dai, cire mutane shida, ƙaramin samfur, rashin ƙimar wasu alamomi, da kuma rashin bayani kan tasirin a kan aikin motsa jiki, suna sanya wannan bincike ya kasance a matakin **ƙirƙirar tunani** – ba dalilin canza duka kayan gina jikinka ba. Mataki na gaba shi ne gwaji mafi girma da zai haɗa da auna aiki a lokacin motsa jiki da kuma ainihin sakamakon ga kowa da kowa.

2 g na Carnosine a Kullum Tsawon Mako 12: Gwajin Mutane 299 Ya Fi Yawanci Ba ya Samun Sakamako

Iron Marcus — Wed, 28 Oct 2026 08:15:39 GMT

# 2 g na Carnosine a Kullum Tsawon Mako 12: Gwajin Mutane 299 Ya Fi Yawanci Ba ya Samun Sakamako ## Gabaɗaya: Gwaji Mai Girma da Ya Fi Yawanci Ba ya Samun Sakamako An tallata kwayar carnosine a matsayin ƙarin da zai ƙara juriya ga tsokoki. Wani sabon gwaji da ya haɗa mutane 299, an raba su zuwa rukuni‑rukuni (carnosine ko placebo), ya gwada wannan ikirari, kuma mafi yawan sakamakon ya nuna babu tasiri. An samu alamu a wasu ƙananan rukunai, amma ba su isa su zama hujja mai ƙarfi ba. Binciken an wallafa shi a *Journal of the International Society of Sports Nutrition* daga tawagar Jami'ar Louisville da Jami'ar Bellarmine, tare da O’Toole da Bhatnagar a matsayin shugabanni. Marubutan sun lura cewa an fi amfani da carnosine da sinadarin da ke samar da shi, beta‑alanine, a matsayin ƙarin ƙarfafa aiki, amma har yanzu “ba a tantance tasirin carnosine ba sosai.” ## Abin da aka Yi da Gaske - **Tsari:** Gwajin likita mai cikakken raba rukuni‑rukuni tare da placebo - **Yawan mahalarta:** Mutane 299 - **Matsakaicin kashi:** 2 g na carnosine a kullum, a cikin ƙwayoyi - **Tsawon lokaci:** Kimanin makonni 12 (auna a farkon gwaji, kusan makonni 6 da makonni 12) - **Gwaje‑gwaje:** Ƙarfi na riƙon hannu, tashi na ƙafafu biyu har sai ƙarfi ya ƙare, gwajin matakai na minti 2, da saurin tafiya - **Karin bayanai:** An tattara jini da fitsari a kowanne ziyara Masu binciken suka ƙididdige canjin da aka samu a kowane matakin ƙarfi (na ainihi da kashi‑kashi daga farkon gwaji) sannan suka kwatanta sakamakon carnosine da na placebo. ## Sakamakon Babba: Yawanci Ba a Samu Tasiri ba A dukkan ma'aunin aikin, carnosine bai fi placebo ba. Marubutan sun ba da rahoton babu bambance‑bambance masu muhimmanci (p < 0.05) a kowanne gwaji, sai a wasu ƙananan rassan da ke ƙasa. Wannan ya haɗa da ƙarfi na riƙon hannu da saurin tafiya, yayin da takaitaccen bayanin ya nuna babu nasara a gwajin matakai ko tashi na ƙafafu. Idan kana neman hujja da ke cewa “carnosine yana ƙara juriya ga kowa,” wannan gwaji ba ya ba da irin wannan tabbaci. ## Alamomin Ƙananan Rukuni Biyu **1. Tashi na ƙafafu a mutane ƙasa da shekaru 40 (mako 6).** Mutanen da suka sha carnosine ƙasa da shekaru 40 sun yi ƙarin tashi na ƙafafu biyu har sai ƙarfi ya ƙare fiye da masu placebo (p = 0.018). **2. Gwajin matakai a maza sama da shekaru 40 (mako 12).** Maza sama da shekaru 40 da ke shan carnosine sun ƙara yawan matakai a gwajin minti 2 (p = 0.010). A dukkan maza, tasirin ya kasance alama (p = 0.06). Marubutan sun kammala da cewa amfanin ya takaita ga maza da wasu ƙananan ƙungiyoyi na shekarun, sannan carnosine “na iya ƙara tasiri ga waɗanda ke yin motsa jiki na ɗan lokaci mai maimaitawa.” ## Dalilin Da Ya Sa Dole A Kalli Wadannan Alamomi Cikin Hankali Wannan shi ne lokacin da gaskiya ta fi ƙayatarwa. - **Binciken ƙananan rassa na da rauni.** Raba gwaji bisa ga shekara da jinsi yana ƙara yawan gwaje‑gwaje da ake yi. Idan aka yi ƙididdiga da yawa, wasu p‑values kan faɗi ƙasa da 0.05 ba da gangan ba. Takaitaccen bayani bai nuna an yi gyaran ƙima ba don gwaje‑gwaje masu yawa. - **Babu haɗin kai a tsarin gwaji.** Alama ɗaya tayi bayyananne a matasa a makonni 6 (gwajin ƙafafu), ɗaya kuma a manyan maza a makonni 12 (gwajin matakai). Babu bayani guda ɗaya da ke haɗa duk lokuta, gwaje‑gwaje, ko ƙungiyoyi. - **Alama ba ta zama sakamako ba.** Sakamakon p = 0.06 ga dukkan maza ba ya kai matakin da aka sanya a binciken ba. - **Kammalawa ta wuce bayanan da ke akwai.** “Yana inganta juriya ta tsoka da na zuciya‑huhu” a ƙungiyoyi na musamman yana da ƙarfi fiye da gwajin da ya nuna yawancin ba tare da sakamako ba. - **Bayanan da suka ɓace a takaitaccen bayani.** Ba a ba da cikakken bayani kan demografi, girman tasiri, ko lokacin da ake sa ran ƙananan rassa su bayyana ba. Don haka, abin da za a dauka daga wannan bincike shi ne alamomi da za su iya ƙarfafa ƙarin bincike, ba hujjoji masu ƙarfi ba. ## Carnosine da Beta‑Alanine: Kwatancen Gaskiya Gwajin ya duba carnosine, ba beta‑alanine ba, kuma ba a kwatanta su kai tsaye ba. Ga wasu bayanai na waje. Carnosine ƙunshi ne na beta‑alanine da histidine. Beta‑alanine ana ɗauka a matsayin muhimmin ɓangare wajen gina carnosine a tsoka, shi ya sa masana kimiyyar abinci na wasanni suka fi mayar da hankali a kan beta‑alanine. Hanyoyin beta‑alanine na yau da kullum suna buƙatar fiye da gram‑gram a kullum tsawon makonni, a raba su zuwa ƙananan ƙwayoyi don guje wa jin ƙaiƙayi (paresthesia). Binciken beta‑alanine ya fi yawa kuma ya ci gaba, yana nuna fa'idodi kaɗan a ayyukan ƙarfin tsanani na minti ɗaya zuwa wasu mintuna. Wannan gwaji na carnosine na 2 g/kwana ba ya nufin carnosine ba shi da amfani; yana nufin cewa, a kan wannan ƙima da yanayin gwaji, ba a ga wani tasiri ba. Akwai buƙatar ƙarin bincike kafin a yanke ƙarshe kan ko carnosine ya fi beta‑alanine. ## Abubuwan Da Za a Iya Amfani Da Su - **Matsakaicin kashi:** Gwajin ya yi amfani da 2 g/kwana na carnosine. Wannan shine kawai ƙima da aka gwada, don haka shi ne kawai abin da wannan binciken zai iya magana a kai. - **Lokaci:** Takaitaccen bayani bai fayyace lokacin da ake shan ƙwayar ba, ko irin tsarin horon da aka yi ba. Kada ka ɗauki wata hanyar musamman a matsayin hujja daga wannan takarda. - **Tsawon lokaci:** Alamar tashi na ƙafafu ta bayyana a kusan makonni 6, alamar gwajin matakai a kusan makonni 12, amma ba a ba da tabbacin lokaci ba saboda ƙarin bayanan da suka ɓace. - **Wanene zai iya la'akari da shi:** Kowa da ke sha'awar gwadawa, muddin ya fahimci cewa shaidar ba ta da ƙarfi. Marubutan sun ba da shawarar carnosine na iya yin tasiri a motsa jiki na ɗan gajeren lokaci da maimaitawa, musamman a manya ƙasa da 40 (tashi na ƙafafu) da maza sama da 40 (gwajin matakai). - **Masu neman ƙara ƙarfi a riƙon hannu ko ƙarfin gaba ɗaya.** Babu nasara a wannan ɓangaren. - **Masu son inganta saurin tafiya.** Babu sakamako. - **Matan da ke fatan ƙaruwa.** Amfanin ya takaita ga maza; babu shaidar tasiri ga mata. - **Masu daƙatar ƙuntatawa a kuɗi.** Za su fi amfana da saka kuɗi a horo, barci, da isasshen furotin. - **Masu ciki, ko da ke da wasu cututtuka ko shan magani.** Ya kamata su tuntuɓi likita kafin fara kowanne ƙari. ## Kammalawa Gwajin da ya haɗa mutane 299, inda aka ba su 2 g/kwana na carnosine na tsawon makonni 12, bai gano wani fa'ida gaba ɗaya a kan placebo a cikin gwajen riƙon hannu, tashi na ƙafafu, gwajin matakai, ko saurin tafiya ba. Nasarorin da aka samu su ne ƙara tashi na ƙafafu a mutanen ƙasa da 40 da kuma ƙara matakai a maza sama da 40. Wadannan alamomi suna da ban sha'awa, amma suna cikin ƙananan rassa ne da ke buƙatar sake gwadawa kafin a ɗauke su a matsayin hujja mai ƙarfi. Marubutan sun ba da rahoton babu rikice‑rikice na sha'awa.

Whey da Collagen Sun Fi Kowane Daya a Masu Horar da Ƙarfi – Da Ɗan Ƙalubale

Dr. Gymbro — Wed, 28 Oct 2026 08:14:33 GMT

## Haɗin Da Ya Latsa Kowane Matsayi (A Takarda) Wani sabon gwaji da aka wallafa a *BMC Sports Science, Medicine and Rehabilitation* ya tambayi maza masu horon ƙarfi: shin ƙara collagen zuwa whey zai fi whey kadai, collagen kadai, ko placebo? A wannan bincike, haɗin whey + collagen ya zama wanda ya ba da sakamakon mafi girma a dukkan ma’aunin da aka auna – yawan tsoka, ƙimar ƙashi a kashin baya (lumbar spine BMD), ƙarfin squat da bench press, da alamun juyin ƙashi. Idan kana shirin canza shirin kari na ka, dole ne ka fahimci yadda aka tsara wannan gwaji. ## Binciken a Taƙaice - **Tsari:** gwaji double‑blind, randomized, placebo‑controlled - **Samfur:** maza 40 masu horon ƙarfi (na ƙarshe 52 aka tantance), duk suka kammala gwajin - **Rukuni:** - whey + collagen (gram 30 na whey + gram 10 na collagen a kowace rana) - whey kadai (gram 30 na whey a rana) - collagen kadai (gram 10 na collagen a rana) - placebo (gram 10 na maltodextrin) - **Horon:** makonni 8 na horo a kulawa, sau uku a mako - **Babban sakamako:** yawan tsoka da aka auna ta hanyar bioelectrical impedance analysis (BIA) - **Sakamako na biyu:** lumbar spine BMD ta DXA, 1RM squat da bench press, da alamun juyin ƙashi P1NP (ƙirƙirar ƙashi) da CTX‑I (warware ƙashi) ## Sakamakon Da Haɗin Ya Lashe **Yawan tsoka** – Haɗin ya ƙara kilogram **2.66 ± 0.25**. Whey kadai ya ƙara kilogram **1.59 ± 0.18**, collagen kadai kilogram **0.46 ± 0.13**, placebo kilogram **0.10 ± 0.12**. Bambance‑bambancen tsakanin rukuni‑rukuni sun kasance masu muhimmanci (p < 0.001). **Lumbar spine BMD** – Haɗin ya hau **0.108 ± 0.027 g/cm²**. Collagen kadai ya hau **0.023 ± 0.018 g/cm²**, kuma wannan canjin ma yana da muhimmanci. Whey kadai da placebo ba su nuna canji mai muhimmanci ba. Bambance‑bambancen sun kasance masu ƙarfi (p < 0.001). **Ƙarfi** – Haɗin ya ƙara **15.22 ± 1.04 kg** a squat da **10.63 ± 1.25 kg** a bench press. Rukunin whey + collagen ne suka fi sauran gaba, yayin da placebo ya kusan ba ya kai wani ƙaruwa. **Alamun juyin ƙashi** – Haɗin ya haifar da ƙaruwa a P1NP da ragin CTX‑I, alamu na haɓakar ƙashi. Collagen kadai ma ya kawo sauyi ƙanana amma masu muhimmanci. Whey kadai da placebo ba su nuna wani canji ma’ana ba. Taƙaitaccen sakamakon yana nuna cewa whey ne ke haifar da mafi girman ƙaruwa a tsoka, yayin da collagen ke motsa ƙashi. Haɗin ya haɗa tasirin duka biyun. Whey kadai ba ta tasiri BMD ko alamun ƙashi a wannan gwaji. ## Dalilin Da Ya Sa Sakamakon Ya Dace Mawallafa sun bayyana whey a matsayin *anabolic driver* – wato mai ƙara gina tsoka – yayin da collagen ke ba da abubuwan gina jiki ga jijiyoyi da ƙashi. Sun nuna cewa duka biyun suna cika juna, ra’ayin da yake da ma’ana. Gwajin ya ƙarfafa wannan tunani, amma ba ya tabbatar da ainihin hanyar aiki, domin babu auna hanyoyin biokimyawa. ## Ƙananan Takardu: Iyakoki Da Ya Kamata Ka Kiyasta - **Ƙaramin samfur** – Maza 40 da aka raba cikin rukuni huɗu, ma’ana mutane kaɗan a kowane rukuni. Gwaje‑gwaje kanana na iya ƙara gurbatar sakamako. - **Tsawon lokaci ƙanƙanta** – Mako 8 ba su ba da tabbacin ɗorewar tasirin ko ci gaba da haɓakar da aka samu ba. - **Auna tsoka da BIA** – Bioelectrical impedance hanya ce mai sauƙi, amma tana ɗaukar ƙarfin ruwa a jiki. Ba ita ce ma’aunin ƙarfi na ƙashi ba. - **Babbar tashi a BMD a ɗan gajeren lokaci** – **0.108 g/cm²** a lumbar spine BMD cikin makonni 8 babban canji ne, amma har yanzu ya kamata a jira ƙarin bincike don tantance ko tasirin na dindindin ne. - **Rashin daidaiton adadin protein** – Haɗin ya ba da **gram 40** na protein (30 g whey + 10 g collagen) a kowace rana, yayin da rukuni whey kadai ya ba da gram 30, collagen kadai gram 10, kuma placebo babu protein. Don haka ba za a iya ware tasirin *synergy* daga tasirin ƙarin protein ba. Takaitaccen takarda ba ta bayyana ko aka kula da cin abinci gaba ɗaya ba. - **Rukunin da aka takaita** – Duk mahalarta maza ne masu horon ƙarfi. Don fahimtar tasirin a sauran al’ummomi (mata, tsofaffi, masu cutar ƙashi) dole ne a yi ƙarin gwaji. ## Amfani Da Za A Iya Yi - **Matsakaicin da aka yi amfani da shi a gwaji:** gram 30 na whey + gram 10 na collagen a kowace rana, tare da horo a kulawa sau uku a mako. Takaitaccen bai fayyace ko an sha kari kafin ko bayan horo ba; wannan bayani yana buƙatar ƙarin bincike. - **Waɗanda za su iya amfana:** maza masu horon ƙarfi da suka dace da mahalarta, waɗanda ke son ƙara tallafi ga tsoka da ƙashi yayin horo. Kayan kari ba su maye gurbin horo ba – duka rukuni sun yi horo, kuma rukunin placebo ya samu karamin ƙaruwa. - **Waɗanda ya kamata su yi hankali ko su guje shi:** - Mata, manya masu shekaru, masu farawa, da wadanda ke da cutar ƙashi – domin ba a gwada su ba. - Duk wanda ke da alerji ga madara ko damuwa da collagen na dabbobi. - Mutanen da ke da matsalolin koda ko cututtuka da ake ba da shawarar rage yawan protein – a tuntuɓi likita kafin amfani. - Masu neman magance osteoporosis, domin gwajin ya mayar da hankali kan masu lafiya, ba marasa lafiya ba. ## Kammalawa Wannan gwaji na randomized, double‑blind ya ba da alamar cewa haɗin whey + collagen ya fi kowanne rukuni daban a cikin maza masu horon ƙarfi na makonni 8. Collagen kadai ya nuna tasiri a ƙashi, whey kadai ya nuna tasiri a tsoka, yayin da haɗin ya kawo duka biyun. Ka ɗauki wannan sakamako a matsayin alamar ƙarfi, ba a matsayin karshe ba. Ƙaramin samfur, auna tsoka da BIA, rashin daidaiton adadin protein, da babbar tashi a BMD duk suna nuna buƙatar ƙarin gwaje‑gwaje kafin a kira wannan haɗin tabbataccen hanya ga gina ƙashi da tsoka.

Abin Mamaki na Ashwagandha: Yana Kara Juriya Fiye da Ƙarfi

Dr. Gymbro — Wed, 28 Oct 2026 08:13:27 GMT

## Jawo Hankali: Me Ya Sa Zaka Iya Samun Amfani Da Ashwagandha? Ashwagandha a yawancin lokuta ana tallata shi a matsayin ƙara ƙarfi da tsoka. Sabuwar **binciken meta‑analysis** ta nuna cewa ribar da tafi tabbatacce na iya kasancewa a wani wuri daban: **juriya mai numfashi**. Wannan takarda, da aka wallafa a mujallar *Nutrients* a 2026, ta haɗa masana daga Jami'ar Shaanxi Normal da Jami'ar Sichuan Agricultural. Ta yi nazari kan gwaje‑gwajen sarrafa kansa na *Withania somnifera* (ashwagandha) da tasirinsa a ainihin aikin motsa jiki. Sakamakon yana da alƙawari, amma akwai wasu ƙuntatawa da ya kamata ku sani kafin ku yanke shawarar siyan ko sha. ## Menene Masu Binciken Sun Yi? Wannan ita ce **binciken meta‑analysis na matakai uku**. Ƙungiyar ta binciko PubMed, Web of Science, Cochrane Library, Embase, da SPORTDiscus daga farkon ƙirƙira har zuwa 1 ga Afrilu 2026. Ta zaɓi gwaje‑gwajen da suka kwatanta shan ashwagandha ta baki da placebo ko wani ƙari, tare da rahoton sakamakon ainihi. Adadin ƙarshe ba shi da yawa: **gwaje‑gwaje 13, mahalarta 599, da ƙimomin tasiri 79**. Hanyar matakai uku ta ba da damar haɗa sakamakon gwaje‑gwajen da ba su da yawa ba tare da ɗaukar kowanne a matsayin ba‑tasiri ba. Ta kuma bayar da 95 % tsaka‑tsakin hasashe, ƙimar GRADE don tantance ingancin shaidar, nazarin ƙasa, da meta‑regression kan ƙima da tsawon lokaci. Mahalarta sun kasance mafi yawansu matasa ko 'yan wasa. Gwaje‑gwaje huɗu sun ƙunshi maza kawai, ɗaya mata kawai, uku haɗe jinsi, kuma biyar ba su bayar da cikakken bayani kan jinsi ba. ## Sakamakon Gabaɗaya Dukkan sakamakon aiki, ashwagandha ya inganta sakamakon a matsakaici, tare da **Hedges' g = 0.47** (95 % CI 0.25‑0.69, *p* < 0.001). Wannan tasiri matsakaici ne kuma an haɗa shi gabaɗaya. Masu rubutun sun jaddada gargadi guda biyu: - **Heterogeneity ya kasance mai girma** (I² = 60 %), wanda ke nufin sakamakon ya bambanta sosai tsakanin gwaje‑gwaje. - **Tsaka‑tsakin hasashen 95 % ya wuce sifili** (‑0.40 zuwa 1.33). Saboda haka, wani gwaji a wani yanayi na iya nuna babu fa'ida ko ma ƙaramin tasiri mara kyau. Matsakaicin alƙaluma yana da kyau, amma ba yana nufin zai yi aiki ga kowane ɗan ɗagawa ko ɗan wasa ba. ## Juriya Mai Numfashi Ta Fi Ƙarfi Nau'in motsa jiki shine babban mai bambanta tasirin (P_between = 0.006). Sakamakon ya rabu kamar haka: - **Juriya mai numfashi:** shaidar da tafi daidaituwa, tare da g = 0.54 (95 % CI 0.22‑0.85, *p* = 0.002). - **Ƙarfi:** tasirin ya kasance na ƙara, amma ba a tabbatar da shi ba. - **Karfin sauri da juriya na tsoka:** babu isasshen shaidar da za a yanke hukunci. Wannan ba yana nufin ba a da wani amfani ba a ƙarfafa, sai dai alamar “ƙara ƙarfi” ba ta da ingantaccen goyon baya kamar yadda take ga juriya. Idan ka nufi ƙara nauyi a bench press, wannan takarda ba ta ba ka hujjar ƙarfi ba. Amma idan kana gudu, hawan keke ko rowing, hujjar ta fi ƙarfi. ## Kima mafi Alheri: 500‑600 mg a Rana Masu rubutu sun tantance **500‑600 mg a rana** a matsayin zangon da shaidar ta fi tallafawa. Sun jaddada cewa wannan ƙimomi **ƙirƙira‑hasashe** ne – yana nuni da alamar da za a ƙara gwadawa, ba da tabbacin cewa wannan shine mafi alheri ba. Meta‑regression ya haɗa duka ƙima da tsawon lokaci, amma takardar ba ta fayyace ko a sha shi kafin motsa jiki, bayan abinci, ko da yamma ba. Haka kuma ba ta nuna wane irin fitarwa (kapsul, tincture, da sauransu) ya fi dacewa. Wannan gibin na buƙatar ƙarin bincike. ## Wa Zai Iya Amfana? - **’Yan wasa masu haɓaka juriya** – masu gudu, masu hawan keke, masu iyo – da ke neman ƙarin kari da alamar bincike. - **Matasa da ‘yan wasa** – su ne mafi yawan waɗanda aka bincika. ### Shawarwarin Amfani 1. Ka tsaya a cikin zangon **500‑600 mg a rana** (ko daidaita da nau’in samfur ɗin da kake amfani da shi). 2. Ka duba alamun samfur (standardized extract) don sanin adadin *fitarwa*. 3. Ka auna tasirin kai tsaye – misali, gwajin VO₂max ko nisan juriya – don ganin ko yana aiki a gare ka. ### Wa Ya Kamata Ya Yi Hanya Ko Ya Daina? - **Masu neman ƙara ƙarfi ko sauri** – shaidar ba ta da ƙarfi ko tabbas a wannan bangaren. - **Matsalolin shekaru** – mafi yawan mahalarta matasa ne; ba a tabbatar da tasiri a manya, yara ƙanana, ko tsofaffi ba. - **Masu cuta, masu shan magani, ko masu juna biyu** – takardar ba ta binciki wadannan rukuni ba; ƙara tuntuɓi ƙwararren likita kafin farawa. ## Ƙuntatawa Da Ya Kamata Ka Kula Da Su 1. **Ƙananan tushe na shaidar** – gwaje‑gwaje 13 da mutane 599 suna da iyaka, musamman idan an raba su kan nau'o'in sakamako. 2. **Heterogeneity mai girma** – I² = 60 % da tsaka‑tsakin hasashe da ke wuce sifili suna rage yarda da sakamakon a kowanne yanayi. 3. **Ƙirƙira‑hasashe kan kima** – zangon 500‑600 mg hanya ce, ba hukunci ba. 4. **Rashin cikakken rahoto kan jinsi** – gwaje‑gwaje biyar ba su ba da cikakken bayani kan jinsi ba, wanda ke iyakance fahimtar tasirin tsakanin maza da mata. 5. **Bayanan ƙarancin ƙarfi da juriya na tsoka** – ba a samu hujja mai karfi ba. Masu rubutu sun ba da shawarar a ci gaba da gudanar da gwaje‑gwaje masu rajista a gaba, masu ƙarfi, a rufe ido biyu, daidaitattun samfur, da rarrabuwa bisa jinsi. Hakanan suna ƙarfafa a duba ɓoyayyen ɓangaren aikin jiki, sa ido kan illa, da gwaje‑gwajen musamman ga wasanni. ## Kammalawa Wannan binciken meta‑analysis yana nuna cewa shan ashwagandha na baka **na iya** inganta wasu sakamakon aikin motsa jiki, tare da shaidar da tafi karfi a kan **juriya mai numfashi** kuma a zangon **500‑600 mg a rana**. Shaidar kan ƙara ƙarfi da sauri ba ta da ƙarfi sosai. Ka ɗauki ashwagandha a matsayin zaɓi mai alƙawari, musamman ga ‘yan wasan juriya, amma kada ka ɗauke shi a matsayin maganin tabbatacce na ƙara ƙarfi.

Creatine + Beta‑Alanine: Haɗin da Ba Su Ba da Fa’ida

Dr. Gymbro — Wed, 28 Oct 2026 08:12:17 GMT

# Creatine + Beta‑Alanine: Haɗin da Ba Su Ba da Fa’ida ## An gabatar da shi a kasuwa – menene hakikanin sakamakon? Kun taɓa ganin buhunan pre‑workout da ake kira “ultimate performance stack”. A cikin su ana sayar da creatine da beta‑alanine a matsayin **kunshin guda** da zai ƙara wa juna ƙarfi. Sai wani sabon *systematic review* da *network meta‑analysis* da aka wallafa a **Journal of the International Society of Sports Nutrition** ya bincika wannan tunani, ya kuma gano cewa **creatine ne ke haifar da tasiri, yayin da haɗin ba ya ƙara wani abu da auna**. ## Menene masu binciken suka yi a zahiri? Bai da Xu da ƙungiyarsa daga Jiangxi University of Science and Technology (China) sun bi ka’idojin PRISMA. Sun yi tanadi a PubMed, Scopus da Web of Science har zuwa watan Agusta 2025. Sun tara gwaje‑gwajen ƙarfafa da aka gudanar a yanayi na **randomized controlled trials** (RCT) na creatine, beta‑alanine, ko duka biyun tare, kuma waɗanda suka ɗauki akalla makonni biyu a jikin ‘yan wasa masu lafiya. Gwaje‑gwajen **52** da suka samu **PEDro score** ≥ 6 sun cancanci shiga. *Network meta‑analysis* yana ba da damar kwatanta dabaru da dama a lokaci guda – a nan an haɗa creatine kaɗai, beta‑alanine kaɗai, haɗin su, da placebo. Abubuwan da aka auna sun haɗa da: - Gudun sprint - Tsallen vertical - Agility (saurin motsi) - Ƙarfin juriya na tsokar sama da ƙasa - Maimaita‑sprint ability (RSA) ## Babbar sakamako: creatine ya yi nasara, haɗin ba ta ƙara komai Idan an kwatanta da placebo, **creatine kaɗai** ya haɓaka matuƙar ƙarfi: - **Gudu:** SMD = ‑0.64 (p = 0.04) – alamar “‑” na nuni da saurin gudu. - **Tsalle:** SMD = 0.33 (p = 0.002) - **Maimaita‑gudu:** SMD = ‑0.78 (p = 0.01) - **Ƙarfin juriya na tsokar sama:** SMD = 0.43 (p = 0.01) Matsayin P na creatine a ƙididdiga na *network meta‑analysis* ya kai **0.90 ko sama** a waɗannan fannoni, wato yana kan gaba ko kusa da shi a jerin zaɓuɓɓuka. Beta‑alanine ta ba da "tasirin da ba shi da muhimmanci ko yanayi‑na‑musamman". Haɗin su biyu **ba ya ba da fa’idar haɗin kai**. Marubutan sun ƙare da cewa ƙara beta‑alanine ba ya ƙara wani ƙarin riba a kan creatine kaɗai. ## Me ya sa “hanyoyi biyu” ba su yi aiki ba? A takardar, an yi bayani kan yadda kowane sinadari ke aiki. **Creatine** yana taimakawa sake gina phosphocreatine da saurin juyin ATP – hakan ya ƙara ƙarfin haɓakar‑ƙarfi a gajeren lokaci. **Beta‑alanine** kuwa na ƙara carnosine a tsoka, wanda ke rage ƙururuwar acid a lokacin wahala. Duk da cewa dabarun su daban‑daban, binciken bai ga wani haɗin tasiri ba. Marubutan sun nuna cewa **buffering** na beta‑alanine na iya zama takamaiman aikin da ba shi da ƙarfi isasshe da zai ƙara tasirin creatine. A ra’ayinsu, fa’idar creatine ta fi fitowa daga ingantaccen dawowar phosphocreatine da ƙarfafa neuromuscular, waɗanda suke da tasiri kai tsaye a gudu, tsalle da maimaita ƙoƙari. ## Abubuwan da ba su motsa ba Creatine **ba ya haifar da canji mai muhimmanci** a **agility** ko **ƙarfin juriya na ƙasa** (duka p > 0.05). Don haka ba zai magance dukkan nau’in aikin jiki ba, kuma ba a samu hujja da ke nuni da cewa zai inganta kowanne gwaji na performance ba. ## Yaya sahihancin wannan shaida? Makalun tana da ƙarfi. Ta ƙunshi kawai RCTs da aka gudanar a yanayi na random tare da **PEDro score** ≥ 6, kuma babu alamar **publication bias** ko rashin daidaito a matakin duniya baki ɗaya. **Sai dai, akwai wasu ƙuntatawa da za a lura da su:** - **Heterogeneity:** I² ya bambanta daga 0 % zuwa 73 %, wato wasu sakamako na iya fitowa daga gwaje‑gwajen da ba su da cikakken jituwa. - **Populasi:** An takaita binciken ga manyan ‘yan wasa masu lafiya; ba lallai sakamakon ya shafi tsofaffi, masu cuta ko masu farawa ba. - **Jinsi da nau’in wasanni:** An ba da shawarar a ƙara nazari kan bambance‑bambancen jinsi da wasanni, domin tasirin zai iya ɓoye a ƙungiyoyi daban‑daban. - **Tsawon lokaci da ƙirƙira:** Ana buƙatar ƙarin RCTs masu tsawon lokaci, manyan ƙungiyoyi da kuma gwaje‑gwajen da ke duba hulɗar sinadiran. - **Beta‑alanine ba “babu amfani” ba ne:** Binciken ya nuna ba ta da tasiri mai mahimmanci a cikin wannan nazari, amma ba yana nufin ba za a samu fa’ida a wasu yanayi ba. - **Ƙarancin bayani a takaitaccen rubutu:** Takaitaccen rubutun ba ya ba da adadin fitowar ’yan wasa ko yawan mahalarta a kowanne rukuni, don haka a duba cikakken takarda kafin yanke hukunci. ## Abubuwan da za a ɗauka a aikace - **Matsakaici da lokacin ɗauka:** Takaitaccen rubutun ba ya fayyace adadin ko tsawon lokacin amfani. A ƙarin bincike da dama, ana ba da shawarar **creatine monohydrate** tsakanin **gram 3‑5 a kullum**, a sha akai‑akai, na akalla makonni biyu don a ga tasiri. - **Wa ya dace da shi:** Bisa ga sakamakon, creatine ya fi dacewa ga ‘yan wasa da aikin su ya dogara da gudu, tsalle, maimaita ƙoƙarin ƙarfi ko ƙarfin juriya na tsokar sama – misali ‘yan wasan ƙungiya, masu tsere, da masu ɗaga nauyi. - **Wa zai guje wa haɗin:** Idan burinku shi ne samun ƙarin fa’ida daga “stacking”, wannan binciken ba ya ba ku dalilin biyan kuɗi ga haɗin. Idan har yanzu kuna ɗaukar beta‑alanine kuma ba ku da wata matsala, ba wata hujja da ke nuna cewa yana da illa, amma ba ya ƙara tasirin creatine a cikin wannan nazari. - **Wa ya kamata ya yi taka tsantsan:** Binciken ya ta’allaka ne akan manyan ‘yan wasa masu lafiya. Duk wanda ke da wata cuta – musamman masu matsalar koda, mata masu dauke da ciki, ko masu shan magani – ya kamata ya tuntuɓi likita kafin fara kowane ƙari. ## Kammalawa Idan kuna neman inda za ku zuba kuɗin ƙarin abincin ku, wannan *network meta‑analysis* na gwaje‑gwajen 52 RCT na goyi bayan **creatine** a matsayin ɗayan manyan ƙari masu ɗorewa ga aikin ƙarfi da anaerobic. **Beta‑alanine** na iya taimakawa a wasu yanayi, amma a wannan nazari ba ta ƙara **creatine** zuwa wani abu mafi girma ba. Gwaje‑gwajen da za su fi tsayi, manya‑manya da rukuni‑rukuni na iya ƙara haske a gaba, amma a yanzu, wannan haɗin ba shi da ƙima don biyan kuɗi na musamman.

Shin Creatine Zai Iya Rage Zafin Jumper's Knee? Bayanan Mako na 4

Dr. Gymbro — Tue, 27 Oct 2026 08:12:03 GMT

# Shin Creatine Zai Iya Rage Zafin Jumper's Knee? Bayanan Mako na 4 Jumper's knee (tendinopathy na patella) na iya dakatar da ‘yan wasa tsawon watanni. A wani sabon gwaji, masu bincike sun tambayi ko **creatine monohydrate (Creapure®)** zai iya hanzarta farfadowa. Daga cikin ‘yan wasa 20 da suka yi shirin *eccentric* rehab, ƙungiyar da ta karɓi creatine ce ta nuna gagarumin ci gaba a zafi (VISA‑P) da tsayin *countermovement jump* (CMJ) a mako na huɗu. A mako na takwas, dukkan ƙungiyoyi sun kai kusan irin wannan matakin, kuma bambancin tsakanin su ya rage (p = 0.099). A ƙasa akwai cikakken bayani kan yadda aka gudanar da binciken, yadda aka sha creatine, wa zai amfana, da kuma dalilan da ya sa ya kamata a yi taka‑tsantsan. --- ## Gajeren Bayani Masana sun yi amfani da **creatine monohydrate (Creapure®)** a haɗe da shirin rehab mai tsari ga ‘yan wasa masu ciwon *patellar tendinopathy* (jumper's knee). A mako na takwas, ƙungiyar da ta sha creatine da wadda ta sha placebo duk sun inganta sosai; bambancin ya bayyana ne a mako na huɗu, inda ƙungiyar creatine ta nuna ƙaruwa mai mahimmanci a **VISA‑P** (wanda ke auna zafi da aikin gwiwa) da a **CMJ**. Wannan alama ce mai ƙarfi, amma ba tabbatacciyar shaida ba. Ga ƙarin bayani a ƙasa. --- ## Abin Da Binciken Ya Yi Sánchez‑Gómez da abokan aikin sa sun wallafa sakamakon a *Journal of the International Society of Sports Nutrition* (2026). Gwajin an gudanar da shi a yanayin **triple‑blind**, kuma an raba ‘yan wasa 20 (matsakaicin shekaru 34) zuwa ƙungiyar creatine (n = 9) da ƙungiyar placebo (n = 11) ta hanyar bazuwar. ### Shirin Rehab - Horon **eccentric** na ƙafafu a kowace rana, tare da shimfiɗa. - Maganin **shockwave (ESWT)** a kowace mako guda ɗaya. - Kula da hannu (manual therapy) a yankin tendin da ke kewaye da gwiwa. ### Kayan Kari A ƙarshen kowanne zama na horon eccentric, an ba su ɗaya daga cikin waɗannan: - **Creatine group:** 3 kwayoyi na Creapure® (kusan 3‑5 g) a ruwa. - **Placebo group:** Kwaya uku na sukari a ruwa. An yi gwaje‑gwaje a matakai uku: kafin fara rehab (baseline), a mako na huɗu, da kuma a mako na takwas. An auna: - **VISA‑P** (zafi da aiki) - Kaura da kaurin tendon ta **ultrasound** - Jimillar jiki ta **bioimpedance** - Tsayin **CMJ** - Ƙarfi ta **5‑RM** na ɗaga ƙafa. --- ## Sakamako Na Dacewa ### Zafi da Aiki (VISA‑P) - Duka ƙungiyoyi sun inganta a mako na takwas: creatine daga 60.6 → 78.0, placebo daga 60.0 → 75.2. - A mako na huɗu, **creatine** ta kai 70.2, wanda ya bambanta da **placebo** (ba a sami ƙaruwa ba) (p = 0.027). ### Tsayin Tsalle (CMJ) - Creatine: 34.3 cm → 36.8 cm a mako na huɗu (p = 0.019), sannan 37.6 cm a mako na takwas (p = 0.015). - Placebo: ba a sami ƙaruwa mai mahimmanci ba a mako na huɗu. ### Kaurin Tendon da Ƙarfi - Duka ƙungiyoyi sun samu ƙaruwa a kaurin tendon da 5‑RM, amma ba a ga tasirin ƙarin creatine a wannan ɓangaren ba. --- ## Gargadi Da Bayanai Masu Muhimmanci - **Samfurin ƙanana:** ‘Yan wasa 20 ne kawai, kuma ƙungiyar creatine ta ƙunshi mutane 9. Wannan yana nufin sakamakon na da ƙarfi ƙasa. - **Alamar yaɗa:** Bambanci tsakanin ƙungiyoyin a lokaci‑lokaci ya nuna `p = 0.099` (partial η² = 0.126). Wannan ba ya wuce ƙa’ida na al'ada (p < 0.05). - **Ba a auna dawowa zuwa wasa ba:** An yi la’akari da raguwar zafi da ƙaruwa a tsayin tsalle kawai, ba a auna lokacin da ‘yan wasa suka koma gasar ba. - **Lokaci mai ƙanƙanta:** Mako takwas ba su ba da damar lura da sake faruwar ciwo ko lafiyar tendon a dogon lokaci ba. - **Rarraba shekaru:** Matsakaicin shekaru 33.7; sakamakon na iya ƙasa a musamman ga matasa ko manyan ‘yan wasa. Masu binciken sun kammala da cewa creatine "na iya zama zaɓi na ƙari" a lokacin dawowa da ƙarfafa. Wannan maganar ta fito ne a hankali, don neman ƙarin bincike. --- ## Wa Za Su Iya Amfana? Da farko za su amfana ne **‘yan wasa a wasanni masu ƙara tsalle ko nauyi** – kamar volleyball, basketball, ko gudun tsalle – waɗanda ke bi da shirin *eccentric* don jumper's knee. Creatine yana daga cikin ƙarin abinci da aka fi bincikawa a fannin wasanni, farashinsa ma ba shi da tsada. Idan ba a samu wani yanayin lafiya na musamman ba (misali matsalar koda), haɗarin rashin amfanin creatine yawanci ƙasa ne, amma a koyaushe ya kamata a tuntuɓi likita kafin a fara. **Ba ya maye gurbin horon ƙarfi**. A wannan gwaji, creatine an ƙara ne a kan shirin rehab mai cike da horon eccentric, maganin shockwave, da kuma maganin hannu. Saboda haka, ci gaban kauri da ƙarfi ya kasance sakamakon shirin gaba ɗaya. --- ## Yadda Ake Amfani da Creatine a Gida - **Lokaci:** An sha creatine nan da nan bayan kowanne zama na horon eccentric. Wannan hanya mai sauƙi ce, amma takardar ba ta kwatanta ko shan a wannan lokaci yafi sauran ba. - **Matsakaicin Kwaya:** Takaitaccen bayani ya nuna kwayoyi uku a rana, amma ba a fayyace gram ɗin ba. Yawanci ana ba da 3‑5 g a rana. - **Nau’in Creatine:** An yi amfani da **creatine monohydrate** (Creapure®), wanda shine mafi yawan nazari a fannin sport. - **Abubuwan da ake Sa Ran:** Ka ɗauka a matsayin ƙara gajeren ci gaba a cikin wata ɗaya, ba magani ba. A mako na takwas, ƙungiyar placebo ta kusan kai ga matakin créatine a kan zafi. - **Haɗa da Kwararren Lafiya:** Kowane shirin rehab ya kamata a jagorance shi ta ƙwararren likita ko ƙwararren mai motsa jiki da zai iya bibiyar ci gaban da alamun ƙarar da ake da su. --- ## Kammalawa Wannan gwaji da ya ƙunshi ‘yan wasa ƙalilan ya nuna cewa **creatine na iya hanzarta rage zafi da inganta tsayin tsalle a farkon makonni na rehab na jumper's knee**. Duk da haka, bambancin tsakanin ƙungiyoyi ya kasance a matsayin alamar yaɗa kawai (p = 0.099), kuma adadin ‘yan wasa 20 ba ya ba da dama ga ƙarfafa shawara a matsayin sabuwar ka’ida ta rehab. Idan kana amfani da creatine ko kana tunanin ƙara shi, wannan sakamakon zai ba ka wani tunani, amma a ko da yaushe ka ci gaba da bin shirin *eccentric* da sauran hanyoyin da aka tabbatar da inganci. **Source:** Sánchez‑Gómez et al., “Could creatine supplementation combined with physical rehabilitation accelerate return to play in athletes with patellar tendinopathy?” *J Int Soc Sports Nutr* (2026). DOI: https://doi.org/10.1080/15502783.2026.2718846 | [PubMed](https://pubmed.ncbi.nlm.nih.gov/42730713/)

Ketone IQ Ya Ɗaga Ketones a Cape Epic, Amma Bai Samu Tasiri ba

Dr. Gymbro — Tue, 27 Oct 2026 08:11:08 GMT

# Takaitaccen Bayani Kwana takwas. Daruruwan kilomita na hanyar dutse mai tsanani a Afirka ta Kudu. Sau biyu a rana ana sha abin sha mai daraja na ketone. A ƙarshen, masu tuka da suka sha Ketone IQ sun yi daidai da waɗanda suka sha placebo – a gani, ji da kuma yadda suka yi. Wannan shi ne taken wani sabon gwajin *double‑blind* da aka wallafa a *European Journal of Sport Science*, kuma yana ba da wani ƙididdiga mai amfani ga duk wanda ke tunanin amfani da ƙarin ketone domin murmurewa. --- ## Menene Masana suka Gwada? Engelbrecht da ƙungiyarsa sun bi sahun masu tuka keke na dutsen da suka horar (mountain bikers) guda 18 (a ƙungiyoyi 10) a tseren **Absa Cape Epic 2025**, wata gasa ce da ake yi tsawon kwanaki takwas da ke da matakai da dama. An rarraba su zuwa biyu: waɗanda suka sha 87.5 mL na **Ketone IQ**, wanda ke ɗauke da sinadarin aiki R‑1,3‑butanediol (BDO), ko kuma suka sha madadin wuri (placebo). An ba su wannan ruwan sau biyu a rana – bayan kowane mataki da safe bayan kwanciya. Ƙungiyar ta tattara alamu da dama na ainihin rayuwa: - Bugun zuciya, duka yayin motsa jiki da a hutu - Yawan kuzari da abincin carbohydrates da ake ci - Shayar da ruwa (hydration) - Bayanai kan bacci - Ayyukan tunani, ciki har da lokutan amsa (reaction time) - Jin damuwa da yadda ake murmurewa (subjective stress & recovery) Wannan shi ne ainihin manufar binciken. Yawancin binciken ketone ana yin su a dakunan gwaje‑gwaje ne kawai. Anan an tambayi ko BDO zai iya taimakawa a yanayin gajiya, bacin bacci da matsin lamba na abinci da ke haifar da gajiya cikin mako guda na tseren. --- ## Sakamakon Da Ya Sha Ban Mamaki: Ketosis, Amma Babu Amfani Abin sha ya cika abin da ya ƙunsa a sinadarai na jini. BDO ya haifar da **ketosis** mai sauƙi, kusan 1.0 mM na β‑hydroxybutyrate (BHB), tun daga mataki na farko. Amma fa, amfanin ba su biyo baya ba. A duk tsawon tseren, **ƙungiyoyi biyu** sun nuna irin alamu iri ɗaya na ƙaruwa a gajiya: - Ƙarancin bugun zuciya yayin motsa jiki - Ƙaruwa a bugun zuciya a hutu - Ɗaga yawan kuzari da carbohydrates da ake ci - Jinkirin lokutan amsa daga mataki na 6 BDO bai canza waɗannan alamu ba idan aka kwatanta da placebo. Taken takardar ya bayyana a fili: **post‑exercise BDO bai inganta alamun gajiya ko murmurewa ba**. Marubutan sun kammala da cewa, ƙananan ketosis ba ta da tasiri a yanayin tseren na ainihi. Wannan al'amari ya zama kamar hoton littafi na gajiya da ke taruwa a tseren matakai da dama, kuma abin sha na ketone bai iya karkatar da shi ba. --- ## Butanediol Ba Kamar Ketone Ester Ba Wannan shi ne ɓangaren da masu saye suka fi rasa fahimta. “Ketone supplement” na nufin nau’o’i da dama. Adabin da marubutan suka ambata yana mai da hankali kan **ketone monoester (KME)**, wanda aka danganta da ƙarin murmurewa da rage damuwar jiki a lokacin motsa jiki na nisa. BDO kuwa wani *precursor* ne na ketone: jiki dole ne ya juya shi zuwa BHB, ba kai tsaye yake ba. A ka’ida, wannan hanya tana samar da ƙananan matakan ketone a jini idan aka kwatanta da monoester, kuma kusan 1 mM da aka samu a nan ya dace da wannan ra’ayi. Marubutan kansu sun jaddada wannan batu, suna kira ga “bincike na takamaiman ƙira”. A sauƙaƙe, sakamakon rashin tasiri na BDO ba yana nufin cewa ketone esters ba su da amfani ba, kuma sakamakon mai kyau daga ester ba yana nufin BDO zai yi aiki ba. Su daban‑daban ne da hujjojin su ma daban. --- ## Menene Wannan Ke Nufi Ga Mai Son Sayi? Binciken bai nuna cewa ketone ba su da amfani kwata‑kwata ba, amma ya rage tunanin cewa **Ketone IQ** wata hanya ce mai saurin murmurewa ga tsare‑tsaren nisa na kwanaki da dama. - **Matsakaicin adadi da lokacin da aka gwada:** 87.5 mL sau biyu a rana, bayan motsa jiki da kafin kwanciya. Wannan shine tsarin da ba ya haifar da canji a alamun murmurewa a nan. Shan ƙarin ko a lokuta daban ba a gwada ba. - **Wanene zai iya cin moriyar sa ba:** Idan babbar burinka shi ne samun murmurewa, bacci mai kyau ko sabuwar ƙarfi a kowanne rana a cikin tseren matakai, wannan gwaji ba ya ba da shaida da ke tallafa wa hakan. - **Ina za ka fi kashe kuɗi?** Masu tuka a rukuni biyu sun ƙara cin carbohydrates da kuzari yayin tseren. Kula da abinci, bacci da shan ruwa na da hujja sosai a matsayin alƙawarin saka jari kafin ka ɗauki wani ƙarin sinadari da ba a tabbata. - **Ka tabbata da sinadarin:** Idan kana saye, duba ko samfurin yana dauke da BDO ne ko ketone ester, kuma kar ka ɗauka cewa sakamakon daya ya shafi ɗayan. --- ## Ƙuntatawar Gwaji Da Za a Lura Da Su Wannan karamin bincike ne, kuma wasu abubuwa suna da tasiri: 1. **Yawan mahalarta:** Masu tuka 18 ne kacal. Gwaji ƙarami na iya rasa tasirin da ba shi da ƙarfi sosai, don haka “babu bambanci da aka gani” ba yana nufin “babu tasiri kwata‑kwata”. 2. **Masu tuka a ƙungiyoyi:** Ƙungiyoyi 10 suna kawo tarin bambance‑bambancen ainihi – kamar yadda aka tsara gudu, yanayin ƙasa da buƙatun matakai daban‑daban – waɗanda gwajin daki ba zai iya kawar da su ba. 3. **Sinadari, adadi, lokuta guda:** Sakamakon yana ƙuntata ga wannan samfurin na BDO, a wannan adadi, a irin jadawalin da aka yi amfani da shi. Ba ya magana kan amfani kafin motsa jiki ko wasu siffofi. 4. **Ketosis mai sauƙi:** BHB ya kai kusan 1.0 mM. Shin matakin da ya fi girma zai iya canza sakamakon ba a gwada ba. Duk da haka, fasalin binciken shi ne ƙarfi. Gwaji double‑blind, da aka yi a ainihin tseren kwanaki takwas, abu ne mai wahala a aiwatar; kuma yana ba da nau’in hujja mai inganci da yawanci tallan ƙarin sinadarai ke rasa. --- ## Ƙarshe **Ketone IQ** ya ƙara ketones a jinin masu tuka a Cape Epic, amma bai rage gajiya, ba ya ƙara saurin amsa, kuma bai inganta murmurewa idan aka kwatanta da placebo. Don ‘yan wasa masu juriya da ke tunanin siyan abin sha mai tsada na ketone, wannan sakamakon na nuna cewa ya kamata su yi taka‑tsan‑tsan da BDO a matsayin hanyar murmurewa. Bincike mafi girma, tare da kwatanta kai tsaye da ketone esters, zai ba da amsa mafi cikakke. **Manbobi:** Engelbrecht et al., “Post‑Exercise R‑1,3‑Butanediol did not Improve Markers of Fatigue or Recovery During a Multi‑Stage Mountain Bike Race,” *European Journal of Sport Science* (2026). DOI: https://doi.org/10.1002/ejsc.70260. PubMed: https://pubmed.ncbi.nlm.nih.gov/42852530/

Baking Soda da Horon Sprint: Gwargwadon Gwargwado Fiye da Placebo a Kowane Gwaji

Dr. Gymbro — Tue, 27 Oct 2026 08:10:13 GMT

## Abubuwan da ke cikin kwandon girki da ke ƙara tasirin horon sprint Sprint interval training (SIT) tuni yana ɗaya daga cikin hanyoyin da suka fi sauri wajen gina ƙarfin sprint da juriya. Sabbin sakamakon wani gwaji na ƙarshe sun nuna cewa foda mai araha, sodium bicarbonate (baking soda), na iya ƙara wa horon tasiri, inda adadin da ya fi girma ke ba da ƙarin fa'ida. Binciken da Wang da abokan aiki suka wallafa a *Journal of the International Society of Sports Nutrition* (2026) ya kwatanta ƙwararren adadi biyu na sodium bicarbonate a tsakanin ‘yan wasan kwallon ƙasa da ke horar da SIT na tsawon makonni huɗu. Babban sakamako: **duka adadin suna fi placebo, kuma adadin da ya fi girma ya fi ƙananan a kowanne ma’auni da aka auna**. ## Abin da masu binciken suka yi An zaɓi ‘yan wasa maza 40, masu shekaru 21.6 ± 2.1, tsayin 185 cm, nauyin 84 kg. An raba su a rukuni hudu, kowanne da ‘yan wasa goma: - SIT + 0.3 g/kg sodium bicarbonate - SIT + 0.45 g/kg sodium bicarbonate - SIT + placebo - Kulawa (ba a yi SIT ba) Horarwa ta tsawon makonni huɗu a lokacin kakar. Rukunan SIT sun yi horo sau uku a kowane mako, ƙari da atisayen kwallon ƙasa na yau da kullum. Kowane taro ya ƙunshi zagaye huɗu na sprint guda 10 s da hutu na sakan 20 tsakanin sprint‑kuna, da minti 2 tsakanin zagaye. Duk ‘yan wasa 40 sun kammala, ba tare da ficewa ba. An auna auna kafin da bayan horon: - Countermovement vertical jump da standing long jump - Sprint na mita 20 - Illinois change‑of‑direction test (agility) - Yo‑Yo Intermittent Recovery Test Level 1 (repeat‑effort endurance) - Wingate test don auna peak da mean power ## Sakamako a sauƙaƙe Duk rukunan SIT sun samu ci gaba a kan lokaci, kuma su ne suka fi rukunin kulawa, abin da ba abin mamaki ba ne domin rukuni na kulawa bai yi sprint ba. Abin da ya fi jan hankali shi ne bambancin tsakanin sinadarin da placebo. Duka rukunan da aka ba da sodium bicarbonate sun fi SIT + placebo haɓaka a tsayin tsalle, tsayin dogon tsalle, lokacin sprint, agility, nisan Yo‑Yo, peak power da mean power (p < 0.05). Rukuni na 0.45 g/kg ya haɓaka fiye da na 0.3 g/kg a dukkan waɗannan ma’auni. Wannan yana nuna tsarin **dose‑response** mai tsabta: placebo → 0.3 g/kg → 0.45 g/kg, inda ribar ke ƙaruwa a kowane mataki. ## Me ya sa baking soda ke taimakawa horon sprint? Baking soda (sodium bicarbonate) sinadari ne mai alkalizing. Ka’idar da aka fi sani ita ce yana ƙara ƙarfin tsarin “buffering” na jiki don rage ƙurar laktate da ke tattare da motsa jiki masu ƙarfi. Idan ‘yan wasa za su iya ci gaba da yin sprint da ƙarin inganci a kowane zagaye, tasirin horon na iya zama mafi girma, wanda zai iya haifar da manyan sauye‑sauye a cikin makonni. Wannan ƙirƙirayyen bayani ne kawai; binciken bai auna yanayin ruwan jini ba, don haka ba za a iya tabbatar da shi ba. ## Yadda ake amfani da shi: adadi, lokaci, wa zai amfana **Adadi bisa ga nauyin jiki** - 0.3 g/kg: kusan gram 25 ga ɗan wasa mai nauyin 84 kg - 0.45 g/kg: kusan gram 38 ga ɗan wasa mai irin wannan nauyi Foda na sodium bicarbonate yana da nauyi kusan gram 4‑5 a cikin cokali ɗaya. Don haka adadi na bukatar cokali da yawa; ‘yan wasa da dama suna amfani da capsules maimakon foda. **Lokaci** Takaitaccen bayanin bai fayyace lokacin ɗaukar adadi ba. A mafi yawan shirin abinci na wasanni, ana ba da bicarbonate a awanni 1‑2 kafin motsa jiki. Duba takardar asali don sanin ainihin tsarin kafin a kwaikwaya. **Wa zai amfana** Sakamakon ya shafi ‘yan wasa maza matasa da suke horar da sprint mai ƙarfi—kamar kwallon ƙasa, kwallon ƙafa, hockey ko wasu wasannin ƙungiya a kakar. Ga masu farawa a dakin motsa jiki, mata, manya, ko masu horo daban, ba a tabbatar da tasirin ba. ## Matsalar hanji da yakamata a kula da ita Masu binciken sun lura cewa adadi mafi girma na iya haifar da rashin jin daɗin ciki. Takaitaccen bayanin bai ba da adadi na ‘yan wasan da suka fuskanci wannan matsala ba, don haka kada a ɗauka cewa adadi 0.45 g/kg ba zai yi rauni ba. Shawarwarin masana abinci na wasanni (ba a gwada su a wannan binciken ba) sun haɗa da: - Gwada adadi a wani lokaci a rana, ba a ranar wasa ba. - Raba cikakken adadi zuwa ƙananan kashi‑kashi (misali, rabi a safe, rabi a gaba). - Sha tare da abincin da ke da carbohydrates da ruwa. - Amfani da capsules maimakon foda a ruwa. - Fara da adadi ƙasa (0.2 g/kg) sannan a ƙara idan jiki ya iya jurewa. Saboda bicarbonate yana ƙara yawan sodium a jiki, duk wanda ke da hawan jini, matsalar ƙoda, ko wasu cututtuka ya kamata ya tuntuɓi likita kafin ya fara. ## Ƙuntatawa da gaskiya - **Bincike ƙanana:** ‘Yan wasa 10 a kowane rukuni, don haka sakamakon na iya bambanta a manyan gwaje‑gwaje. - **Lokaci ƙanƙanta:** Makonni huɗu ba su ba da cikakken bayani game da fa'idodin dogon lokaci ko ko ribar za ta tsaya ba. - **Maza kawai:** Dukkan mahalarta maza ne. - **Rukuni na kontrol ba shine babban kwatancen ba:** Muhimmiyar kwatanta ita ce Sb vs placebo da high vs low dose. - **Babu ƙididdiga na girman tasiri:** Significance na ƙididdiga ba ya nuna girman ribar a aikace, don haka ikirarin “ya ninka” na iya ƙara wuce abin da ke a bayanai. - **Hadari ga hanji:** Adadi mafi girma na iya jawo matsalolin hanji ga wasu mutane. ## Kammalawa A wannan gwaji, ƙara sodium bicarbonate ga horon sprint na makonni huɗu ya haifar da muhimman haɓaka a tsalle, sprint, agility, repeat‑effort endurance da anaerobic power idan aka kwatanta da placebo, kuma adadi 0.45 g/kg ya fi 0.3 g/kg a dukkan ma’auni. Wannan hanya ce mai araha kuma mai jan hankali ga ‘yan wasa na ƙungiya, amma dole ne a yi ta da hankali, tare da gwajin adadi da lura da lafiyar hanji. **Source:** Wang et al. *Dose-dependent effects of sodium bicarbonate supplementation combined with sprint interval training on performance adaptations in basketball players: a randomized placebo-controlled trial.* J Int Soc Sports Nutr, 2026. DOI: https://doi.org/10.1080/15502783.2026.2735090 | PubMed: https://pubmed.ncbi.nlm.nih.gov/42853711/

Ninkawa Kafeyin Ba Ya Taimaka ‘Yan Boxers—Ga Abin Da Ya Faru

Dr. Gymbro — Tue, 27 Oct 2026 08:09:04 GMT

# Ninkawa Kafeyin Ba Ya Taimaka ‘Yan Boxers—Ga Abin Da Ya Faru Ka yi tunanin cewa ninka adadin caffeine a pre‑workout zai ninka aikinka? Gwaji na kwanan nan da aka gudanar a kan ‘yan boksi masu gasa ya nuna hakan ba lallai ba ne. Masana sun kwatanta **3 mg/kg** da **6 mg/kg** na caffeine da kuma placebo. Duk rukuni biyu sun inganta aikin tsalle, amma **ƙarin adadi ba ya ba da ƙarin fa’ida a dukkan lokuta**. ## Abin Da Masana Suka Gano Binciken da aka wallafa a *Journal of the International Society of Sports Nutrition* (2026) daga Tuerhongjiang da abokan aikin, ya yi amfani da tsari **randomized, double‑blind, placebo‑controlled crossover**. An yi gwajin ne a kan **‘yan boksi maza 15**, duka ‘yan wasa na ƙwararru daga Sin, aji na biyu ko ƙasa da haka. Kowane ɗan boksi ya halarta a yanayi uku, a jere na bazuwar, tare da sati ɗaya tsakanin kowanne gwaji: - Placebo - 3 mg/kg caffeine (CAF3) - 6 mg/kg caffeine (CAF6) Ƙungiyar ta auna **countermovement jump (CMJ)**, **ballistic push‑up (BPU)** da **isokinetic peak torque (PT)** a kafada da gwiwa. An yi gwaje‑gwaje a minti 0, 30, da 60 bayan shan kwayar. An yi amfani da gyaran Holm kan gwaje‑gwajen hulɗa guda 10 don rage yiwuwar sakamakon ƙarya. ## Babban Sakamako: Duka Doses Sun Aiki A Minti 60 A ƙididdigar minti 60, duka **3 mg/kg** da **6 mg/kg** sun wuce placebo a tsayin tsalle na CMJ, ƙarfin matsakaici, da torque da aka auna. **Ba a sami bambanci mai mahimmanci tsakanin adadin caffeine biyu ba**. Don ƙara ƙarfi a gwiwa, adadi mafi ƙanƙanta ya cimma fa’ida da aka auna. Ninkawa adadi ba ta ƙara wani abu da za a iya gani a wannan gwaji ba. ## Inda 6 mg/kg Ya Fi Amfani Adadi mafi girma ya yi fice a wasu gwaje‑gwaje: - **Ballistic push‑up:** CAF6 ya haifar da ƙarin *concentric impulse*, ƙarfin matsakaici da ƙarfi fiye da placebo a minti 60. CAF3 ba ta bambanta da placebo ba a waɗannan ma’aunai. - **Knee extension torque:** Wannan shi ne sakamakon da ya fi bayyana. CAF6 ta doke duka placebo da CAF3 a minti 60. - **Shoulder torque:** *Flexion* da *extension* PT sun ƙaru a ƙarƙashin caffeine a wasu lokuta, amma ba tare da fa’ida mai yawa ba. Marubutan sun kammala da cewa amsa ga caffeine tana bambanta dangane da adadi da aikin da ake bukata, kuma **6 mg/kg ba ta zama mafi alheri a kowane yanayi ba**. Ƙarin adadi ya haifar da ‘yan nasarori kaɗan, ba duka‑daga‑baki ba. ## Jadawalin Mg‑per‑Kg Ga yadda adadin caffeine yake a milligram ga nauyin jiki daban‑daban: | Nauyin Jiki | 3 mg/kg | 6 mg/kg | |---|---|---| | 60 kg (132 lb) | 180 mg | 360 mg | | 70 kg (154 lb) | 210 mg | 420 mg | | 80 kg (176 lb) | 240 mg | 480 mg | | 90 kg (198 lb) | 270 mg | 540 mg | | 100 kg (220 lb) | 300 mg | 600 mg | Duba alamar pre‑workout dinka. Yawancin samfuran suna nuna **200–400 mg** a kowanne serving, wasu kuma suna ƙunshe da caffeine tare da sauran sinadarai masu ƙara kuzari. Idan ka sha cokali biyu, kofi, da abin sha na makamashi a lokaci guda, ka iya wuce 6 mg/kg ba tare da ka gane ba. ## Lokaci: Nemi Kusan Minti 60 Tasirin da aka samu ya bayyana a **minti 60** bayan shan caffeine. Wannan shine lokaci mafi inganci da binciken ya nuna, don haka shan caffeine kusan **sa’a guda kafin horo** ya fi dacewa. Takaitaccen bayanin ya nuna minti 60 ya fi minti 30, don haka kada ka yi tsammanin samun ƙarin fa’ida idan ka sha a lokaci guda da fara aikin. ## Overdose: Me Ya Sa Fiye Ba Za Ta Iya Zama Mafi Alheri Ba Binciken bai lissafta illolin gefe a cikin takaitaccen bayanin sa ba, don haka za mu yi nuni da abubuwan da aka sani gaba ɗaya. **Caffeine mai yawa na iya haifar da tashin zuciya, damuwa, bugun zuciya da sauri, ciwon ciki, da matsalar barci**. Ga ɗan boksi, kasancewa da ƙwarin gwiwa sosai na iya lalata hankali da riƙon ƙarfi, yayin da shan a yammaci na iya tsangwama barcin dare. Idan 3 mg/kg ke ba ka fa’ida mafi yawa, zuwa 6 mg/kg zai ƙara haɗarin illolin gefe ba tare da ƙaruwa mai yawa a yawancin sakamako ba. Wannan canjin na iya zama da amfani ga wasu gwaje‑gwaje kamar ƙarfi a gwiwa, amma ba zai zama “kyauta” ba. ## Wanene Ya Dace Da Wannan - **‘Yan wasa masu ƙarfi‑karfi da gasa** da ke neman fara da adadi mai ma’ana. - **Masu ɗagawa da masu zuwa dakin motsa jiki** waɗanda ke tunanin pre‑workout ɗinsu ya fi ƙarfin da suke bukata. - **Mutanen da ke da saukin caffeine**, wato waɗanda ke jin tasirin caffeine da wuri. Hanya mafi ma’ana ita ce ka fara da **3 mg/kg**, ka sha kusan **sa’a guda kafin horo**, ka ƙara idan kana buƙatar ƙarin ƙarfi kuma ka ga jikin ka na jurewa. Amsa ga caffeine tana bambanta tsakanin mutane, don haka gwada adadi a horo, amma **kar ka yi shi a ranar gasar**. ## Iyakokin Da Ya Kamata Ka San Su - **Ba a gwada duka kai ba.** Marubutan sun ce sakamakon na nuna wasu ƙwayoyin neuromuscular da aka zaɓa, ba ainihin ingantaccen duka kai ko nasarar gasar ba. - **Samfurin ƙanana.** Ɗalibai maza 15 ba su isa su wakilci mata ko sauran matakan wasa ba. - **Gwaje‑gwajen dakin gwaje‑gwaje.** Tsalle, push‑up da torque na isokinetic an auna a yanayi na kulawa, ba a cikin wasa na ainihi ba. - **Tsarin adadi mai gauraya.** Bambance‑bambancen tsakanin adadi ya danganta da aikin, kuma takaitaccen bayanin ya nuna cewa amsar mutum tana bambanta. - **Shan caffeine na yau da kullum.** Takaitaccen bayanin ba ya magance yadda yawan caffeine da aka saba sha ke shafar amsa, don haka ka ɗauki amsarka a matsayin tambaya da ke buƙatar gwaji. ## Gabaɗaya A cikin ‘yan boksi masu horo, **3 mg/kg** na caffeine ya inganta aikin tsalle kusan daidai da **6 mg/kg** a minti 60. Adadi mafi girma ya nuna fa’idodi ne kawai a wasu gwaje‑gwaje, musamman ballistic push‑up da torque na gwiwa. Kafin ka ƙara ƙarin cokali, **ka ƙididdige mg/kg ɗinka, ka sha kusan sa’a guda kafin horo, sannan ka tuna cewa babu shaidar da ke tabbatar da cewa hakan zai haifar da duka mafi ƙarfi**. **Source:** Tuerhongjiang et al. *Acute effects of 3 and 6 mg·kg‑1 caffeine on strength‑power performance and isokinetic peak torque in competitive male boxers: a randomized, double‑blind, placebo‑controlled crossover trial.* J Int Soc Sports Nutr. 2026. DOI: [10.1080/15502783.2026.2743368](https://doi.org/10.1080/15502783.2026.2743368) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/42841357/)

Kreatin Na Aiki Ko Da Ba Ka Iya Numfashi Ba: Gwajin Freediver Ya Nuna

Dr. Gymbro — Tue, 27 Oct 2026 08:07:58 GMT

# Kreatin Na Aiki Ko Da Ba Ka Iya Numfashi Ba: Gwajin Freediver Ya Nuna **Takaitaccen Bayani:** Kreatin an san shi da taimaka wa ‘yan wasa su ɗaga nauyi da yin sauri, amma shin zai iya taimaka a yanayin da ba a shakar iska kwata‑kwata? Wani sabon gwaji double‑blind da aka gudanar a tsakanin masu horar da *freediving* ya nuna cewa shan gram 20 na kreatin a kowace rana tsawon kwanaki bakwai ya ƙara jimillar aiki da tsawon lokacin gajiya a gwajin kekuna yayin rike numfashi. Abin mamaki, matakin lactate a jini ya ƙasa a ƙungiyar da ta sha kreatin fiye da ta placebo duk da sakamakon ƙarfi. Anan za ku ga abin da binciken ya yi, wa zai amfana, da kuma dalilin da ya sa ƙananan samfurin (20 ‘yan wasa) ke nufin a yi hankali da tsammanin. ## Me ke faruwa ga tsokoki idan ba a shakar iskar oxygen ba? Wani sabon gwaji da aka yi a cikin ‘freedivers’ ya nuna cewa kreatin – wanda aka fi bincika a cikin ƙara wa jiki ƙarfi – na iya taimaka wa jiki a yanayi marar iskar oxygen. Lokacin da mutum ya rike numfashi, tsokoki suna dogara sosai kan makamashin anaerobic; phosphocreatine na ba da taimakon ATP da ke kara wa tsokoki ƙarfi a wannan yanayin. ## Babban Gano: Ƙarin Aiki, Ƙananan Lactate Masu binciken da **Kurmazovic** ke jagoranta sun gwada tsarin shigar da kreatin monohydrate ga ‘freedivers’ masu horo. Mahalarta sun tuka kekuna a kan ergometer yayin rike numfashi guda ɗaya, suna ƙoƙarin yin nisan da zai fi tsawo. Bayan mako guda na shan kreatin, sun ƙara jimillar aiki (p = 0.011) kuma sun yi jurewa (p = 0.028) fiye da rukunin placebo. Abin da ya fi birgewa kuwa shi ne matakin **lactate** a jini. A ƙungiyar da ta sha kreatin, lactate ya ragu (p = 0.003) duk da cewa an samu ƙarin aiki. Wannan ya saba da ƙa’ida, inda a ƙara aiki yawanci ke haifar da ƙaruwa a lactate. ## Yadda Gwajin Ya Gudana - **Tsarin Gwaji:** Binciken farko, sannan a ba mahalarta ƙarin kari ko placebo, sannan a gwada su sake. - **Kari:** Kreatin monohydrate 20 g a rana na tsawon kwanaki 7 (ba a raba adadin ba a wannan takarda). - **Ma'auni:** Jimillar aiki, lokacin gajiya, matakin lactate a jini, pCO₂ da aka fitar bayan ƙoƙari, jurewar rike numfashi, da yanayin ƙashi/tsoka ta hanyar DXA scan. - **Rijista:** ClinicalTrials.gov NCT07233707. Wannan gwaji double‑blind ne, rarrabe, kuma an wallafa shi a *Journal of the International Society of Sports Nutrition* (2026). An shiga ‘freedivers’ 20 (maza 18, mata 2) da suke da matsakaicin shekaru 41.6. ## Dalilin Da Yasa Kreatin Zai Iya Amfani Lokacin Rike Numfashi Kreatin na ƙara adadin phosphocreatine a tsokoki, wanda ke ba da ATP nan da nan lokacin da iskar oxygen ta ƙare. Saboda haka, a yanayin apnea, kreatin na iya zama babban taimako ga samar da makamashi anaerobic. ## Sauran Sakamako - **Matsakaicin ƙashi mara mai (lean body mass)** ya ƙaru a ƙungiyar kreatin (p = 0.017). Wannan ƙaruwa na iya kasancewa sakamakon riƙon ruwa, don haka ba a iya ɗaukar ta a matsayin ƙarin tsoka ba. - **Karfafa rike numfashi** ba ta bambanta tsakanin ƙungiyoyi ba; kreatin ya inganta aiki ba tare da ƙara ƙalubale ga rike numfashi ba. - **Jin gajiya a tsoka** ya nuna ɗan ƙaruwa a ƙungiyar kreatin, alamar cewa ribar ba ta zo ba tare da ɗan tasiri ba. - **pCO₂ da ƙimar jiki (body composition)** ba su nuna bambanci mai ma'ana ba tsakanin ƙungiyoyi. ## Amfanin Aiki Da Kwarai - **Yawan da aka yi amfani da shi:** gram 20 a rana na kreatin monohydrate tsawon kwanaki 7 – tsarin da aka saba amfani da shi a mafi yawan bincike‑bincike. Rubutun bai fayyace ko an raba adadin a ranaku ba; wasu ‘yan wasa kan raba shi zuwa ƙananan ƙididdiga a fadin yini, amma wannan ba a gwada shi a wannan takarda ba. - **Lokaci:** Binciken ya duba sakamako bayan mako guda na shigar da kreatin. Ba a tantance ko akwai bukatar “loading phase” ko “maintenance phase” a yayin horo ko gasa ba. ### Wa Zai Iya Amfana? - **‘Freedivers’ da masu hulɗar ruwa (spearfishers):** Wannan ne ainihin rukunin da aka bincika, don haka su ne suka fi amfana. - **‘Yan wasa na rike numfashi (apnea athletes):** Ko da ba a gwada su ba, ra'ayin cewa kreatin zai iya ƙara ƙarfin anaerobic yana da ma’ana. - **Kowa da ke yin aikin anaerobic mai ƙarfi:** Kreatin ya riga ya nuna inganci a fannoni da dama; wannan gwaji ya ƙara wani yanayi na musamman. ## Iyakoki 1. **Samfurin ƙanƙanta.** Mahalarta 20 kacal – sakamakon farko ne da ke buƙatar maimaitawa a manyan gwaje‑gwaje. 2. **Rukunin gama‑gari.** Maza ne mafi yawa (90 %), mata biyu kawai; ba a iya fitar da bambancin jinsi sosai. 3. **Gwajin kekuna ba ya wakiltar nutsewa ta hakika.** Yin tuka keke a dakin gwaje‑gwaje ba ya ba da cikakken hoton yanayin rike numfashi a cikin ruwa. 4. **Lafiya.** Freediving yana da haɗari, ciki har da *shallow water blackout*; kreatin ba ya ƙara aminci ga rike numfashi na dogon lokaci. 5. **Lactate da ba a fayyace ba.** Ƙarancin lactate tare da ƙarin aiki na da ban sha'awa, amma ba a ba da dalilin da ya sa ba. 6. **Jin gajiya a tsoka.** Ƙaruwa a jin gajiya na nuni da cewa ribar na iya zuwa da wasu tasiri masu kyau. ## Kammalawa Gwajin ya nuna cewa mako guda na shigar da kreatin monohydrate (20 g/ruwa) na iya ƙara jimillar aiki da tsawon lokacin gajiya a gwajin kekuna yayin rike numfashi a tsakanin ‘freedivers’ masu horo, tare da matakin lactate da ya ragu. Saboda ƙaramin samfurin, wannan alama ce mai ƙarfi amma ba ta zama ƙarshe ba. Idan kana ɗaukar nauyin anaerobic ko wasan rike numfashi, kreatin na iya zama ƙarin taimako, amma ka tuntubi ƙwararren likita musamman idan kana da matsalolin koda ko wasu cututtuka. **Manoman Bayani:** Kurmazovic et al. *Load and breath‑hold: impact of 7‑day creatine monohydrate loading on breath‑hold exercise performance – a double‑blind randomized controlled trial.* J Int Soc Sports Nutr, 2026. DOI: [https://doi.org/10.1080/15502783.2026.2732743](https://doi.org/10.1080/15502783.2026.2732743) | [PubMed 42868132](https://pubmed.ncbi.nlm.nih.gov/42868132/)

Rage Kiba na Lalata Hanji: Probiotic na Rage Alamomin Leaky‑Gut

Dr. Gymbro — Mon, 26 Oct 2026 08:15:27 GMT

# Rage Kiba na Lalata Hanji: Probiotic na Rage Alamomin Leaky‑Gut Rage kiba a gaggawa kafin takamaiman gasa yawanci ana yi da cin abinci da aka iyakance, shan ruwa da ƙarfi, da kuma horon tsanani. Wannan tsarin na iya jefa hanji cikin hadari – yana hana abinci da ruwa su shige yadda ya kamata. Binciken da aka buga a **Frontiers in Nutrition** (Wang et al., 2026) ya nuna cewa probiotic na iya taimakawa wajen kare shingen hanji a irin wannan yanayi. Sakamakon na da alƙawari, amma karamin adadin mahalarta da wasu iyakoki suna nuni da bukatar ƙarin bincike. ## Abin da Gwajin Ya Gwada Masu binciken sun zaɓi ‘yan wasa ‘yan dambe maza 24 masu ƙwarewa, waɗanda ke cikin shirin rage kiba cikin sauri kafin gasar. An raba su zuwa rukunai biyu ta hanyar bazuwar: - **Rukuni na probiotic:** an ba su probiotic (1.5 × 10¹⁰ CFU) sau biyu a rana. - **Rukuni na placebo:** an ba su placebo da ba shi da wani tasiri. An gudanar da aikin tsawon makonni huɗu, kuma an buga rijistar gwajin a **ChiCTR2400079908**, wadda ke da buɗewa ga jama’a. ## Dalilin Da Yasa Rage Kiba Ke Damun Hanji Rage kiba cikin gaggawa na haifar da ƙalubale da dama ga hanji, kamar: - ƙarancin makamashi da ruwa, - canjin tsarin cin abinci, - ƙarin nauyin horo, - damuwa ta tunani. Wadannan abubuwan na iya raɓa **tight‑junctions** – shingen da ke tsare hanji daga ƙazanta. Idan shingen ya lalace, alamun da za a iya fuskanta sun haɗa da: kumburi, ciwon ciki, amai, gudawa, da ɗan ƙaramin kumburi. ## Abin Da Probiotic Ya Canza A cewar sakamakon gwajin, rukunin da ya sha probiotic ya samu ci gaba sosai a fannonin da aka auna: ### Alamomin Ciwon Ciki - Alamu na rashin lafiyar hanji sun ragu sosai. ### Alamomin Zubewar Hanji (Leaky‑Gut) - **Zonulin**, furotin da ke kula da tight‑junctions, ya sauka. - **I‑FABP** (intestinal fatty‑acid binding protein), alamar lalacewar ƙwayoyin hanji, ya ragu. - **D‑lactate**, sinadarin da ke nuni da wucewar abubuwa ta shingen da ya lalace, ya yi ƙasa. ### Alamomin Garkuwar Jiki da Kumburi - **SIgA** (secretory immunoglobulin A), muhimmin antibodi a mucosa, ya ƙaru. - Jimillar alamar kumburi a jiki ta ragu idan aka kwatanta da placebo. ### Sauyin Microbiome - Kwayoyin da ke samar da **butyrate** – ciki har da *Blautia* da *Latilactobacillus* – sun ƙaru. - Yawan ***Streptococcus*** mai yiwuwa cutarwa ya ragu. **Butyrate** na daga cikin **short‑chain fatty acids** (SCFAs) da ke ƙarfafa selolin hanjin ƙafa kuma ke tallafawa tsayayyen shinge. Don haka canjin microbiome ya yi daidai da sauran sakamakon da aka samu. ## Dalilin Da Yasa Waɗannan Alamomi Ke Da Ƙarfi Abu mafi jan hankali a wannan bincike shi ne daidaiton sakamakon: alamu uku na leaky‑gut sun sauka, SIgA ya ƙaru, kumburi ya ragu, sannan microbiome ya canza zuwa kwayoyin da ke ƙara butyrate. Wannan haɗin kai ya fi tasiri fiye da canjin alamar biometric guda ɗaya kawai. ## Takaitaccen Kiyayewa Wannan ba umurnin a sanya probiotic a matsayin magani ba ne da ba zai iya kawo matsala ba. Ga wasu ƙuntatawa da ya kamata a sani: - **Karamin adadi:** ‘Yan wasa 24 ne kawai, don haka akwai bukatar a maimaita gwaji a manyan rukuni. - **Maza ne kawai, ƙwararru ne kawai:** Ba a san ko zai yi aiki ga mata, masu farawa, ko ‘yan wasa a wasu fannoni ba. - **Samfur mai ƙwayoyin halittu da yawa:** Takaitaccen ya ambaci probiotic mai ƙwayoyin halittu sosai, amma bai fayyace nau’in kowane ƙwaya ba. *Blautia* da *Latilactobacillus* da aka gano a hanji ba lallai su kasance a cikin kowanne probiotic ba. - **Babu sakamakon ƙwarewa:** An auna alamomin hanji da na garkuwa, ba a auna tasirin a kan ƙarfin fitarwa, nasarar yin nauyi, ko ingancin faɗa ba. Alamu masu kyau ba su nufin ƙara ƙwarewa a gasar ba. - **Alamomin wakili ne:** Zonulin, I‑FABP, da D‑lactate na da amfani a bincike, amma ba su wakilta cikakken lafiyar jiki ba. Kammalawar marubuta cewa wannan hanya "tsari ne na abinci mai aminci, tasiri" ya dace da rukunin da aka gwada, amma ba za a iya ɗauka a matsayin hujja mai ƙarfi ba har sai an sake gwada shi a manyan samfura. ## Amfani A Aikace‑Aikace Idan kai ‘yan wasa ne ko mai horar da ƙungiyar nauyi, ga wasu shawarwari: - **Matsakaicin da aka gwada:** 1.5 × 10¹⁰ CFU, sau biyu a rana. Duba alamar samfur don tabbatar da adadin da ake bayarwa a kullum. - **Lokaci:** Gwajin ya gudana tsawon makonni huɗu a lokacin rage nauyi kafin gasar. Don haka, a fara sha probiotic kusan makonni huɗu kafin a fara rage nauyi. - **Waɗanda za su amfana:** ‘Yan wasan dambe, MMA, ƙwanto, judo, da sauran wasanni da ke buƙatar rage nauyi da ke haifar da matsalolin hanji. - **Waɗanda ya kamata su tuntuɓi likita:** Duk wanda ke da cutar hanji, rashin lafiyar garkuwar jiki, ko ke ƙarƙashin kulawar likita ya danışa likita ko ƙwararren mai ba da shawara kan abinci kafin fara amfani. - **Gwada da wuri:** Kada a ƙara sabuwar kari a makon gasar. Fara a lokacin horo don sanin yadda jikinka ke ɗauka. ## Muhimman Abubuwan Da Za A Tuna - Probiotic (1.5 × 10¹⁰ CFU, sau biyu a rana) na tsawon makonni huɗu ya rage alamomin leaky‑gut da ciwon hanji a ‘yan wasan da ke rage kiba cikin gaggawa. - Ya ƙara SIgA, ya rage kumburi, kuma ya ƙara kwayoyin da ke samar da butyrate. - Gwajin ƙanana ne (n = 24), duk maza, kuma ba a ba da sakamakon ƙarfin faɗa ba. - Ba a san tasirin kowane ƙwaya ba; sakamakon na nuni ne ga irin wannan samfur, ba ga kowane probiotic ba. - Probiotic na iya zama ƙari mai amfani, amma ba zai maye gurbin tsari mai kyau na rage nauyi, abinci da ruwa ba. Ga ‘yan wasa masu fama da radadin hanji sakamakon rage nauyi, wannan dabara mai sauƙi, ƙaramin haɗari tana da daraja a tattaunawa tare da ƙwararren mai ba da shawara kan abincin wasanni. Gwaje‑gwajen da za su haɗa da alamar ƙwarewa da ƙayyadaddun ƙwayoyin halitta za su ƙara ƙarfafa hujjar.

Astaxanthin 12 mg na Kwanaki 28: Lalacewar Tsoka da Gajiya a Masu Taekwondo

Dr. Gymbro — Mon, 26 Oct 2026 08:14:31 GMT

# Astaxanthin 12 mg na Kwanaki 28: Lalacewar Tsoka da Gajiya a Masu Taekwondo Astaxanthin, wani carotenoid ja da ke baƙin salmon da krill launi, an dade ana talla masa ga ‘yan wasa masu bukatar ƙarfi da juriya. Wani sabon bincike da aka wallafa a *Nutrition Journal* (Shu et al., 2026) ya duba ko wannan kwayar na da tasiri ga wani rukuni daban: matasan maza masu horar da taekwondo, waɗanda ke fuskantar belin ƙarfe, fashe‑fashe na jiki, da kuma matsalolin tunani. Sakamakon na da alƙawari, amma yana buƙatar a duba shi da hankali. ## Abin da Masu Binciken Suka Yi Ƙungiyar ta gudanar da gwaji na kwana 28 tare da tsari na bazuwa‑bazuwa, dubi‑dubawa biyu (double‑blind), kuma an ba da placebo ga rukunin gwaji. Matasan maza ‘yan taekwondo sun sha ko 12 mg na astaxanthin a kowace rana ko kuma placebo. Masu binciken suka bi diddigin abubuwa uku a cikin tsawon makonni huɗu: alamu na lalacewar oxidative, alamar lalacewar tsoka, da yanayin gajiya ta amfani da **Athlete Burnout Questionnaire (ABQ)**. Alamomin da aka auna sun haɗa da: - **Creatine kinase (CK)** – alamar lalacewar tsoka. - **Superoxide dismutase (SOD)** – enzyme ɗin da ke kare jiki daga radikal masu ƙonewa. - **Malondialdehyde (MDA)** – alamar peroxidation na lipids. - **Sassakan ABQ** – domin auna gajiya ta tunani da jiki. An yi ƙididdiga ta hanyar *mixed‑design ANOVA*, wadda ke gwada ko akwai mu’amala tsakanin rukunin (astaxanthin vs. placebo) da lokaci (makonni 2 vs. 4). ## Sakamakon Mafi Muhimmi: Creatine Kinase Sakamakon CK ya ƙunshi mu’amala mai ƙarfi tsakanin rukunin da lokaci (p < 0.01). Wato, matakan CK a rukunin astaxanthin sun ragu a hankali yayin da a rukunin placebo suka ci gaba da ƙaruwa. CK yana fitowa daga tsoka zuwa jini idan ƙwayoyin tsoka suka samu lahani; don haka, raguwar CK na nuni da cewa astaxanthin zai iya rage wani ɓangare na lalacewar tsoka a lokacin horo. Wannan shine sakamakon da ya fi cancanta a ba da hankali, domin an samo shi daga gwajin mu’amala – wato hanya mafi ƙarfi a kimiyyar motsa jiki. ## Alamun Antioxidant: SOD ya Ƙaru, MDA Ya Ragu (karkara) - **SOD**: An samu ƙaruwa mai ma'ana a matakan SOD a rukunin astaxanthin a makonni na 2 da 4 (p < 0.05). Wannan yana goyon bayan ƙwaƙwalwar astaxanthin a matsayin “free‑radical scavenger”. - **MDA**: Ba a sami mu’amala mai ƙarfi ba tsakanin rukunin da lokaci (p > 0.05). Sai dai a gwajin ƙarfi‑ƙarfi (post‑hoc) an gano cewa a makon 4 matakan MDA sun fi ƙasa a rukunin astaxanthin. Wannan alama ce da ba za a ɗauki a matsayin hujja mai ƙarfi ba, amma tana nuna yiwuwar tasiri. ## Gajiya: Alamar Da Bai Kai Ga Gamsasshen Sakamako Ba Daga cikin sassakan ABQ, **emotional da physical exhaustion** (ABQ‑a) ne kawai suka bambanta a makon 4, kuma wannan bambanci ya fito ne daga gwajin “between‑group” kawai (p < 0.05). Babu wani sashe na gajiya da ya nuna mu’amala mai ƙarfi a duk lokacin gwajin, saboda haka tasirin astaxanthin a kan gajiya ya kasance maras ƙarfi. Masu rubutun sun ƙare da cewa, duk da cewa an samu wasu canje‑canje a wasu bangarori, astaxanthin ba ya canza gajiya gaba ɗaya. Yana iya ɗan sauƙaƙa ɓangaren gajiya, amma ba a samu ƙwararrun hujjoji da za su tallafa masa a matsayin maganin tunani ba. ## Iyakoki Da Ya Kamata A Tuna Da Su - **Gwajin ƙanana** – Adadin mahalarta (n ≈ 30) ya yi ƙasa, don haka ƙarfafa ƙididdiga ya kasance karami. - **Alamun jini kawai, ba auna aiki ba** – Binciken ya mai da hankali kan CK, SOD, MDA da tambayoyi, ba ya auna ƙwarewa kamar gudu, hawan nauyi, ko saurin dawowa bayan gajiya. - **Populashen mai iyaka** – An yi gwajin ne kawai a kan matasan maza ‘yan taekwondo; sakamakon ba lallai su shafi mata, manyan ‘yan wasa, ko sauran wasanni ba. - **Tsawon lokaci ɗan gajere** – Makonni huɗu ba su ba da cikakken hoto game da amfanin dogon lokaci ko amincin aminci ba. - **Sakamakon ƙarfi‑ƙarfi ba tare da mu’amala ba** – MDA, SOD a wasu makonni, da ABQ‑a sun fito ne daga gwaje‑gwajen da ba su da mu’amala mai ƙarfi, wanda ke ƙara yiwuwar sakamakon ƙarya. ## Abubuwan Da Za A Iya Aiwatarwa Idan kana sha’awar ƙara astaxanthin a tsarin abincinka, ga wasu shawarwari da gwajin ya nuna: - **Matsakaicin ƙima**: 12 mg a kowace rana, kamar yadda aka yi a binciken. - **Lokaci**: Kwana 28; ba a gano fa’idodin bayan wannan lokaci ba. - **Sha tare da abinci mai mai**: Astaxanthin yana narkewa a cikin mai, don haka a sha tare da abincin da ke ɗauke da ƙanƙara (misali, avocado, ƙwai, ko man ƙwai). - **Waɗanda za su amfana**: ‘Yan wasa masu horar da nauyi mai ƙarfi da manyan ƙoƙarin tsoka, inda lalacewar tsoka da gajiya ke zama babbar ƙalubale. - **Waɗanda ba za su tsammani sihiri ba**: Kowa da ke neman maganin gajiya kai tsaye. Barci mai kyau, sarrafa nauyi, da dabarun tunani har yanzu sune manyan abubuwa masu tasiri. ## Kammalawa Binciken ya ba da hujja mai ma'ana, duk da ƙananan girma, cewa shan 12 mg na astaxanthin a kowace rana na tsawon makonni huɗu na iya rage alamun lalacewar tsoka a maza ‘yan taekwondo, tare da ƙara alamar antioxidant (SOD) da kuma raguwar matakan MDA da gajiya (ABQ‑a) – duk da cewa waɗannan canje‑canjen ba su da ƙarfi sosai. Astaxanthin bai nuna ƙaruwa a ƙwarewar motsa jiki ba, kuma bai rage gajiya a dukkan fannoni ba. Don haka, har sai an yi manyan gwaje‑gwaje na dogon lokaci da suka haɗa da auna aiki da nau’o’in ‘yan wasa daban‑daban, ba za a iya ɗaukar astaxanthin a matsayin ƙwararren kayan taimako ba. A yanzu, ana iya ɗaukar sa a matsayin kariya marar haɗari, amma a tattauna da ƙwararren mai ilimin abinci ko likita kafin a yi amfani da shi a matsayin maye gurbin dabarun horo ko dawo da jiki.

Gram 48 na Furotin na Shinkafa Ya Kwatanta Whey a Ƙaruwa da Tsoka da Ƙarfi a Mako 8

Dr. Gymbro — Mon, 26 Oct 2026 08:13:21 GMT

## Binciken Da Ya Kalubalanci Tunani "Whey Ko Babu" Akai‑akaitacen magana ce cewa furotin na shuka ba zai kai ga whey ba. Whey na ɗauke da sinadarin **leucine** mai yawa, yana narkewa da sauri, kuma an yi masa dogon bincike a fannin gina tsoka. Rice protein kuwa, a mafi yawan lokuta ana ɗaukar sa a matsayin “zaɓi marar ƙarfi”, saboda ƙarancin leucine da kuma ɗan ƙasa a wasu muhimman amino acid. Wani gwaji da Joy da abokan aikinsa suka wallafa a *Nutrition Journal* a shekarar 2013 ya gwada wannan zato a yanayin da ya fi dacewa ga shinkafa. Sakamakon ya nuna: **gram 48 na rice protein isolate sun haifar da irin ci gaban da gram 48 na whey isolate suka haifar a cikin makonni takwas na horo – karin nauyin tsoka, kaurin tsoka, ƙarfi, da ƙarfin jiki**. ## Yadda Gwajin Ya Gudana Kungiyar ta zaɓi maza 24 masu shekaru tsakanin 18 – 35, waɗanda ke yin horon juriya a lokaci guda. An raba su kashi uku da rabo daidai da 8 a kowane rukuni. Rukuni na farko ya sha gram 48 na rice protein isolate, rukuni na biyu gram 48 na whey protein isolate, yayin da rukuni na uku ya rike placebo (babu furotin). An daidaita adadin kalori da nitrogen a dukkan abincin, don haka yawan makamashi da furotin ya kasance iri ɗaya a kowanne rukuni. Horon ya bi tsarin *periodization* – sau uku a mako, tsawon makonni takwas. Bayan kowanne zaman horo, mahalarta sun sha wani lokaci na ƙari (supplement) da aka tsara a sama. An auna abubuwa da dama: - **Kaurin tsoka** – ta hanyar ultrasonography - **Tsarin jiki** – ta hanyar Dual‑energy X‑ray Absorptiometry (DXA) - **Ƙarfi a sama da ƙasa** – bench press da leg press - **Ayyukan ƙarfi (power)** - **Matsayin jin daɗi, ciwo, da shirye‑shirye don horo** a kusa da zaman horo na farko An yi waɗannan auna a makonni 0, 4, da 8. ## Abin Da Suka Gano Rukunan uku duk sun samu ci gaba mai ma'ana a kowane lokaci. Nauyin jiki mara kitse, yawan tsoka, ƙarfi, da ƙarfin jiki sun ƙaru, yayin da kitse ya ragu. Abin da ya fi jan hankali shi ne **babu bambanci tsakanin rukuni‑by‑lokaci** – wato rice protein da whey ba su bambanta juna ba a kan waɗannan al'amura. Haka kuma, matakan jin daɗi, ciwo, da shirye‑shirye don horo sun kasance iri ɗaya a rukunan. Zanen gwajin ya cika cikas da yawa: an daidaita kalori, nitrogen, lokacin sha, da horo, don haka tushen furotin ne kawai ya bambanta. Wannan yana nufin babu wani abu na waje da ya shafi sakamakon. ## Me Ya Sa Ƙimar Da Ta Fi Girma Ta Muhimmanci? Masu binciken sun mayar da hankali kan “ƙimar da ta fi girma”. A baya an nuna cewa furotin na dabbobi kan wuce irin na shuka idan an ba su a adadi ƙanƙanta. A wannan gwaji, an yi amfani da **gram 48** – adadi mai yawa sosai – wanda zai iya cike gibin leucine da sauran muhimman amino acid. Leucine shi ne amino acid da aka fi danganta da farfadowar tsoka (anabolic signaling). Whey na da mafi yawan leucine a kowanne gram. Idan an ba da adadi mai yawa na rice protein, zai samar da isasshen leucine don haifar da amsa irin ta whey. Tabbas, wannan ba sabuwar hujja ba ce, sai dai tunani ne da ke tallafa wa sakamakon. ## Iyakokin Gwajin Kafin ka ɗauki matakin canja abincin ka, ka lura da waɗannan ƙuntatawa: - **Karamin samfur.** Mutane 24, 8 a kowane rukuni, na iya zama ƙasa ga bambance‑bambancen da ba su da ƙarfi. "Babu bambanci mai ƙarfi" ba yana nufin “ba a sami ƙarin fasaha ba”. - **Lokaci gajere.** Mako takwas ya isa don ganin canje‑canje na farko, amma ba zai bayyana tasirin dogon lokaci ba. - **Maza ne kawai.** Ba a gwada mata, manya, ko masu farawa ba. - **Tallafi daga masana'antu.** Irin waɗannan gwaje‑gwaje sau da yawa suna samun kuɗi daga kamfanonin da ke samar da samfurin. Ka duba takardun tallafi da kudaden da suka ba da. - **Ƙimar da ta fi girma.** Gram 48 na rice protein ya fi na yawancin masu amfani; adadi kamar gram 20‑25 na iya kasa kaiwa ga tasiri iri ɗaya saboda ƙarancin leucine. - **Abincin yau da kullum.** Jimillar cin furotin da sauran abinci ba a ƙayyade ba, don haka ba a iya ware tasirin su gaba ɗaya. ## Abubuwan Da Za Su Iya Zama Amfani - **Matsakaicin adadi.** Idan kana son maimaita sakamakon, ka nufi gram 48 na rice protein isolate a kowanne lokaci na sha. Kada ka rage shi zuwa ƙananan cokali. - **Lokacin sha.** Mahalarta sun sha kari nan da nan bayan horo. Duk da haka babu hujja da ke nuna cewa wannan lokaci shi ne mafi mahimmanci – adadin furotin a rana gaba ɗaya ne ke da tasiri. - **Masu amfana.** Wannan ya fi dacewa ga ‘yan vegan, mutanen da ke da rashin jure madara, ko duk wanda ke son furotin na shuka. Gwajin ya nuna cewa barin whey ba lallai ne ya haifar da rasa ci gaba ba, muddin an ba da isasshen adadi. - **Idan adadin bai isa ba.** Za ka iya ƙara adadi ko haɗa rice protein da wasu furotin na shuka ko kuma da leucine a matsayin ƙari. - **Idan kana iya amfani da whey.** Ba wani abu a cikin binciken da ke nuna cewa rice protein ya fi whey. Gwajin ya nuna daidaito; zaɓi na karshe ya dogara ne kan narkewa, farashi, ɗanɗano, da zaɓin ka. ## Kammalawa Gwajin ya ƙara hujja cewa tsohuwar al'ada ta fifita whey a kan furotin na shuka ba lallai ba ce. Idan an daidaita adadi, kalori, da nitrogen, kuma an ba da ƙima mai girma, rice protein isolate zai tallafa ci gaban nauyin tsoka, ƙarfi, da ƙarfin jiki kamar whey a cikin maza masu horo na makonni takwas. Koyaya, gwajin ya ƙunshi ƙananan samfur, lokaci gajere, da ƙima mai girma – abubuwan da ke rage ƙarfin jan hankalin sakamakon ga yanayi na yau da kullum. **Taƙaitaccen bayani:** - Gram 48 na rice protein isolate ya kwatanta gram 48 na whey isolate a gwaji da maza 24 masu horo. - Nauyin tsoka, kaurin tsoka, ƙarfi, da ƙarfin jiki sun inganta a duka rukunan ba tare da bambanci ba. - Ƙimar da ta fi girma ce ta ba da damar rice protein ta ɗauki matsayin whey – ƙananan ƙima ba za su iya haifar da irin wannan tasiri ba. - Ka duba takardun tallafi da ka ɗauki sakamakon a matsayin ƙarin hujja, ba matsayin ƙarshe ba.

Karancin ƙarfe, sau ɗaya a kowanne kwana biyu: daidaitaccen haɓakar ferritin a mata

Dr. Gymbro — Mon, 26 Oct 2026 08:12:26 GMT

## Binciken Sha'awa: Me ya sa ƙarfe a ƙananan ƙima zai iya haɓaka ferritin? Idan ferritin ɗinki ta ragu, shawarar da ake ba da ita a mafi yawan lokuta ita ce ki sha ƙarfe a kullum har sai ta dawo daidai. Sai dai wani gwaji da aka wallafa a *European Journal of Nutrition* a 2026 (Valerii et al.) ya gwada wani ra'ayi daban: an ba da ƙarfe a ƙananan ƙima, sau ɗaya a kowanne kwana biyu, don ganin ko ajiyar ƙarfe na jiki zai girma har yanzu. A gwajin, an zaɓi mata 66 da ke da ƙarancin ƙarfe. A tsawon kwanaki 42, dukkan rukuni biyu sun samu ƙaruwa mai ma'ana a matakin serum ferritin, kuma bambanci tsakanin su ba a samu ba. Rukunin da ya sha a kowanne kwana biyu ya samu irin wannan sakamako ba tare da ƙara yawan ƙarfe mai yawa ba. ## Matsalar Hepcidin Hepcidin horman ne da ke sarrafa yadda jiki ke shan ƙarfe daga hanji zuwa jini. Lokacin da ake shaƙa ƙarfe a lokaci guda, hepcidin yakan ƙaru, yana rage ƙarin shan ƙarfe a gaba. Manufar ba da ƙarfe a kowanne kwana biyu ita ce ba da damar hepcinin ya sauka kafin a sake shan ƙarfe, ta yadda jiki zai iya shan ƙarfe da kyau. A wannan binciken ba a auna matakin hepcidin ba, don haka ba za a iya tabbatar da cewa shi ne ke bayanin bambancin da ake gani ba. Sai dai an nuna cewa rarraba shan ƙarfe na iya tasiri alamu na ƙarfe a jiki. ## Abin da gwajin ya ƙunsa Gwajin ya kasance mai bazuwar, an raba mahalarta zuwa rukuni biyu (active‑controlled). Mahalarta mata ne tsakanin shekaru 18‑50, kuma serum ferritin ɗinsu ƙasa da 30 ng/mL. Tsawon kwanaki 42, kowanne ya karɓi ɗaya daga cikin tsare‑tsaren biyu: - **Rukunin ƙaramin ƙima:** micronized, dispersible ferric pyrophosphate da ke ba da 21 mg na elemental iron a kowanne kwana biyu, tare da wani sinadari da ke gyara microbiota na hanji a kullum. - **Rukunin kwatanta:** sucrosomial ferric pyrophosphate da ke ba da 30 mg na elemental iron a rana. Babban abin da aka auna shi ne serum ferritin. An kuma auna serum iron, transferrin, transferrin saturation (TSAT), total iron‑binding capacity (TIBC), hemoglobin da ƙimar ƙwayoyin jini (RBC). ## Sakamako Ferritin ya ƙaru sosai a duka rukuni (p < 0.001), ba tare da bambanci mai ma’ana tsakanin su ba. Serum iron, transferrin, TSAT da TIBC suma sun inganta daidai gwargwado. Hemoglobin ya tsaya a daidai matakin sa a duk lokacin. Wannan ya dace da mahalarta da aka zaɓa bisa ƙarancin ferritin ba saboda anemia ba, kuma kwanaki 42 kaɗan ne don a ga canjin hemoglobin. Karɓuwar maganin ta kasance mai kyau a duka rukuni. Rahoton ya nuna ƙananan tasirin hanji na ɗan lokaci, ba tare da wani canjin alamu na ƙuruciya da ya zama mai muhimmanci ba. Adadin ƙarfe da aka ba a tsawon wannan lokacin ya bambanta sosai. A kwanaki 42, 21 mg a kowanne kwana biyu ya kai kimanin 441 mg na elemental iron, yayin da 30 mg a kullum ya kai kusan 1,260 mg. Wannan ya nuni da cewa adadin ƙarfe na jimilla ƙasa da ɗaya‑uku ba ya nufin “ƙananan ƙara ƙarfe” ba. ## Gane Gaskiyar Duk da cewa sakamakon na da ƙarfafa gwiwa, akwai manyan iyakoki: - **Daidaito, ba fifiko ba.** Gwajin ya nuna haɓakar ferritin iri ɗaya a rukunin biyu; ba ya nuni da cewa tsarin kwana biyu yafi. - **Babu placebo.** Duka rukuni sun samu ƙarfe, don haka ba a san yadda sakamakon zai kasance ba idan ba a ba da wani magani ba. - **Canje‑canje biyu a lokaci guda.** Nau’in ƙarfe (micronized dispersible vs. sucrosomal) da ƙari na gyaran microbiota sun sha bamban; ba za a iya danganta sakamakon ga tsarin lokaci kadai ba. - **Ƙananan girma da gajere.** Mata 66 a tsawon makonni shida ba su ba da damar tantance tasirin dogon lokaci ko sake faruwa ba. - **Takamaiman ƙungiya.** Sakamakon ya shafi mata masu ƙarancin ƙarfe a shekarun haihuwa, ba ga kowa ba. ## Abubuwan Amfani ga Mata Masu Horaswa Karancin ƙarfe ya fi yawa a mata masu ɗagawa, gudu da ayyukan juriya, kuma ƙarancin ferritin yana haifar da gajiya da dawowa mai rauni. Wannan gwaji yana ƙara ƙarfafa ra'ayin cewa ƙara ƙarfe ba koyaushe ke nufin mafi alheri ba. Ƙarfe a ƙananan ƙima, da aka raba a ranaku, na iya cika ajiyar ferritin ba tare da haifar da matsalar hanji ba. 1. **Yi gwajin farko.** Gwajin ya haɗa mata da serum ferritin ƙasa da 30 ng/mL. Ka nemi a auna ferritin da cikakken panel na ƙarfe kafin ka fara ƙara. 2. **Kada ka ɗauka kana da anemia.** Hemoglobin da ya tsaya a daidai yana nuna cewa ferritin na iya inganta kafin hemoglobin ya sauya. Tattauna da likita don fahimtar dalilin ƙarancin ƙarfe. 3. **Tambayi game da raba shan a kwana biyu.** Idan shan ƙarfe a kullum yana haifar da ciwon ciki ko tashin haihuwa, tattauna yiwuwar raba lokutan shan da likita ko mai ba da shawara. 4. **Kada ka ɗauka kowane samfur zai yi aiki iri ɗaya.** Gwajin ya haɗa sinadirin da ke gyara microbiota; ba lallai ne kowanne tablet 21 mg a kowanne kwana biyu zai yi tasiri iri ɗaya ba. 5. **Sake gwada a kai a kai.** Duba serum ferritin bayan wani lokaci mai ma'ana don tabbatar da cewa hanyar da kake bi tana aiki. ## Gabaɗaya Binciken ya nuna cewa dabarun ƙarfe a ƙananan ƙima, musamman waɗanda aka tsara bisa ilimin halitta, suna buƙatar kulawa sosai. A mata masu ƙarancin ƙarfe, 21 mg a kowanne kwana biyu yana kawo haɓakar ferritin daidai da 30 mg a kullum a cikin makonni shida, tare da tasirin hanji ƙanana. Ana buƙatar ƙarin gwaje‑gwaje masu girma da dogon lokaci waɗanda za su ware tasirin lokaci daga nau’in magani, kuma su auna hepcidin kai tsaye, don tabbatar da cewa tsarin ne ke da muhimmanci.

Kofe a Kafin Horon Na Ɗaure Hanyoyin Jini; Furen Beetroot Na Rage Shi

Dr. Gymbro — Mon, 26 Oct 2026 08:11:02 GMT

# Idan Tsarin Horon Ka Ya Dogara Da Kofe, Hanyoyin Jinin Ka Na Iya Sanyawa Sabon gwaji **crossover** da aka wallafa a *Food & Function* (2026) ya nuna cewa shan kofe kafin horo na iya ƙara alamun ɗaurewar hanyoyin jini, ko da kuwa matsin jinin ba ya nuna wani canji. Idan aka ci furen beetroot mai nitrate a lokaci guda, waɗannan alamun suna komawa matakin placebo. ## Menene Masana Suka Yi Mataimakan bincike sun zaɓi matasa 24 masu lafiya (samari 17, matsakaicin shekaru 24) a cikin gwaje‑gwajen **randomized, double‑blind, placebo‑controlled crossover**. Kowane mahalarta ya sha kowane yanayi huɗu, don haka an sami damar kwatanta tasirin ba tare da rabon rukuni ba. ### Yanayin Gwaji - **PL:** furen beetroot mara nitrate (92 mg nitrate), babu kofe - **CAF:** furen beetroot mara nitrate + kofe 6 mg/kg - **BR:** furen beetroot mai nitrate (400 mg nitrate), babu kofe - **BR‑CAF:** furen beetroot mai nitrate + kofe 6 mg/kg Ga mutum mai nauyin kilogram 80, 6 mg/kg yana nufin miligram 480 na kofe – adadin da ke a manyan pre‑workout kuma ya wuce na kofi guda ɗaya da aka saba sha. Masana suka auna: - Matsin jinin **brachial** da na tsakiyar jiki - Alamun **augmentation pressure** da **augmentation index** (alamun yadda ƙarshen jijiyoyi ke dawowa ga zuciya) - Ayyukan **endothelium** ta hanyar **flow‑mediated dilation (FMD)** ## Sakamakon Da Ya Fi Bayyanawa: Kofe Ya Ƙara Alamun Ɗaurewar Hanyoyin Jini Kofe kadai ya haɓaka **augmentation pressure** da kimanin **mmHg 3**, yayin da placebo ya nuna kusan **mmHg 1**. Haka kuma, **augmentation index** ya ƙaru da kusan **10 %**, alhãli yaƙinda placebo ya kasance **4 %**, kuma beetroot mara nitrate ya kasance **1 %**. Bambancin yana da ƙarfi a ƙididdiga (P = 0.001 – 0.007). Wadannan alamun na nuni da cewa jijiyoyin da ke dawowa daga ƙarshen su sun yi sauri, abin da ke ƙara nauyin zuciya. A cikin al'ada, ƙaruwa a waɗannan ma'aunin ba su da alaka da fa'ida ga lafiyar zuciya. ## Gyarawa: Nitrate Ya Dakatar Da Tasirin Kofe Lokacin da aka haɗa kofe da furen beetroot mai nitrate **400 mg**, alamar ƙaruwa ta "vanishe". **Augmentation pressure** ya ƙaru da kusan **mmHg 1**, kuma **augmentation index** ya ƙaru da **3 %** — ba su bambanta da placebo ko beetroot kadai ba (P = 0.505 – 0.689). Gwajin ya tabbatar da cewa nitrate na haifar da ƙaruwa a **plasma nitrite**, mataki na gaba ga samar da **nitric oxide**, wanda ke sassauta jijiyoyi. Duk da haka, **plasma cyclic GMP**, abin da ke nuna ainihin tasirin nitric oxide, ba ya bambanta tsakanin yanayi, don haka hanyar aikin nitrate ba a fayyace ta ba. ## Abubuwan Da Ba Su Canza Ba - **Matsin jinin brachial** ba a samu wani canji mai ma'ana ba. - **Matsin jinin tsakiyar jiki** ya tsaya kamar yadda yake. - **Flow‑mediated dilation (FMD)** – ma'aunin aikin endothelium – ba ta nuna wani bambanci ba. Saboda haka, ba mu da hujja da ke nuna cewa kofe yana ƙara matsin jini ko yana lalata endothelium; tasirin ya takaita ne ga alamun dawowar jijiyoyi. ## Abubuwan Da Za a Iya Amfani Da Su - **Nitrates**: furen beetroot da aka yi amfani da shi yana ɗauke da nitrate **400 mg**. Idan kana sayen ƙwayar beetroot, duba alamar samfur don tabbatar da adadin nitrate; wasu samfura ba su bayyana wannan ba. - **Lokaci**: an sha kofe da nitrate a lokaci guda kuma a auna bayan **awa 2.5** – lokacin da aka fi shirin horo. Ba a gwada tasirin a lokuta daban‑daban ko bayan motsa jiki ba. - **Waɗanda Zasu Iya Amfana**: masu shan manyan kofe kafin horo, musamman waɗanda ke haɗa kayan ƙarfafa, za su iya samun fa'ida daga beetroot don rage alamun ɗaurewar jijiyoyi. Sha kofi guda ɗaya bai kai **6 mg/kg** ba, don haka ba zai haifar da wannan sakamako ba. - **Hanyar Da Ta Fi Aiki**: idan kana riga riga kana amfani da beetroot ko sinadaran nitrate don juriya, haɗa su da kofe ba zai ƙara haɗari ba, amma ba ya nufin ka ƙara ƙimar kofe. ## Abubuwan Da Ba Mu Sani Ba - **Dogon lokaci**: ba a san tasirin amfani na tsawon shekaru ba. - **Rukunin mutane**: gwajin ya ƙunshi matasa masu lafiya kawai; manya, masu hawan jini, ko masu cutar jijiyoyi na iya amsa daban. - **Motsa jiki**: aunan an yi a hutu, ba a lokacin ko bayan horo ba. - **Adadin mahalarta**: mutane 24 ne kawai (mafarki maza), don haka ba a iya faɗin sakamakon ga jama'a gaba ɗaya. - **Hanyar aiki**: rashin bambanci a cGMP ya bar tambaya kan ainihin hanyar da nitrate ke rage ƙara augmentation. - **Mahimmancin ƙliniki**: ko ƙaruwa a augmentation index na ɗan gajeren lokaci zai haifar da haɗari a zuciya ba a tabbatar ba. ## Kammalawa Wannan gwaji na **randomized crossover** ya nuna cewa shan babban adadin kofe kafin horo na iya ƙara alamun ɗaurewar hanyoyin jini, yayin da nitrate daga furen beetroot **400 mg** ke iya kawar da wannan ƙaruwa. Matsin jini da aikin endothelium ba su canza ba, don haka ba a samu wata matsala a matakin farko. Duk da haka, ana buƙatar ƙarin gwaje‑gwaje masu tsawo, a rassa‑rassa daban‑daban, da kuma cikin yanayin motsa jiki, kafin mu ɗauka beetroot zai zama “maganin kariya” ga zuciya daga tasirin kofe.

Dipeptide na Glutamine da Ya Tabbatar da Daidaiton Harin ‘Shooter’ Lokacin da Ruwa Ya Gaza

Dr. Gymbro — Sun, 25 Oct 2026 08:15:22 GMT

# Kowa na ce wa ‘yan wasa su sha ruwa. Amma a wani ƙananan binciken ƙwallon kwando, ruwa kaɗai bai daidaita harin ‘shooter’ kamar yadda ruwan da aka ɗan gauraya da L‑alanyl‑L‑glutamine (AG) ke yi. Abin mamaki shi ne ƙaramar ƙima ta yi nasara akan babbar ƙima. ## Binciken a Taƙaice Takardar da aka wallafa a *Journal of the International Society of Sports Nutrition* a shekarar 2012, ta fito daga ƙungiyar da Jay Hoffman ke jagoranta a Jami'ar Central Florida. Ga tsarin binciken: - **Tsari:** maimaitawa (crossover), inda kowane ɗan wasa ya shiga dukkan gwaje‑gwaje huɗu. - **Masu Halarta:** mata 10, ‘yan wasa masu tallafi a NCAA Division I (shekaru 21.2 ± 1.6, nauyi 73.5 ± 8.0 kg). - **Gwaji:** wasanni huɗu na minti 40 na ƙwallon ƙafa tare da dakatarwa da aka tsara don shan ruwa. - **Yanayi:** babu shan ruwa (DHY), ruwa kaɗai (W), ƙaramar AG (1 g per 500 ml, AG1), da babbar AG (2 g per 500 ml, AG2). - **Bincike:** canjin daga farko zuwa ƙarshe, an kwatanta da ANOVA na hanya ɗaya mai maimaitawa. ## Menene L‑Alanyl‑L‑Glutamine? AG dipeptide ne, wato glutamine da alanine da suka haɗu. Yana narkewa cikin sauƙi a ruwa, shi ya sa za a iya gauraya shi cikin abin sha na wasanni. Binciken ya gwada ko ƙara wannan a cikin ruwan shan ruwa zai iya canza ƙwarewa da aikin jiki a ƙarshen wasa idan aka kwatanta da ruwa kaɗai. ## Yadda Suka Saita Matakan Ruwa Gwajin farko shine wasan rashin ruwa. ‘Yan wasa ba su sha komai ba, kuma adadin nauyin da suka rasa ya ƙayyade yawan ruwan da za su sha a gwaje‑gwaje uku na gaba. Sun rasa **1.72 ± 0.42 kg, ko kashi 2.3 % na nauyin jikinsu**. A wasanni uku na shan ruwa, yawan da suka sha ya kai **1.55 ± 0.43 L**, ba tare da bambanci tsakanin ruwan da AG ba. Don haka ba za a iya zargin ɗaya daga cikin yanayi ya ba da ruwan fiye da ɗayan ba. ## Babban Sakamako: Harin ‘Shooter’ Sakamakon harin shine inda abubuwa suka fito fili: - **AG1 vs. babu shan ruwa:** bambanci na **kashi 12.5 %** a harin (p = 0.016). - **AG1 vs. ruwa kaɗai:** bambanci na **kashi 11.1 %** (p = 0.029). Ruwa kaɗai bai bambanta sosai da wasan rashin ruwa ba a cikin ƙididdigar da aka bayar. Gwajin AG1 ya bambanta da duka biyun. A takaice, maye gurbin ruwan ba ya isa don riƙe daidaiton harin; ƙara dipeptide ya zama muhimmi. ## Lokacin Amsa da Gajiya **Lokacin amsa na gani** ya bambanta sosai bayan AG1 idan aka kwatanta da babu shan ruwa (p = 0.014). Mawallafa sun ƙara da cewa shan AG ya kiyaye ƙwarewar wasa da lokacin amsa na gani fiye da ruwa kaɗai. **Gajiya**, wadda auna ta hanyar *player load*, ba ta da tabbas sosai. Bambanci (p = 0.045) ya bayyana ne kawai tsakanin gwajin AG2 da wasan rashin ruwa. Don haka babbar ƙima ta bayyana a gajiya, yayin da ƙaramar ƙima ta bayyana a harin da lokacin amsa. **Karfafa tsalle** ba ta motsa ba. Matsakaicin ƙarfi a tsaye ba su nuna bambanci a kowanne gwaji. Idan kuna neman ƙara tsalle, wannan binciken ba ya ba da wata fata. ## Me Ya Sa Karamar Ƙima Ta Fi Manya? Takardar ba ta fayyace dalilin da ya sa ƙaramar ƙima (AG1) ta fi babbar ƙima (AG2) aiki a harin ba, kuma ƙungiyar tana da ‘yan wasa 10 ne kawai, don haka hasashe ba zai zama tabbatacce ba. Karanta a sauƙaƙe na nuna cewa ƙari ba koyaushe ke nufin mafi kyau ba, kuma alakar ƙima‑amsa ba ta bi layi madaidaici ba. Duk wani dalili zai kasance zato har sai manyan bincike suka tabbatar da shi. ## Menene Wannan Ke Nufi a Gare Ku? **Kima:** Kima mai tasiri a wannan binciken shine **1 g AG a kowace 500 ml na ruwa**. Idan ‘yan wasa suna shan kusan 1.55 L a matsakaici, hakan ya kai kimanin **3 g gabaɗaya** a tsawon wasa. Wannan lissafi ne na kaina, ba a fadi shi a takardar ba. Kima na 2 g a kowace 500 ml ba ta inganta harin fiye da ƙaramar ƙima ba. **Lokaci:** ‘Yan wasa suna shan ruwan a dakatarwar da aka tsara a cikin wasan minti 40, tare da adadin ruwan da ya dace da asarar nauyin da aka auna. Hanya mafi sauki ita ce a gauraya AG a cikin ruwan da za a sha a lokacin wasanni ko horo masu tsawo, maimakon a ɗauka shi sau ɗaya kafin fara wasa. **Wadanda Zai Iya Amfana:** - ‘Yan wasa na ƙwallon ƙafa ko sauran wasanni da ake samun dakatarwa a lokuta masu tsawo, inda daidaito a ƙarshe ke da muhimmanci. - ‘Yan wasa da ke zuba zufa har su rasa kashi kaɗan na nauyin jikinsu. - Kwararru ko masu horo da ke da tsarin shan ruwa kuma suna son gwada wani ƙari. **Wadanda Ya Kamata Su Guji:** - Duk wanda ke neman ƙarin tsalle ko ƙarfi, domin binciken bai nuna wani tasiri a wannan fanni ba. - Masu motsa jiki marasa tsawo ko masu yin wasa a mataki na yau da kullum, wanda ba a gwada a wannan binciken ba. - Mutane da ke da cutar koda ko hanta, ko kuma ke shan magani – su tuntubi likita kafin su ɗauki kowanne ƙarin amino acid. - Duk wanda ke tsammanin tabbataccen sakamako, domin shaida ba ta da ƙarfi sosai. ## Abubuwan Da Ya Kamata Ku San 1. **Ƙananan samfur.** ‘Yan wasa 10 ne kawai suka halarta, don haka sakamakon yana da rauni. 2. **Mata kawai, ƙwararru kawai.** Dukkan su ‘yan wasa ne a Division I na mata. Ba a san ko za a iya shafa su ga maza, masu wasa na wasanni na hutu, ko wasu wasanni ba. 3. **Wasan rashin ruwa ya zo a farko.** Asarar nauyin sa ta ƙayyade ruwan da za a ba a gwaje‑gwaje gaba. Takardar ba ta bayyana ko an canza tsari ba, don haka tasirin tsari ko sanin juna ba a iya kawar da su ba. 4. **Tallafi da rikici na sha'awa.** Takardar ba ta ambaci inda aka samu kuɗi ko haɗin gwiwa da masana'antu ba. Duba cikakken rubutu (PMC3316133) don ganin bayanan kuɗi da sha'awar da ke akwai kafin yanke hukunci. 5. **Bincike guda ɗaya.** Wannan ba ta zama ilimin ƙarshe ba, kuma za a buƙaci maimaitawa. ## Takaitaccen Bayani A wannan ƙananan gwajin maimaitawa, ƙara **1 g AG a kowace 500 ml** na ruwan shan ruwa ya kiyaye aikin harin kusan **11 %** fiye da ruwa kaɗai kuma kusan **12.5 %** fiye da rashin shan ruwa, kuma ya taimaka daidaita lokacin amsa na gani. Karfin tsalle ba ya canzawa, kuma ƙarin ƙima ba ta wuce ƙaramin ƙima a harin ba. Wannan hanya ce mai ban sha'awa ga dabarun shan ruwa a wasanni masu tsawo, amma ba a tabbatar da ita ba, don haka ku yi la’akari da dukkan ƙayyadaddun ka’idojin da ke sama kafin ku yanke shawara.

Man Kifi da Tsokar da Ke Tsufa: Gaskiyar Abin da Bincike 14 Ya Nuna

Dr. Gymbro — Sun, 25 Oct 2026 08:14:26 GMT

# Man Kifi da Tsokar da Ke Tsufa: Gaskiyar Abin da Bincike 14 Ya Nuna Man kifi yana daga cikin kayan kari da ake tallatawa a matsayin magani ga kusan komai; a yanzu kuma ana yi masa kira a matsayin kari ga asarar tsoka da ke faruwa da shekaru. Sabon bincike mai fadi da aka gudanar a 2026 ya tattara mafi kyawun shaida kan **omega‑3s** da tsokar da ke tsufa. Sakamakon ya fi ban sha'awa, amma a hankali fiye da yadda tallace‑tallacen kayan kari ke nuna. ## Binciken a Taƙaice Takardar da **Shao** da abokan aiki suka wallafa a *International Journal for Vitamin and Nutrition Research* (2026; 96(5)) ita ce **umbrella review** – wato nazari kan nazarce‑nazarcen da ake da su maimakon sabon gwaji. Kungiyar ta bincika PubMed, Web of Science, EBSCO, da ScienceDirect domin nemo *randomized controlled trials* (RCTs) da meta‑analyses na RCTs da suka gwada ƙara **n‑3 polyunsaturated fatty acids** (n‑3 PUFA) a kan sakamakon tsoka a manya masu shekaru 55 da sama. Gabaɗaya an zaɓi **gwaje‑gwajen RCT bakwai da meta‑analysis bakwai**, shi ya sa ake kiran binciken “**14 studies**”. An yi rijistar binciken a PROSPERO (CRD420251165901). An kimanta meta‑analyses da AMSTAR 2, an tantance ƙwararrun shaida da **GRADE**, sannan an auna yadda aka maimaita nazarin da aka haɗa ta hanyar **corrected covered area** (CCA). ## Abin da Aka Gwada da Gaskiya Yawancin gwaje‑gwajen sun kunshi haɗin **EPA** da **DHA**, wato omega‑3s na teku da ke cikin man kifi. Kaɗan ne suka yi amfani da man ƙwai (ALA), wanda ke da yawan omega‑3s na tsirrai. Kadarorin sun bambanta sosai – daga **1.3 g/kwana har zuwa 14 g/kwana**, kuma tsawon lokacin binciken ya kai **kowane mako 6 zuwa watanni 6**. Manyan sakamakon da aka bi su ne: - yawan ƙwayar ƙashi (bone mineral density) - ƙarfi tsoka (muscle strength) - aikin jiki (physical performance) Wannan bambanci yana da ma’ana: binciken bai fayyace adadin da ya tabbata ba, don haka duk wanda ya ce ya san “matsakaicin” milligram don ƙara ƙarfi ya wuce abin da shaida ke nuna. ## Babban Sakamako: Ƙarami Amma Auna Gabaɗaya, ƙara n‑3 PUFA an danganta shi da **ƙaramin ƙaruwa a ƙarfi tsoka**. Hakanan an ga yiwuwar amfanin ga **aikin ƙafafu ƙasa** da **yawan ƙashi**. Marubutan sun kammala da cewa omega‑3s na teku na iya ba da *farko* na fa’ida wajen rage raguwar ƙarfi da ke faruwa da shekaru a tsakanin manya masu lafiya. Kalmar da aka yi amfani da ita a nan “ƙarami”, “yiwuwa”, “farko” – ba wani abu a nan ke nuna cewa man kifi zai gina tsoka shi kaɗai. ## Inda Shaidar Ta Fi Ƙarfi (da Rauni) Nazarin ya gano **tabbataccen matsakaici** ga wasu sakamako: - **ƙarfi na ƙafafu ƙasa** (lower‑extremity strength) - **aikin jiki na ƙafafu ƙasa** (lower‑extremity physical performance) Sauran sakamakon an ba su **ƙaramin ko ƙwarai ƙaramin tabbaci**: - ƙarfi rike (grip strength) - saurin tafiya (gait speed) - ƙarfi tsoka a sassan sama (upper‑extremity strength) Marubutan sun danganta ƙarancin tabbaci da ƙarancin gwaje‑gwaje da ƙuntatawar hanyoyin bincike. A aikace, alamar ta fi bayyana ga ƙafafu—inda taimakawa mutum ya tashi daga kujerar, ya hau matakai, ya tsaya lafiya. Ga rike, saurin tafiya, da ƙarfi a sama, amsar gaskiya ita ce: har yanzu ba mu da shaida. ## Matsalar: Sau da yawa Ana Maimaita Bincike Binciken 14 ba su ne kuri’u 14 masu zaman kansu ba. An samu **CCA na 14.02 %**, ma’ana akwai maimaituwa sosai: meta‑analyses sun dogara kan yawancin gwaje‑gwajen da aka yi a baya. Wannan na iya sa shaida ta bayyana a matsayin ƙarfi fiye da ainihi. Hada wannan da ƙananan adadin gwaje‑gwajen a mafi yawan sakamako, marubutan sun ce gabaɗayan amincin sakamakon “na iya zama an sami matsala.” Sun kira manyan RCTs masu ƙarfi kafin a rubuta ƙa’idojin da suka dogara da shaida ga **sarcopenia**. ## Menene Wannan Ke Nufi a Gaban Ka **Wanda zai iya amfana:** manya masu shekaru 55 da sama, musamman waɗanda ke damuwa da *sarcopenia* – raguwar tsoka da aiki da ke faruwa da shekaru. Shaidar ta samo asali ne daga manya masu lafiya, don haka ba ta tabbatar da amfanin ga masu cuta da aka tantance. **Wane iri za a yi la’akari da shi:** omega‑3s na teku (EPA/DHA) su ne suka fi yawan bincike, kuma marubutan sun nuna su ne mafi alƙawari. Man ƙwai (ALA) ya bayyana a kaɗan ne, don haka hujja a kansa ba ta ƙarfi ba. **Kadarar:** binciken ya haɗa **1.3 g zuwa 14 g/kwana**, amma bai ba da shawara kan adadin da ya fi dacewa ba. Babban adadi ba yana nufin zai fi tasiri ba; 14 g/kwana ya wuce yawan da mafi yawan mutane ke ɗauka. Duba adadin **EPA + DHA** a kan lakabi, ba kawai jimillar mai ba, kuma ka tattauna da likita kan adadin da ya dace da kai. **Tsawon lokaci:** gwaje‑gwajen sun ɗauki **makonni 6 zuwa watanni 6**. Ka yi tunani a matsayin watanni na ci gaba da amfani, ba ranaku ba. Yawan shan kifi a kowace rana ba a tantance ba a cikin wannan binciken. Shan man kifi tare da abinci yana da al’ada, amma ba shi ne ke haifar da sakamakon da aka gani ba. **Haɗa da horo:** wannan binciken ba ya nuna cewa man kifi zai aiki shi kaɗai. Hanya mafi hikima ita ce a ba da kari a kan abubuwan da aka tabbatar: **horon ƙarfi sau biyu a mako** da **isasshen furotin**. Ka ɗauki man kifi a matsayin ƙari mai yiwuwa, ba a matsayin maye gurbi ba. **Matsayin da ya dace:** ka sa ran tasiri **ƙarami**, mafi kyau ga ƙafar ƙasa. Kada ka yi tsammanin manyan canje‑canje a rike ko saurin tafiya bisa ga wannan hujja. **Wanda ya kamata ya guje shi ko ya tuntuɓi likita da farko:** ba a ambata a takarda, amma duk wanda ke shan magungunan rage jini, wanda ke da ƙwarin jini a jikinsa, wanda ke shirin tiyata, ko mai fama da cuta mai tsanani ya kamata ya tuntuɓi likita ko magini kafin ya fara ɗaukar manyan ƙarin omega‑3s. Wadanda ke kan iyakar adadi da aka bincika su ma su yi hankali. ## Gabaɗayan Bayani Man kifi ba sihiri ne na gina tsoka ba, amma wannan **umbrella review** na nuna zai iya ba da **ƙaramin ƙaruwa a ƙarfi**, musamman a ƙafafun ƙasa da aikin jiki. Shaidar tana da *farko*, tana maimaituwa, kuma a lokuta da yawa ba ta da ƙarfi, don haka karanta ta a matsayin “mai alƙawari, ba a tabbatar ba.” Har sai an samu manyan gwaje‑gwaje, **horon ƙarfi** da **cin abinci mai kyau** su ne ginshikin gina tsoka, kuma omega‑3s na teku na iya zama ƙarin da za a yi la’akari da shi ga mutanen da suka kai shekaru 55 da sama.

Whey, Pea, da Kwai: Binciken 51 da Suka Kwatanta Wane Protein Yafi Gina Tsoka Bayan Horo

Coach Ryan — Sun, 25 Oct 2026 08:13:34 GMT

## Babban Gano An yi wannan bincike ne don kwatanta whey, protein ɗin peas, da kuma kwai domin gano wanne ke da tasiri mafi girma wajen gina tsoka bayan horo. Sakamakon ya ba da mamaki – whey ne kawai ya nuna muhimmancin ƙaruwa a ƙimar **muscle protein synthesis (MPS)**. Wannan ba yana nufin whey ya fi ƙarfin sauran ba, amma yana nufin an gudanar da bincike da yawa kan whey, yayin da sauran ba a bincika su da yawa ba. #### Yadda Binciken Aka Gina Takardar da aka wallafa a *Journal of the International Society of Sports Nutrition* (2026) ta yi nazari ne ta hanyar **network meta‑analysis (NMA)**, wadda ke ba da damar kwatanta ƙwayoyin protein da ba a taɓa gwada su kai tsaye ba ta hanyar haɗa su da bayanan da ake da su. - **Bincike:** PubMed, EBSCOhost (MEDLINE, SPORTDiscus, CINAHL) da Scopus. - **Mahalli:** manya masu lafiya, shekaru 18 da sama. - **Tsari:** horo na ƙarfi a kai‑kai, an ba da ƙarin protein guda ɗaya bayan horo, ba tare da ƙarin abinci tsakanin ba. - **Mizanin:** an auna MPS a kowane awa ta hanyar **tracer technique** a cikin biopsies na tsoka kafin da bayan horo. - **Kekasasshen:** an ware gwaje‑gwaje waɗanda ba su haɗa da ƙarin magungunan anabolic ba. - **Samfur:** an haɗa gwaje‑gwaje 51 da cika ka’idojin ƙira da gudanarwa. Marubutan sun bayyana babu wani son kai ko ruwan hanci a cikin binciken. ## Jerin Matsayi An tantance protein ɗin ta hanyar **P‑score**, ƙima da ke tashi daga 0 zuwa 1 wadda ke nuni da yuwuwar samun MPS mafi girma bayan horo. | Protein | P‑score | Mean difference (%/h) | |---|---|---| | Native whey | 0.81 | 0.05 [0.00; 0.10] | | Pea | 0.77 | 0.05 [-0.02; 0.11] | | Whole egg | 0.72 | 0.04 [-0.01; 0.09] | | Mycoprotein | 0.66 | 0.03 [-0.02; 0.08] | | Whey | 0.58 | 0.02 [0.01; 0.04] | Sahihancin shaidu an tantance shi a matsayin **ƙasa zuwa matsakaici**. ## Dalilin da Ya Sa Whey Shi Ne Kaɗai da Aka Samu "Mahimmanci" Wannan shi ne abin mamaki. Duk da cewa whey ya zo a matsayi na biyar a cikin jerin, shi ne kaɗai da ke da **confidence interval** da ba ya haɗa da sifili (0.01 zuwa 0.04). Native whey, peas, kwai, da mycoprotein dukkansu suna da P‑score mai girma, amma tazara (interval) nasu ta ƙare da sifili, don haka ba a iya ƙara su a matsayin "mahimmanci" a ƙididdiga. Babban dalilin shine *ƙarfin samfur* – whey an bincika shi sosai, don haka ƙimar sa ta zama mafi ƙarfi a ƙididdiga. Pea da mycoprotein kuwa an samu su ne daga ƙananan gwaje‑gwaje, don haka ƙimar su ba ta da ƙarfi sosai. P‑scores na nuna **matsayi a jerin**, ba ƙarfin tasiri ba. P‑score na 0.77 ga pea ba yana nufin ya tabbatar da tasiri ba – yana nufin kawai cewa, idan muka duba bayanan da ake da su, pea na cikin manyan zaɓuɓɓuka. ## Matsakaicin Dosage: Gramm 18–25 Binciken amsa‑sauyi ya gano cewa **gram 18 zuwa 25** na protein ne ke haifar da mafi girman amsar MPS ga native whey, whole egg, peas, da mycoprotein. Wannan ya nuna cewa yawan protein da ake sha bayan horo yana da muhimmanci kamar irin protein da ake amfani da shi. ## Menene Wannan Ke Nufi a Gare Ka? - **Dosage:** Ka sha kimanin gram 18–25 na protein a cikin awa guda bayan horo. - **Lokaci:** Gwaje‑gwajen sun gwada shan protein guda ɗaya bayan horo, ba tare da takamaiman “time window” ba. Don haka ba sai ka damu da mintuna kaɗan ba – muhimmin abu shi ne shan protein cikin sauri bayan horo. - **Waɗanda ke ɗaga nauyi:** Idan kana shan madara, whey ne zaɓi mafi ƙarfi a ƙididdiga. - **Masu bin tsarin tsire‑tsire ko guje wa madara:** Peas da mycoprotein na da inganci, amma shaidun su ba su da yawa; suna buƙatar ƙarin bincike. - **Masu cin kwai:** Whole egg na zuwa a matsayi na uku, kuma yana ba da amsa mai kyau ga adadin dosage da aka ambata. ### Abubuwan Da Ya Kamata A Guji Ko A Yi Cautious Da Su - Idan kana da rashin jituwa da madara, kwai ko peas, kana buƙatar kauce wa su. - Mutanen da ke da cutar koda ko wasu yanayin lafiyar da ke shafar amfani da protein su tuntubi likita kafin su canza abincinsu. - Idan kana tunanin haɗa proteini daban‑daban (kamar peas da shinkafa), ka sani cewa wannan bincike bai ƙididdige irin wannan haɗaka ba. ## Muhimman Iyakoki - **MPS na ɗan lokaci ba yana nufin girman tsoka a dogon lokaci ba.** Gwaje‑gwajen sun auna ƙirƙirar protein a cikin awanni kaɗan, ba a tsawon watannin horo ba. Don haka ƙara MPS na ’yan awanni ba zai tilasta maka samun ƙarin tsoka ko ƙarfi a kai a kai ba – akwai tasirin yawan protein na kullum, ingancin horo, adadin kalori, da hutu. - **Bambance‑bambancen suna ƙanana.** Matsakaicin bambanci tsakanin nau'ukan protein ya kai 0.02–0.05 a kashi na kowane awa. Wannan na iya zama a kaikaice a ƙididdiga, amma ba lallai ya zama mai ainihi a aikace ba. - **Ingancin shaidu yana da iyaka.** Tabbatarwa daga ƙasa zuwa matsakaici na nufin ƙarin gwaje‑gwaje za su iya canza jerin, musamman ga protein da ba a bincika su sosai ba. ## Kammalawa Babu protein da ya wuce whey a wannan bincike, amma ba a saita whey a matsayin “na ƙarshe” ba. Whey ne kawai ya nuna tasiri mai ma'ana a wannan nazari, yayin da peas, mycoprotein, da whole egg ke matsayin zaɓuɓɓuka masu kyau waɗanda ke bukatar ƙarin bincike. Idan kana son tsarin sauƙi, ka sha gram 18–25 na protein da ke da sauƙin samun su (whey, kwai, peas, ko mycoprotein) bayan horo, ka kuma kula da adadin protein na kullum da ingantaccen horo – waɗancan su ne mabuɗan ci gaba na dogon lokaci.

Sha 100 g na Carbs a Sa’a Yana Kara Saurin Masu Keke—Ba Glycogen ke Jawo Ba

Coach Ryan — Sun, 25 Oct 2026 08:12:41 GMT

# Sha 100 g na Carbs a Sa’a Yana Kara Saurin Masu Keke—Ba Glycogen ke Jawo Ba **Takaitaccen Bayani:** Bayan awanni huɗu na tuki mai tsanani, masu keke da suka sha 100 g carbohydrate a kowace awa sun rasa ƙarfin su ƙasa da waɗanda suka sha 60 g. Abin mamaki, adadin glycogen a tsokar su ya kasance kusan daidai. Wannan bincike na bazuwar, double‑blind, crossover da aka yi a kan maza masu horo 15 ya nuna alamar wani abu fiye da adana glycogen. Mun fitar da ƙididdiga, tsarin 1:0.8 na glucose:fructose, da yadda za a yi amfani da shi. Haka kuma mun tattauna dalilin da yasa samfurin ga “ƙananan mazaje” ke da mahimmanci. --- ## Binciken: Menene Aikinsu? - **Tsari:** Randomized, double‑blind, crossover. - **Masu Halarta:** Maza masu horo 15 – kankara, masu keke da triathletes. - **Shiri:** Abincin da ke dauke da carbohydrate na kwanaki 24 kafin kowanne gwaji. - **Tafiya:** Mintuna 240 na tuki mai tsaka‑tsaki (60 % na ƙarfin watt na 15‑minute time‑trial) da tsokanar high‑intensity intervals. - **Gwaji:** Time trial na mintuna 15 bayan tuki, aka kwatanta da sabuwar mintuna 15 a yanayin farfadowa. - **Canji:** 60 g carbohydrate a kowace awa (CHO60) vs 100 g a kowace awa (CHO100), an ba su ta hanyoyin ruwan sha da gels da ratio 1:0.8 na glucose:fructose. - **Matsakaici:** Biopsies na tsokar vastus lateralis kafin da baya tuki, da kuma auna carbon oxidation na jiki da glucose a jini. Tsarin crossover yana nufin kowanne dan gwaji ya samu duka yanayi biyu; saboda haka kwatancen ya fi sahihi. Babu wanda daga masu atisaye ko masu binciken ya san wane yanayi ake ba shi a lokacin gwaji. ## Sakamakon Da Ya Fi Fitowa: Ƙarancin Fade Bayan Awanni 4 Masu binciken sun auna “durability”, wato yawan ragin aiki bayan dogon lokaci. Duka yanayi biyu sun haifar da raguwar ƙarfin a gwajin minti 15, amma girman raguwar ya bambanta: - **CHO60:** kusan **‑9.3 %** (± 2.0) - **CHO100:** kusan **‑6.4 %** (± 1.7) - **Bambanci:** statistically significant (P = 0.025) A ma'aunin da ba a raba ba, matsakaicin ƙarfin da aka samu a ƙarshe ya fi na CHO60 da **9 W** (P = 0.028). Wannan ƙarin ƙarfin na iya zama wani abu mai mahimmanci a tseren dogon lokaci. ## Abinda Ba Ya Bayyana: Glycogen Bai Bayyana Tasirin Ba Alamar farko ita ce karin carbs zai rage glycogen a tsokoki. Amma biopsies ba su nuna wani bambanci ba. Glycogen ya ragu sosai a duka yanayi, kuma matakin bayan tuki ya kusan daidai: - **CHO60:** 192 ± 99 mmol·kg⁻¹ (dry weight) - **CHO100:** 209 ± 111 mmol·kg⁻¹ (dry weight) - **P = 0.56** Bambancin da ke tsakanin mutane ya yi yawa, don haka “babu bambanci da aka gano” ba yana nufin ba shi da tasiri ba. Marubutan sun kammala da cewa CHO100 ya inganta durability ba tare da canjin glycogen ba. ## Abinda Ya Canza: Oxidation Na Carbon Daga Jiki Baki‑ɗaya Abin da karin shan carbs ya canza shi ne yadda jiki ke ci gaba da ƙone carbohydrate yayin tuki: - **CHO60:** 2.6 ± 0.6 g·min⁻¹ a farkon, ya sauka zuwa 1.9 ± 0.4 g·min⁻¹ - **CHO100:** 2.6 ± 0.4 g·min⁻¹ a farkon, ya sauka zuwa 2.3 ± 0.5 g·min⁻¹ - **Interaction (condition × time):** P = 0.047 Glucose a jini ya tsaya a daidaito a duka yanayi (kimanin 5.6‑5.7 mmol·L⁻¹ tare da CHO60, 6.0‑6.1 mmol·L⁻¹ tare da CHO100). Don haka rukunin 60 g/h ba su fuskanci hypoglycemia ba. Fa'idar 100 g/h ta samo asali ne daga wani abu banda ceto sukari a jini. Bayanan takarda suna nuna cewa ƙarin carbohydrate da aka sha yana ci gaba da zama “fuel” a ƙarshen tuki, yana ƙara oxidize carbohydrate. Sauran mekanis—kamar tasirin kwakwalwa, hanji, ko wasu ƙwayoyin jiki—ba a tabbatar da su ba, kuma su ne kawai zato. ## Menene Wannan Ke Nufi Ga Ka? ### Wa Ya Dace Da Shi - Masu keke da triathletes da ke yin tseren dogon lokaci (≈ awanni 3 ko fiye). Gwajin ya ɗauki awanni 4, kuma fa'idar ta bayyana a ƙarshe. - Atisaye da ke buƙatar ƙarfin ƙarshe (tudu, tsallake nesa, ko sprint a ƙarshe). - Masu da hanjin su ya saba da shan carbs ba tare da matsalar ciki ba. ### Adadin Da Ya Dace - Nufi **100 g carbohydrate a kowace awa** maimakon 60 g/h. - Yi amfani da **glucose da fructose a ratio 1:0.8**, kamar yadda binciken ya nuna. Duba alamun samfuran ruwan sha da gels don tabbatar da wannan rabo. - Raba jimillar cikin ruwan sha da gels, kamar yadda aka yi a gwajin, maimakon dogaro da wani abu guda. ### Lokaci Da Yadda Ake Sha - Binciken ya ba da carbohydrate a kai‑kai a kowace awa tsawon awanni huɗu. Ka nufa ƙananan allurai na yau da kullum, ba manyan allurai masu fadi ba. - 'Yan atisaye sun ci abincin da ke dauke da carbs a cikin awanni 24 kafin tseren. Kada ka watsar da wannan shiri na pre‑event. ### Horas Da Hanji - Canza daga 60 g/h zuwa 100 g/h a lokaci guda na iya haifar da matsalar ciki. Ka ƙara yawan shan a hankali cikin makonni da dama, ka kuma gwada samfuran a ranakun horo. - Idan ba za ka iya kaiwa 100 g/h ba kai tsaye, ƙananan allurai da ka iya jurewa su fi kyau fiye da alluri babba da ka haifar da rashin lafiya. ### Wa Ya Kamsa Ya Guje Shi (na ɗan lokaci) - Masu yin tseren ƙasa da awanni 2‑3. Gwajin bai gwada gajerun ƙoƙari ba. - Masu da matsalolin hanji da ke tashi da karin carbs. Nemi shawarar likita ko dietitian. - Duk wanda ke da cutar da ke shafar yadda jiki ke sarrafa carbs ya kamata ya tuntubi likita ko ƙwararren abinci. ## Ƙuntatawa Wannan gwaji yana da ƙarfi amma samfurin ƙanana ne: maza 15, duk masu horo. Ba za a iya ɗaukar sakamakon kai tsaye ga mata, manya, masu horon da ba su da ƙwarewa, ko sauran wasanni ba. Kwatancen kawai tsakanin 60 g/h da 100 g/h, don haka ba a san ko 80 g/h zai ba da fa'ida mafi girma ba. Bayanai kan glycogen suna nuna babban bambanci tsakanin masu tuki, wanda ke rage yawan karantawa. Duk da haka, binciken ya ba da tunani mai muhimmanci ga masu keke da ke ɗaukar 60 g/h a matsayin iyaka. Abincin na iya taimaka wa dogon tuki ta hanyoyi da glycogen ba ya bayyana ba. Idan kana gasa fiye da awanni uku kuma hanjinka ya saba da carbs, ka gwada 100 g/h a ratio 1:0.8 na glucose:fructose a lokacin horo.

Smoothie na Blueberry Ya Sa Ƙafafu da Suka Ji Ƙaura Sake Samun Ƙarfi Cikin Sauri

Dr. Gymbro — Sun, 25 Oct 2026 08:11:34 GMT

Ka san yanayin: kwana biyu bayan wani horo mai tsanani a ƙafa, hawa matakala ya zama gwagwarmaya. Tsokoki da ya kamata su kasance ƙarfi suna jin rauni, sannan horon na gaba yakan jinkirta. A wani gwaji ƙanana a New Zealand an gwada maganin abinci mai sauƙi—smoothie na blueberry—kuma an gano cewa ya hanzarta dawowar ƙarfi da ake auna. Sakamakon gaskiya ne amma ba shi da girma sosai, kuma cikakkun bayanai na da mahimmanci. ## Binciken a Takaitaccen Bayani Binciken da aka wallafa a *Journal of the International Society of Sports Nutrition* a shekarar 2012, ya fito ne daga Massey University da New Zealand Institute for Plant and Food Research. Ga yadda aka tsara shi: - **Tsari:** randomised crossover – kowane mahalarta ta shaƙata duka yanayi biyu, don haka ƙididdiga sun fi kusantar juna fiye da a binciken ƙungiyoyi biyu na al'ada. - **Mahalarta:** mata 10. - **Halin lalata:** kwashewa 300 na ƙaura mai nauyi (eccentric) na quadriceps, wato matakin saukowa na ɗaga nauyi da ke haifar da ciwo da rauni na ɗan lokaci. - **Abubuwan gwaji:** smoothie da aka yi da blueberries na New Zealand vs. smoothie placebo da ke da adadin antioxidants iri ɗaya. - **Lokutan auna:** sa'o'i 5 da 10 kafin motsa jiki, nan da nan bayan an gama, sannan a sa'o'i 12 da 36 da 60 bayan haka. - **Abubuwan auna:** torque na gwiwa (concentric, isometric da eccentric) da alamu a jini na oxidative stress, ƙarfin antioxidant da kumburi a duk tsawon awanni 60 na dawowa. Takaitaccen rubutun bai bayyana adadin gram na blueberries a kowanne smoothie ba, don haka babu wani ainihin adadi da za a kawo a nan. ## Babban Sakamako: Isometric Strength Ya Dawo Da Sauri Halin lalata ya yi aiki. Sa'o'i 12 bayan motsa jiki, torque na isometric, concentric da eccentric duk sun ragu sosai (p < 0.001) a **duka** yanayi. Kowa ya ji rauni, kuma smoothie bai hana hakan ba. Bambanci ya bayyana a dawowa. Bayan awanni 60, isometric peak torque ya nuna muhimmin tasiri na haɗin guiwa (**p = 0.047**), wato ƙarfi ya dawo da sauri bayan shan smoothie na blueberry fiye da placebo. Concentric da eccentric strength sun nuna alamun irin wannan, amma rubutun ya bayyana su a matsayin *trend* kawai, ba sakamakon muhimmi ba. Don haka, sakamako guda ɗaya ne ya tsallake ƙimar muhimmi, kuma adadin mahalarta ƙanana ne. Wannan alama ce mai ƙarfafa fata, amma ba tabbacin ƙwarai ba. ## Dalilin Da Ya Sa Placebo Ya Mahimmanta Yawancin gwaje‑gwajen berries suna barin tambaya: shin ƙwayar itace ce ke kawo fa'ida, ko kuwa kawai antioxidants gaba ɗaya? An yi amfani da placebo smoothie da aka daidaita don adadin antioxidants, don haka ba za a iya cewa fa'idar blueberry ta samo asali ne daga antioxidants kawai ba. Masu binciken sun kai ga cewa tasirin ba ya dogara ne kacokam da ƙarfin antioxidant na abin sha. Sun yi ikirari cewa blueberries, idan aka haɗa da motsa jiki na eccentric, suna ƙara haɓaka hanyoyin antioxidants na jiki na ciki. Wannan ra'ayi ne da aka samo daga bayanan da aka tattara, ba tabbacin ƙa'ida ba. ## Abinda Alamu a Jini Suka Nuna Duk rukuni biyu sun ga ƙaruwa a oxidative stress da alamu na kumburi bayan aikin lalata, kamar yadda ake tsammani. Rukunin blueberry ya ga oxidative stress ya sauka da sauri, amma bambancin ya zama muhimmi ne a **sa'o'i 36 bayan motsa jiki** – lokacin da aka ga ƙaruwa a ƙarfin antioxidant na plasma. Kumburi ya ci gaba da kasancewa a sama har zuwa awanni 60 na dawowa, don haka smoothie bai nuna ragi a matakin kumburi a wannan lokacin ba. Amfanin ƙarfi ya bayyana ba tare da tabbacin rage kumburi ba. ## Menene Wannan Ke Nufi a Gaban Ka? Wannan ƙaramar gwaji ne kadai, don haka ka ɗauki waɗannan ra'ayoyi a matsayin shawarwari, ba ƙa'idoji ba. - **Lokaci:** An auna torque a lokuta da dama: sa'o'i 5 da 10 kafin horo, nan da nan bayan, sannan a sa'o'i 12, 36 da 60 bayan. Idan kana son yin kwaikwayo, manufar ita ce ka rufe rana mai nauyi da smoothie, ba kawai sha bayan an gama ba. - **Adadin blueberry:** Rubutun ba ya fayyace adadin gram na blueberries da aka yi smoothie da su, don haka ba za a iya ambaton adadi na kimiyya ba. Hanya mafi kyau ita ce ka yi smoothie da 'ya'yan itace na al'ada da blueberries masu inganci. Duba cikakken nazari idan kana buƙatar takamaiman girke‑girke. - **Mafi Kyawun Amfani:** Sessions masu ƙarfi na eccentric – misali, ragowar nauyi mai yawa, gudun saukewa (downhill), squat ko lunge mai zurfi, ko dawowa bayan hutu – su ne lokutan da wannan shaida ke da amfani. - **Waɗanda Zasu Amfana:** 'Yan wasa masu sha'awa ko masu horo da ke son su samu dawowa cikin kankanin lokaci ba tare da ƙara yawan abincin ba. - **Waɗanda Zasu Guje Shi:** - Mutanen da ke kula da adadin kalori ko sukari, waɗanda za su bukaci ƙididdige smoothie ɗin. - Duk wanda ke da rashin jurewa ga blueberries ko wasu 'ya'yan itace. - Duk wanda ke neman tabbacin sakamako. Sakamako guda ɗaya ne ya kai muhimmin ƙima a cikin mata 10, don haka ba tabbatacce ba ne. ## Iyakoki Da Ya Kamata Ka Lura Da Su - **Misali ƙanana:** mata 10 – sakamakon na iya bambanta ga maza ko wasu ƙungiyoyi. - **Sakamako guda muhimmi:** isometric peak torque (p = 0.047). Concentric da eccentric sun nuna kawai alamar tafiya a waje ɗaya. - **Awanni 60 na dawowa:** babu bayanai kan tasirin dogon lokaci a horo. - **Babu ƙayyadadden adadi:** takaitaccen rubutu bai bada auna gram na blueberries ba. - **Ba magani ga ciwon tsoka:** torque ya ragu sosai a duka rukuni, kuma kumburi ya ci gaba da kasancewa a sama a duka rukuni. ## Kammalawa Smoothie na blueberry, da aka sha a kusa da lokacin motsa jiki mai tsanani na eccentric, ya taimaka wa mata 10 su dawo da isometric strength a ƙafafu cikin awanni 60 fiye da placebo da aka daidaita don adadin antioxidants. Tasirin ya kasance ƙanƙanta kuma yana kan iyakar ma'ana, kuma asalin ƙa'idar har yanzu ra'ayi ne. Idan kana shirin wani horo mai tsanani a ƙafa, ƙara blueberries a kusa da shi gwaji ne mai ƙananan haɗari. Ka yi amfani da shi a matsayin ƙari, ba a matsayin maganin mu'ujiza ba.

Turkesterone An Gwada A Kan IGF‑1 A Maza: Sakamako Ba Su Da Abin Da Masu Tasiri Suka Ikirari

Coach Ryan — Sat, 24 Oct 2026 07:20:14 GMT

## Takaitaccen Bayani Ƙaramar ƙungiyar da jami'ar **Baylor** ta jagoranta ta bai wa matasa goma sha ɗaya **turkesterone**. Binciken ya gano **babu tasiri mai ma’ana a kan IGF‑1, matakin metabolism na hutu (RMR), ko kuma sarrafa kitse da carbohydrates**. An yi wannan gwaji da ba shi da tsauraran ƙa'idodi na talla, amma ba a kai ga samun ƙwarewar ƙididdiga da ta dace ba. **Turkesterone** wani *ecdysteroid* ne da ake samu daga wasu tsire‑tsire, kuma a kafafen sada zumunta ana tallata shi a matsayin "**steroid na halitta**" da ke haɓaka tsoka ba tare da illa kamar **anabolic‑androgenic steroids (AAS)** ba. An sha shi a duniya ba tare da cikakken bincike a kan mutane ba. Wannan takarda, da aka buga a *Muscles* a shekarar 2024, tana daga cikin manyan ƙoƙarin da ake yi don gwada wannan ikirari. ## Abin Da Masana Su Ka Gane Binciken ya kasance gwaji na farko da aka yi da placebo. An zaɓi matasa maza **goma sha ɗaya** (ƙimar shekaru **23.3 ± 2.2**) waɗanda lafiyarsu ke da kyau. Duk mahalarta sun karɓi turkesterone a cikin ƙwayoyin lokaci‑lokaci, an kwatanta su da placebo. An tara samfurori a lokuta uku: - **Kafin shan** (asali) - **Sa’o’i 3 bayan shan** - **Sa’o’i 24 bayan shan** Mun auna manyan alamu kamar **serum IGF‑1** (hormone da ke da alaƙa da girman tsoka), **resting metabolic rate (RMR)** don duba ikirarin cewa turkesterone yana ƙara *thermogenesis*, da kuma alamu na metabolism na **lipid** da **carbohydrates**. Takardar ba ta bayyana adadin milligram‑din da aka yi amfani da su ba, don haka wannan muhimmin bayani ya ɓace. ## Sakamako: Babu Abin Da Ya Banbanta Binciken ƙididdiga ya nuna **babu bambanci mai ma’ana tsakanin yanayi, lokaci, ko hulɗa** a kan serum IGF‑1, RMR, metabolism na lipid ko carbohydrate (duka **p > 0.05**). Da kalmar gama gari, masu bincike ba su iya nuna tasirin turkesterone daga placebo ba. ## Alamomin Da Ba Su Da Muhimmanci Mawallafa sun lura da wasu canje‑canje biyu da ba su da ƙarfi: 1. **IGF‑1** ya tashi kadan a ƙungiyar turkesterone, amma ban da bambanci mai ƙarfi daga placebo. 2. **RMR** ya ɗan ƙaru a awanni uku da aka auna, amma ba tare da ƙara mahimmanci ba. Saboda adadin mahalarta ya kasance **11 kacal**, binciken ya rasa ƙarfin dawo da ƙananan tasiri. Don haka, waɗannan alamu na iya zama gaskiya ko kuma kawai hayaniya, kuma ba za a iya bambanta su ba. ## Dalilan Da Suka Sa Binciken Bai Magance Tambayar Ba - **Ƙananan adadi**: Samfurin matasa maza 11 ba zai wakilta mata, manya, ko masu horo yadda ya kamata ba. - **Lokaci ɗaya kawai**: An auna a cikin yini ɗaya, ba a yi gwaji na makonni ko watanni ba tare da tsari na horo ba. - **Ƙayyadadden auna**: An auna IGF‑1 ne kawai; ba a auna girman tsoka, ƙarfi, ko synthesis na furotin ba. - **Babu horo**: Gina tsoka na bukatar motsa jiki, isasshen protein da lokaci – abubuwan da ba a haɗa su a wannan bincike ba. Mawallafa sun kira ga ƙarin bincike don tantance tasirin turkesterone a kan IGF‑1 da girman tsoka a lokuta masu tsawo da horo mai tsanani. ## Labari Mai Tabbatarwa: Amintaccen Gwaji Masana sun lura cewa turkesterone ya nuna **lafiyar zuciya da hanji** a cikin wannan ƙananan gwaji. Bai haifar da matsalolin zuciya ko matsa lamba a hanji ba a cikin mahalarta 11. Wannan yana nuni da cewa yana da **amintacciyar halin ɗan gajeren lokaci**, amma ba ya ba da hujja ga amincin dogon lokaci. ## Menene Wannan Ya Nufasa Ga Kai? **Shin yana gina tsoka?** – Har yanzu ba a tabbatar da hakan ba. Binciken bai auna girman tsoka ko ƙarfi ba, kuma tasirin hormone da metabolism ba su banbanta da placebo ba. **Matsakaicin ƙima:** – Ba a bayar da kowane ƙimar da zai nuna yadda ake amfani da turkesterone don gina tsoka ba. **Lokacin sha:** – An auna bayan sa’o’i 3 da 24, don haka ba a sami bayanin da zai taimaka wajen tsara **pre‑workout** ko **post‑workout** ba. **Waɗanda za su iya amfana:** – Mutanen da ke neman ƙarin bayani game da lafiyar su, waɗanda ba su yarda da tallace‑tallacen da ba su da hujja ba. Kada ku kashe kuɗi a kan samfur ba tare da ba da fifiko ga abubuwa masu tushe ba: motsa jiki, isasshen protein, barci mai kyau, da adadin kalori da ya dace. - Mutanen da ke tsammanin sakamako kamar na steroid – wannan bincike ba ya ba da goyon baya ga wannan zato. - Mutanen da ke da cututtuka masu alaƙa da hormone ko ke shan magungunan ba tare da tuntuɓar likita ba. - Matan da ke ciki ko masu shayarwa, da kuma ƙasa da shekaru 18. - ‘Yan wasa masu gogewa da ke duba ƙa’idodin ƙungiyarsu da abubuwan da ke cikin samfur. ## Takaitaccen Bayani Bayanan farko na turkesterone a kan IGF‑1 a cikin mutane ba su nuna tasiri mai ma’ana ba. Suna nuna alamar da za a iya bincika a ƙananan adadi da lokaci ɗaya. Har sai an yi gwaje‑gwaje masu tsawon lokaci, tare da auna girman tsoka da ƙarfi kai tsaye, turkesterone zai kasance **ƙarin da ba a tabbatar da fa’idarsa ba**, ba a matsayin maganin da zai maye gurbin steroid ba.

Tribulus Terrestris Ya Rasa Tasiri a Ɗan Wasan Rugby Masu Daraja: Gwajin Mako Biyar

Dr. Gymbro — Sat, 24 Oct 2026 07:19:17 GMT

# Tribulus Terrestris Ya Rasa Tasiri a Ɗan Wasan Rugby Masu Daraja: Gwajin Mako Biyar Idan ka duba kowane shafin kayan ƙari, za ka ga Tribulus terrestris an yi masa alƙawarin ƙara ƙarfi da tsoka a cikin kwanaki **5 zuwa 28**. To me ya faru lokacin da masana kimiyya suka sanya shi a gwajin da aka yi a kan ’yan wasa ƙwararrun **Rugby League**? **Babu wani tasiri.** Binciken da aka wallafa a *Journal of Strength and Conditioning Research* a 2007 ya zama abin koyi ga duk masu neman "ƙara testosterone na halitta". --- ## Manyan Ci Gaban da ake Ikirari a Ƙasa da Wata Tribulus terrestris wani kari ne daga ganyen da ake tallata wa ’yan wasa da masu ɗaga nauyi. A tallace‑tallacen, ana “ƙara” ƙarfi, tsoka ba tare da ƙarin kitse ba, a cikin kwanaki 5‑28. Wannan alƙawari na da ɗan ban mamaki ga kowane abu da ake sayarwa a kasuwa. Wasu masana sun yi ikirarin cewa Tribulus na iya ƙara **ratio** na testosterone/epitestosterone (T/E) a fitsari, abin da zai sa ’yan wasa su fuskanci matsala a gwajin ƙwayoyin ƙwaya. Don haka, masu binciken sun mayar da hankali kan tambayoyi biyu: 1. Shin Tribulus na ƙara ƙarfi da tsoka? 2. Shin yana canza ratio na T/E a fitsari? --- ## Yadda Gwajin Ya Gudana - **Tsari:** Randomized, double‑blind, placebo‑controlled, match‑paired trial - **Maharta:** ’Yan wasa 22 na Rugby League a Ostiraliya (shekaru 19.8 ± 2.9, nauyi 88.0 ± 9.5 kg) - **Rukuni:** 11 suna sha Tribulus, 11 suna sha placebo - **Kudiri:** 450 mg na extract na Tribulus a rana guda, sau ɗaya a rana - **Tsawon lokaci:** makonni 5 - **Horowa:** Dukkan ’yan wasan suna cikin shirin horon nauyi mai ƙarfi na pre‑season An auna ƙarfi, ƙimar jiki (ciki har da ƙarin tsoka ba tare da ƙarin kitse ba) da ratio na T/E a fitsari kafin da bayan gwajin. --- ## Sakamako: Kowa Ya Ƙara Ƙarfi – Tribulus Ba Ya Taimaka Bayan makonni biyar, an ga **kowa** ya ƙara ƙarfi da ƙarin tsoka ba tare da ƙarin kitse ba. Amma ƙaruwa ta faru a duka rukuni, kuma **babu bambanci** tsakanin ƙungiyar da ta sha Tribulus da ta sha placebo. A takaice, ribar da aka samu ta samo asali ne daga horon nauyi, ba daga ganyen ba. Marubutan sun kammala da cewa Tribulus terrestris **bai haifar da ci gaban da aka ikirari ba** a cikin kwanaki 5‑28. --- ## Ratio na Testosterone/Epitestosterone: Babu Canji Binciken ya kuma gano cewa **ratio na T/E a fitsari ba ta bambanta** tsakanin rukunan biyu. Wannan yana nufin Tribulus ba zai sa ’yan wasa su fuskanci matsalar gwajin ƙwayoyin ƙwaya ba, a cewar ka’idar WHO wadda ke ɗaukan 4:1 a matsayin iyaka. --- ## Iyakoki da Ya Kamata Ka Sani | Iyaka | Bayani | |-------|--------| | **Samfurin ƙanƙanta** | ‘Yan wasa 22 ne kawai – ƙananan adadi na iya ɓoye tasiri ƙanana. | | **Kudiri guda** | An gwada 450 mg a rana – ba a gwada wasu ƙuduri ko tsari ba. | | **Lokaci ƙanƙanta** | Makonni 5 ne kawai – watakila ba su ba da damar ganin tasiri na dogon lokaci ba. | | **Mahalli na musamman** | Matasa, maza, ’yan wasa ƙwararru – sakamakon na iya bambanta a tsofaffi, mata ko masu horo mai sauƙi. | | **Horon mai ƙarfi** | Horon yana iya ɓoye tasirin ƙaramin kari. | --- ## Menene Wannan Ke Nufi a Gashinka? - **Kudiri da Lokaci:** 450 mg na extract a rana na makonni 5 ba su nuna fa’ida a kan placebo ba. Ba mu da wani shawarwarin amfani da shi don ƙara ƙarfi ko tsoka. - **Wanda Ke Sha’awar Testosterone na Halitta:** Idan kana neman ƙara testosterone ta hanyar kari, wannan gwaji ya nuna Tribulus ba shi da wani tasiri a wannan fanni. - **Wanda Ya Kamata Ya Gujewa:** Idan burinka shine ƙara ƙarfi, tsoka ko inganta aiki, ka guje shi – musamman idan kasafin kuɗi ya takaita. - **Matsayin Kuɗi:** A maimakon haka, kashe kuɗi a kan abubuwan da suka samu hujjojin kimiyya masu ƙarfi: - **Creatine** – ƙara ƙarfi da tsoka a fili. - **Protein** – taimaka wa girman tsoka da gyaran jiki. - **Shirin horon nauyi mai inganci**, barci mai kyau, da isasshen kalori. --- ## Takaitaccen Bayani A gwajin duplu‑blind da aka yi a kan ’yan wasa 22 na Rugby League, 450 mg na Tribulus terrestris na makonni 5 **bai ba da wani fa’ida a kan placebo ba** a fannin ƙarfi, ƙarin tsoka ba tare da kitse ba, ko ratio na T/E. Duk da ƙarancin samfurin da kudiri guda, sakamakon ya ba da hujja mai ƙarfi don shakku game da dukkan maganganun talla. Don haka, ka ajiye kuɗinka ga abubuwan da aka tabbatar suna aiki.

Wannan Sukar Mara Kalori Ta Fi Ɗanɗita Abin Sha Na Diyeta A Rehydratation

Dr. Gymbro — Sat, 24 Oct 2026 07:18:17 GMT

# **Wannan Sukar Mara Kalori Ta Fi Ɗanɗita Abin Sha Na Diyeta A Rehydratation** **Takaitaccen Bayani**: Sukar mara kalori da ake kira *allulose* ya shanye mukamin abin sha da aka ƙara masa sucralose a cikin gwajin da aka gudanar a yanayi na bai-bai, inda aka sami maza 15 masu lafiya. Dawowar yawan plasma ta kai kashi **28.16 %** idan aka kwatanta da **4.13 %** na sucralose, yayin da riƙon ruwa ya kai **91.54 %** a kan allulose kuma **80.55 %** a kan sucralose. Mahalarta sun kuma ba da rahoton raguwa mai tasiri a ƙishirwa, ba tare da wata matsala ta sukari ko yanayin zafi ba. Sai dai gwajin ƙanana ne, kamfanin da ya samar da allulose ne ya tallafa masa, kuma ba a kwatanta shi da abin sha na wasanni na al'ada ba. Ga abin da lambobin ke nuna, waɗanda za su amfana, da waɗanda ya kamata su jira ƙarin hujjoji. ## Mece Ce Allulose Kuma Me Ya Sa Aka Gwada Ita Don Rehydratation? *Allulose* sukari ce mai wuyar samu wacce ba ta da kalori ko da kaɗan, kuma masana kimiyya sun ɗauke ta a matsayin zaɓi mai alkawari. Duk da cewa sukari na al'ada kan taimaka wajen shigar da ruwa da sodium a hanji, suna ƙara yawan kalori da nauyin sukari—abubuwan da mafi yawan ‘yan wasa da masu motsa jiki ba su son su ɗauka. Sukari mara kalori kamar sucralose suna magance batun sukari, amma ba su taimaka wajen karɓar ruwa. Allulose tana cike wannan gibi. Ita ce sukari mara kalori da ke da adadin kalori ƙasa da sifili, kuma marubutan sun bayyana ta a matsayin wani zaɓi mai tasiri. Har yanzu shaidu kan yadda za ta iya tallafawa sake samun ruwa ba su da yawa. Wannan gwajin, da aka wallafa a *Food Science and Biotechnology* (doi: 10.1007/s10068-026-02329-z), yana nufin cike wannan gibi. ## Tsarin Gwaji - **Tsari:** gwaji mai bai‑bai, ɗimbin rashin sani ga masu halarta da masu bincike, tare da canja wurin gwaji (crossover). - **Masu Halarta:** maza 15 masu lafiya. - **Hanyar Gwaji:** kowane mahalarta ya sha ruwa bayan an tilasta masa zub da ruwa ta hanyar motsa jiki, sannan ya sha ɗayan abubuwan biyu – daya da allulose, dayan kuma da sucralose (na gwaji). - **Abubuwan Da Aka Auna:** dawowar yawan plasma (PV), riƙon ruwa, ƙishirwa, yanayin ruwan jiki, ƙarfin fitsari, glucose da yanayin zafin jiki. A tsarin canja wurin, kowane mahalarta ya kasance a matsayin kansa a gwajin da aka kwatanta, wanda ke ƙara ƙarfin kididdiga a cikin ƙananan samfurin. Rashin sani ga duka bangarorin na nufin ba mahalarta ba ko masu bincike sun san wane abin sha ne suke sha a lokacin gwaji. ## Lambobin Da Suka Fice **Dawowar yawan plasma.** Allulose ta haifar da canjin **28.16 ± 11.61 %**, yayin da sucralose ta haifar da **4.13 ± 5.34 %** (p = 0.0001). Wannan kusan ninki bakwai ne a cikin canjin matsakaici, kuma yawan plasma alama ce mai muhimmanci na yadda jinin ke samun daidaito bayan rasa ruwa. **Riƙon ruwa.** Mahalarta sun riƙe **91.54 ± 5.18 %** na ruwan da aka sha da allulose, kuma **80.55 ± 10.24 %** na ruwan da aka sha da sucralose (p = 0.0023). A aikace‑aikace, wannan na nufin an adana ƙarin ruwa a jiki. **Raguwar ƙishirwa.** Alamar raguwar ƙishirwa ta kasance **6.47 ± 1.46** ga allulose da **4.60 ± 1.12** ga sucralose (p = 0.0012). Allulose ta sa mahalarta su ji ƙananan ƙishirwa. Masu bincike sun kuma ba da rahoton babu wata illa ta sukari ko yanayin jiki. An lura da glucose na jini da yanayin zafin jiki, kuma abin sha da allulose bai haifar da wata matsala ba. Wannan yana tallafawa ra'ayin cewa za a iya samun taimakon rehydratation ba tare da ƙarin sukari ba. ## Sharhin Gwajin **Abun kwatanta shi ne sucralose, ba sukari ba.** Sucralose ba ta da kalori kuma ba sukari na al'ada ba ce. Don haka gwajin ya nuna allulose na cin nasara a kan abin sha na salo ɗin diyeta. Bai nuna allulose na doke abin sha na wasanni da ke ɗauke da sukari ba. **Samfurin ya ƙunshi mutane kaɗan kuma da ƙuntatawa.** Maza 15 kawai ne aka yi amfani da su; ba a gwada mata, tsofaffi, ‘yan wasa masu dogon lokaci a waje, ko mutanen da ke da matsalolin metabolism ba. **An tallafa shi da masana'antar.** Aikin an samu goyon baya daga *Samyang Corporation*, kamfanin da ke kera allulose, wanda shima ya samar da kayan gwaji. Mafi yawan marubutan ma'aikatan *Samyang* ne. Wannan ba ya kawar da sahihancin bayanai, amma yana nuna wani ɓangare na rashin zaman kai, don haka maimaita gwajin ba tare da tasiri ba yana da muhimmanci. **Gwajin ya yi amfani da motsa jiki na gajeren lokaci kawai.** Sakamakon na fito ne daga dakin gwaji. Ba a sani ba yadda za su kasance a marathon mai zafi, a horo na tsawon kwanaki, ko a aikin da ke buƙatar ƙoƙari na tsawon lokaci. Bugu da ƙari, takardar ba ta shigo PubMed ba tukuna; DOI ne kawai hanyar da ake samun ta. ## Me Wannan Ke Nufi A Gaba Ga Kai ### Waɗanda Zasu Amfana - **‘Yan wasan da ke zufa da yawa** waɗanda ke rasa ruwa sosai kuma suke son dawo da yawan plasma ba tare da ɗaukar ƙarin kalori ba. - **Masu guje wa sukari a abubuwan sha na wasanni**, ciki har da waɗanda ke kula da adadin kalori, glucose na jini, ko yawan sukari gaba ɗaya. - **Kowa da ke amfani da abin sha na electrolytes na diyeta**, domin wannan gwaji ya nuna zaɓin ɗanɗano na iya tasiri ga rehydratation, ba kawai ga ɗanɗano ba. ### Waɗanda Ya Kamata Su Janye Ko Su Jira - **‘Yan wasa da ke buƙatar ƙarfi.** Idan kana horo mai ƙarfi kuma kana buƙatar carbohydrate don aiki, abin sha mara kalori ba zai maye gurbin wannan ba. Wannan binciken ya auna rehydratation, ba aikin fasaha ba. - **Masu neman shaidu kan abin sha na wasanni na al'ada.** An kwatanta allulose da sucralose, ba da sukari na al'ada ba. - **Mutanen da ke da cututtukan ciki ko wasu yanayi na kiwon lafiya.** Binciken bai haɗa waɗannan rukunin ba, kuma amincewa da kowanne sabon ɗanɗano na iya bambanta. Ka tuntuɓi likita idan kana da ciwon sukari ko wata cuta ta narkewa. ### Yawan da Lokaci Mahalarta sun sha abin sha bayan gajeren rashin ruwa na motsa jiki, don haka hujja tana shafi rehydratation bayan horo. Ba a bayyana ainihin adadin allulose, girman kofin, ko tsawon lokacin jinkiri (washout period) ba a takardar da na duba. Ka duba cikakkiyar takarda don ƙarin bayani kafin ka maimaita tsarin, kuma kar ka ƙara yawan haɗin. Ruwan allulose na kasuwa na iya bambanta da adadi da abubuwan electrolytes da aka yi gwaji da su. ## Kammalawa Alamar da wannan bincike ya nuna tana da alƙawari: a cikin maza 15, abin sha da allulose ke ɗanɗano ya fi abin sha da sucralose a kan dawowar yawan plasma, riƙon ruwa, da raguwar ƙishirwa, ba tare da wata illa ta sukari ko yanayin jiki ba. Amma wani ƙuntatawa na akwai—gwajin ƙanana ne, kamfanin ne ya tallafa, kuma an kwatanta da abin sha mara kalori. Ka yi amfani da wannan sakamakon a matsayin ƙira don manyan gwaje‑gwaje masu zaman kansu, ciki har da kwatanta da ruwan wasanni na al'ada da gwaje‑gwaje a mata, ba a matsayin hujja ɗaya da za ta canza tsarin shan ruwa ba.

Creatine Yana Taimaka wa Matan da ke da Matsalar Gwiwa su Tsaya Da Sauƙi. Ba Kamar yadda Kuke Tunanin ba

Dr. Gymbro — Sat, 24 Oct 2026 07:17:13 GMT

## Abin Mamaki da Aka ɓoye a Cikin Gwajin Osteoarthritis na Gwiwa Creatine na da suna mara kyau: ana ɗaukarsa a matsayin ƙari ga masu ɗaga ƙiba masu shekaru 20‑30 da ke neman ƙara ƙarfi. Amma wani gwaji na bazuwar da aka wallafa a *Medicine & Science in Sports & Exercise* ya gwada wannan ƙari a wani rukuni gaba ɗaya daban – matan da suka haura shekaru kuma ke fama da osteoarthritis (OA) a gwiwa. Ƙungiyar da ta sha Creatine ta fi saurin fita daga kujerar. Ƙarfinsu ba su fi na placebo ba, kuma rage radadi ma ba su bayyana ba. Ga abin da binciken ya gano a zahiri, da abin da ba zai iya tabbatar ba. ## Binciken a Taƙaice - **Tsari:** Gwaji mai bazuwa, mai rabe‑raben biyu, an sarrafa placebo (Neves et al., 2011, Jami'ar São Paulo) - **Mahalli:** Matan da suka haura shekaru kuma ke da osteoarthritis na gwiwa - **Yawan mahalarta:** Takaitaccen ba ya bayyana adadin mahalarta. Duba cikakken rubutu kafin a ɗauki sakamakon a matsayin tabbatacce, kuma a tuna cewa irin waɗannan gwaje‑gwajen su kan kasance ƙanana. - **Hanyar magani:** Creatine – 20 g a rana na mako 1, sannan 5 g a rana – ko placebo - **Horon jiki:** Kowa ya bi shirin horon ƙarfafa tsokar ƙafa ƙasa - **Tsawon lokaci:** Makonni 12, an tantance a farkon gwaji da ƙarshen sa - **Manufa ta farko:** Ayyukan jiki, an auna ta gwajin “timed‑stands” (yawan fitowar daga kujerar a cikin dakika) Saboda duka kungiyoyin sun yi horo, tambayar ba ta kasance “shin Creatine ya fi na rashin yin komai?” ba. Tambayar ita ce “shin Creatine yana ƙara wani abu a kan horon ƙarfi?”. ## Lambar da Ta Fi Kowa Jiɓa: Tsayawa Da Sauri Matsakaicin sakamakon “timed‑stands” a ƙungiyar da ta sha Creatine ya tashi daga 15.7 ± 1.4 zuwa 18.1 ± 1.8, ƙaruwa ta maki 2.4, kusan 15 %. Kungiyar placebo ta daga 15.0 ± 1.8 zuwa 15.2 ± 1.2, wato ba a sami ci gaba ba. Ci gaban a cikin ƙungiyar Creatine ya kasance mai mahimmanci (P = 0.006), haka kuma bambanci tsakanin ƙungiyoyin (P = 0.004). Kungiyar placebo ta yi horo iri ɗaya amma ba ta ga wani canji mai ma’ana a wannan gwaji ba. Wannan ne ya sa sakamakon ya zama abin sha’awa. ## Ƙarin Riba da Creatine Ta Nuna Amfanin ba su tsaya ga gwajin farko ba. Kawai ƙungiyar Creatine ta nuna ingantacciyar ci gaba a: - **WOMAC – aikin jiki:** P = 0.005 - **WOMAC – ƙyalli:** P = 0.024 - **Matsakaicin ƙaramin tsoka a ƙafafu:** P = 0.04 - **Ingancin rayuwa:** P = 0.01 Kungiyar placebo ba ta sami canji mai mahimmanci a sassan WOMAC na aikin jiki da ƙyalli ba (P > 0.05). WOMAC wata tambaya ce da marasa lafiya ke amsa dangane da radadi, ƙyalli, da wahalar gudanar da ayyukan yau da kullum, don haka waɗannan canje‑canjen su ne abin da mata suka lura da su da kansu. ## Inda Creatine Ba Ya Nasara ### Radadi Duka kungiyoyin sun bayar da rahoton raguwar radadi mai ma’ana (P < 0.05). Creatine bai fi placebo ba a wannan fanni. Abin da ke yiwuwa shine horon ƙarfafa tsoka da aka yi a duk masu hali, ko da yake binciken ba ya raba wannan tasiri. Creatine ba a nuna shi a matsayin maganin radadi ga gwiwar arthritic. ### Ƙarfi na danna ƙafa Matsakaicin ƙarfi na danna ƙafa (leg‑press one‑repetition max) ya tashi a duka kungiyoyi (P = 0.005), ba tare da bambanci ba (P = 0.81). Creatine bai sa waɗannan mata su zama ƙwararrun danna ƙafa fiye da placebo ba. Don haka labarin ba “Creatine yana gina ƙarfi mai yawa” ba ne. Wani abu ne ke faruwa: ingantaccen aiki na yau da kullum da ƙarin ƙaramin tsoka ba tare da bambanci a 1RM ba. Maƙasudin marubuta an takaita ga aikin jiki, ƙaramin tsoka a ƙafafu, da ingancin rayuwa. ## Me Yasa Ayyuka Zasu Iya Inganta Ba Tare da Ƙarfi ba? Takaitaccen ba ya fayyace dalilin wannan, don haka za mu ɗauka a matsayin hasashe mai ilimi. Gwajin fitowa daga kujerar yana ba da lada ga maimaitawa, ba ga ɗaukar nauyi mafi girma ba. Creatine yana da tasiri sosai a cikin gajerun lokuta yayin maimaitawa, wanda ya dace da gwajin da aka gina a kan maimaituwa. Ƙarin ƙaramin tsoka a ƙafafu ma na iya taimakawa. Gwajin 1RM da gwajin maimaitawa suna auna abubuwa daban‑daban, don haka yana yiwuwa su ba da amsa a hanyoyi daban‑daban. ## Menene Wannan ke Nufi a Gaban Ka? - **Kima:** Gwajin ya yi amfani da mako 1 na lodin 20 g a rana, sannan 5 g a rana na makonni 11 na ƙarshe. Kima na yau da kullum shine 5 g a rana, shi ne abin da ya kamata a mayar da hankali akai. Lodin na daga cikin tsarin, amma ba a gwada ko tsallakewa zai canza sakamako ba. - **Lokaci:** Takaitaccen bai bayyana lokacin da mahalarta suka sha ba, don haka ba za a iya fitar da ka’idar lokaci ba. Daidaito ya fi mahimmanci fiye da agogo. - **Horon jiki:** Creatine an ba shi tare da horon ƙafafu na 12 makonni. Sakamakon yana shafi Creatine *tare* da horo, ba Creatine kaɗai ba. Idan ba ka yin horon ƙarfafa, kar ka yi tsammanin za ka samu irin wannan riba. - **Wanene zai amfana:** Matan da suka haura shekaru kuma ke da OA a gwiwa, waɗanda ke yi ko za su fara horon ƙafafu na kulawa, kuma suke son ƙarin taimako a ayyukan yau da kullum kamar fitowa daga kujerar da rage ƙyalli. - **Wanene yakamata ya guje shi ko ya tuntuɓi likita da farko:** - Duk wanda ke da cutar koda ko rage aikin koda, ko yana shan magunguna da ke shafar koda. - Duk wanda ke tsammanin Creatine zai rage masa radadi, domin gwajin ya nuna babu fa’ida a kan placebo. - Maza, matasa, da masu nau’in arthritis daban‑daban waɗanda ba a bincika a wannan gwaji ba. - Duk wanda ke da manyan cututtuka ko ke shan ƙwayoyi da yawa, ya kamata ya nemi izinin likita kafin amfani da kowanne ƙari. ## Kaɗan Kaɗa Wannan gwaji ne guda ɗaya na makonni 12 a cikin wani rukunin mutane, kuma takaitaccen ba ya ba da yawan mahalarta. Ya kamata a maimaita shi kafin a canza jagororin kiwon lafiya. Sakamakon yana da ƙarfafa amma ba tabbatacce ba, kuma sakamakon na biyu ya kamata a ɗauke shi a matsayin tallafi, ba hujja ba. Amma babban darasin shine: ga matan da ke da OA a gwiwa kuma suke yin horon ƙarfi, ƙara 5 g a rana na Creatine ya haifar da ƙaruwa a aikin yau da kullum wanda horon tare da placebo ba zai iya ba. Rage radadi da ƙarfafa matsakaicin nauyi sun kasance iri ɗaya. Creatine zai iya zama mai amfani ga mutanen da ba matasa masu ɗaga ƙiba ba, amma yana aiki ne tare da na’urar squat ko leg‑press, ba a matsayin magani mai kai tsaye ba.

Man Fetur na Krill Ya Rage Asarar Tsoka a Lokacin Azumin Kwanaki 8 a Binciken Gwaji

Dr. Gymbro — Sat, 24 Oct 2026 07:16:02 GMT

# Man Fetur na Krill Ya Rage Asarar Tsoka a Lokacin Azumin Kwanaki 8 a Binciken Gwaji **Cin abinci da ƙananan kalori galibi na haifar da rasa nauyi da asarar tsoka.** Sai dai, wani sabon gwaji mai rarraba bazuwar da aka wallafa a *Obesity* ya nuna cewa ƙarin krill oil na iya rage wannan asara. Duk ƙungiyoyi sun rasa nauyi iri ɗaya, amma ƙungiyar da ta sha krill oil ta kiyaye kusan dukkanin **ƙashin da ba a raba ba (lean mass)**, yayin da ƙungiyar placebo ba ta yi hakan ba. Sakamakon ya burge, amma gwajin ƙanana ne kuma ƙwallon tana ɗauke da sinadarai fiye da omega‑3 guda ɗaya. Ga abin da masu bincike suka gano da kuma abin da ke nufin ga masu sha'awar kiwon lafiya. ## Binciken a Taƙaice Masana daga Jami'ar Glasgow sun gudanar da gwaji mai rarraba bazuwar, tare da sarrafa takardun martaba (placebo‑controlled), a cikin manya masu kiba ko overweight (ClinicalTrials.gov NCT06001632). Mahalarta sun bi **kwanaki 8 na azumin rana‑da‑rana (ADF)**, inda aka ba su ƙwallon krill oil ko takardar placebo sau huɗu a rana. - **Mahalarta:** 41 (mata 25, maza 16) - **Shekaru:** 39 ± 10 - **BMI:** 31.1 ± 4.2 kg/m² - **Abubuwan da aka auna:** nauyin jiki, ƙashin da ba a raba ba (FFM), da ƙarfin riƙe da hannu (grip strength) – kafin da bayan gwaji. An wallafa sakamakon a shekarar 2025 ta Alblaji, Gray, Almesbehi, Morrison da Malkova. Marubutan sun bayyana babu wani rikice‑rikice na sha’awa. ## Abubuwan da ke Cikin Ƙwallon Kowane ƙwallon krill oil na dauke da: - **EPA:** 191 mg - **DHA:** 94 mg - **Choline:** 78 mg - **Astaxanthin:** 100 µg Da shan ƙwallon huɗu a rana, jimillar sinadarai ya zama: - **EPA:** 764 mg - **DHA:** 376 mg - **Choline:** 312 mg - **Astaxanthin:** 400 µg Krill oil wani rukuni ne na omega‑3 da aka haɗa a cikin phospholipids, tare da choline da antioxidant astaxanthin. Gwajin ba zai iya tantance wane sinadari ko haɗin su ne ya haifar da tasiri ba – an gwada cikakken ƙwallon, ba kawai omega‑3 ba. ## Lambobi: Kamar Nauyi Daidai, Amma Bambanci Mai Girma a Tsoka **Rashin nauyi ya kusan zama ɗaya.** Ƙungiyar krill oil ta rasa **4.6 ± 1.4 kg**, yayin da ƙungiyar placebo ta rasa **4.5 ± 1.9 kg**, babu bambanci mai ma'ana. **Ƙashin da ba a raba ba (FFM) ya bambanta sosai:** - Krill oil: **‑0.2 ± 0.9 kg** (ba canji mai ma'ana) - Placebo: **‑1.2 ± 2.0 kg** (ragi mai ma'ana, p < 0.05) Wannan kusan kilogram 1 na bambanci a tsoka. A matsakaici, ƙungiyar placebo ta rasa kimanin sau 5‑6 na yawan tsoka da ƙungiyar krill oil ta rasa. **Karfin riƙe da hannu (grip strength) ya bi tsarin daya:** - Krill oil: **‑0.2 ± 0.5 kg**, ba canji mai ma'ana - Placebo: **‑0.9 ± 0.7 kg**, ragi mai ma'ana (p < 0.05) Bambancin tsakanin ƙungiyoyi ya kasance mai ma'ana, wanda ke nuni da kariyar tsoka da ke samuwa daga krill oil. ## Shin Ragin Kiba Ya Dace? Abubuwan da aka bayar suna nuna **jimillar ragin nauyi** ne, ba ragin ƙiba kai tsaye ba. Saboda ragin nauyi ya zama daidai tsakanin ƙungiyoyi, kuma ƙungiyar krill oil ta rasa ƙasa da **FFM**, lissafi yana nuna cewa krill oil ya hana asarar tsoka, yayin da placebo ya rasa tsoka da yawa. Wannan ba yana nufin krill oil ya sa ɗanɗano ya fi yawa ba, amma yana rage yawan asarar tsoka a lokacin azumi. ## Kari‑karin Da Ya Kamata A Lura Da Su - **Ƙananan samfur.** Mahalarta 41 ne kawai; canjin FFM a placebo ya nuna bambanci mai girma (±2.0 kg), don haka amsoshin mutum‑mutum sun bambanta. - **Lokaci gajere.** Kwanaki 8 ba su ba da cikakken bayani game da riƙon tsoka ko ƙarfi a dogon lokaci ba. - **Sinadarai masu hade.** Astaxanthin da choline suna cikin ƙwallon tare da EPA da DHA, don haka ba za a iya danganta tasiri ga omega‑3 kawai ba. - **Mahalarta masu kiba ne kawai.** Sakamakon na iya rashin dacewa ga 'yan wasa masu ƙananan nauyi, tsofaffi, ko masu cututtuka. - **Gwaji guda.** Ana bukatar maimaitawa da manyan ƙungiyoyi, har da shirye‑shiryen motsa jiki na ƙarfi. ## Menene Wannan Ke Nufi Ga Masu Sha'awa? **Waɗanda za su amfana:** - Mutanen da ke cin abinci da ƙananan kalori sosai kuma suke damuwa da rasa tsoka. - Mutanen da ke yin azumin rana‑da‑rana (ADF) ko wasu hanyoyin azumi na tsaka‑tsaki, wadda ita ce yanayin da aka yi gwajin. **Yawan da aka yi amfani da shi a gwaji** Huɗu ƙwallon a rana, wanda ke ba da kusan 764 mg EPA, 376 mg DHA, 312 mg choline da 400 µg astaxanthin, na tsawon kwanaki 8. Duba alamar samfurinka, domin ƙwallon krill oil na iya bambanta ƙarfi sosai. Daidaita jimillar yau da kullum ya fi muhimmanci fiye da adadin ƙwallon. **Lokacin shan ƙwallon** Takaitaccen bayani ba ya fayyace ko an sha ƙwallon a ranar azumi ko a ranar cin abinci. A al'ada, ana shan kari masu narkewa da mai a lokacin cin abinci – wato a ranar da ake cin abinci a tsarin ADF. Wannan shawara ce kawai, ba wai ainihin yadda gwajin ya yi ba. **Wanda ya kamata ya yi taka‑tsantsan ko ya guje shi** - **Allergy ga ƙamshin teku:** krill na daga cikin crustaceans, don haka a guje shi idan akwai ƙwaƙwalwa. - **Magungunan hana jini ko cutar jininsu:** manyan adadin omega‑3 na iya tasiri kan daskararrun jini; tuntubi likita kafin amfani. - **Mata masu ciki, masu shayarwa ko masu cututtuka masu tsanani:** nemi shawarwarin likita. - **Duk wanda ke tunanin sauƙaƙe hanya:** wannan ba maye gurbin isasshen furotin, motsa jiki na ƙarfi ko rage kalori mai hankali ba ne. ## Karshe A cikin wannan gwaji na kwanaki 8 mai rarraba bazuwar, krill oil ba ya canza adadin nauyin da mutane suka rasa a azumin rana‑da‑rana. Amma yana da alamar kariya ga **ƙashin da ba a raba ba (‑0.2 kg vs ‑1.2 kg)** da **karfin riƙe da hannu (‑0.2 kg vs ‑0.9 kg)**. Wannan sakamako mai ban sha'awa ne ga duk wanda ke yanke nauyi da ƙarfi. Duk da haka, tare da mahalarta 41 kawai da ƙwallon da ke ɗauke da sinadarai da yawa, ya kamata a ɗauke shi a matsayin alamar farko, ba a matsayin hujja ƙwarai ba. Idan za ku yi amfani da shi, ku ci gaba da cin abinci mai inganci da motsa jiki na ƙarfi – waɗannan su ne manyan kariya ga rasa tsoka yayin cinyewa.

Man Kifi Ya Sauya Kitse Da Muscles A Cikin Mako 6: Ma'aunin Ba Ya Motsi

Dr. Gymbro — Fri, 23 Oct 2026 07:17:17 GMT

# Ka Tuna Ka Duba Ma’aunin Kaza… Babu Canji Wataƙila ka ga ma’aunin kiba ya tsaya a wuri guda, amma a hakikanin gaskiya jikinka na musayar kusan rabi kilo na kitse da rabi kilo na tsoka a hankali. Wannan shi ne sakamakon wani bincike double‑blind da aka gudanar a kan manya marasa cuta, wanda ya kuma nuna alaka tsakanin raguwar cortisol da wannan sauyi. Nazarin ya ƙunshi mahalarta ƙanana, don haka mu dubi ainihin abun da ke cikin bayanan da abin da ya kamata mu kula da su. ## Binciken: Abin Da Aka Aiki Da Gaskiya Masana daga **Gettysburg College** karkashin jagorancin **Eric Noreen** sun wallafa sakamakon a *Journal of the International Society of Sports Nutrition* a shekara ta 2010. Gwajin ya kasance **randomized, double‑blind, placebo‑controlled** tare da **mutane 44 (maza da mata)** masu shekara‑matsakaici **34 ± 13**. An raba mahalarta gida biyu na **mako 6**: - **Ƙungiyar man kifin:** 4 g a rana na man kifin, wadda ke ba da **1,600 mg EPA** da **800 mg DHA** (kimanin gram 2.4 na omega‑3 gaba ɗaya). - **Ƙungiyar sarrafa:** 4 g a rana na man safflower. Duk gwaje‑gwajen an yi su da safe bayan azumi. An auna **resting metabolic rate (RMR)** ta hanyar indirect calorimetry da facemask, an auna rabe‑raben jiki ta **air displacement plethysmography (Bod Pod)**, sannan an tattara saliva mai‑passive drool don auna **cortisol**. ## Sakamako Mai Muhimmi: Kitse Ya Ragu, Tsoka Ta Ƙaru Idan aka kwatanta da man safflower, man kifin ya haifar da canje‑canje kamar haka: - **Fat‑free mass (masa mara kitse):** +0.5 ± 0.5 kg vs. -0.1 ± 1.2 kg (p = 0.03) - **Fat mass (masa kitse):** -0.5 ± 1.3 kg vs. +0.2 ± 1.2 kg (p = 0.04) - **Kashi na kitse a jiki:** -0.4 ± 1.3 % vs. +0.3 ± 1.5 % (ba mai muhimmanci, p = 0.08) - **Nauyin jiki:** 0.0 ± 0.9 kg vs. +0.2 ± 0.8 kg (ba bambanci mai muhimmanci) Wannan yana nuni da cewa ma’aunin ya tsaya a wuri guda, amma rabe‑raben jiki ya sauya: an samu ƙarin lean mass da ragin kitse, duk da cewa kusan ba a sami canjin nauyi ba. Idan ka duba kawai nauyin jiki, za ka rasa wannan muhimmin canjin. ## Cortisol: Dodo Mai Kiqua Masana sun auna cortisol a cikin saliva – hormone da ke alaka da damuwa, kuma a matakai masu tsanani na iya haifar da ajiye kitse da rushe tsoka. A ƙungiyar man kifin, cortisol ya sauka **-0.064 ± 0.142 µg/dL**, yayin da a ƙungiyar sarrafa ya tashi **+0.016 ± 0.272 µg/dL**. Wannan bambanci **ba ya da muhimmanci statistically** (p = 0.11). Duk da haka, a ƙungiyar man kifin, canjin cortisol ya yi alaka mai ƙarfi da: - **Fat‑free mass** (r = -0.504, p = 0.02) - **Fat mass** (r = 0.661, p = 0.001) Wannan na nufin mutanen da cortisol ɗinsu ya ragu sosai, su ne suka fi samun ƙarin tsoka da ragin kitse. ## Fahimtar Gaskiyar: Abin Da Binciken Ba Ya Nuna - **Tasirin yana ƙanana.** Kusan 0.5 kg a kowanne ɓangare, tare da bambancin mutum‑mutum mai girma. Standard deviation na canjin kitse (±1.3 kg) ya fi girman matsakaicin canjin, don haka wasu za su ga ƙasa da ko babu canji. - **Adadin mahalarta ƙanana ne.** Mutane 44 a cikin 6 kweeks ba su isa ba don kammala hujja. Ana buƙatar maimaita nazari. - **Cortisol alaka ce kawai.** Bambancin cortisol tsakanin ƙungiyoyi ba shi da muhimmanci, kuma alakar da aka samu a cikin ƙungiyar ɗaya ba ta tabbatar da cewa cortisol ne ke haifar da sauyin jiki ba. - **Metabolism bai canza ba.** RMR ya kasance kusan ba a bambanta ba (+17 ± 260 kcal da man kifin vs. -62 ± 184 kcal da safflower). RER ma bai nuna bambanci ba. Don haka “ƙaruwa a metabolism” ba ta da hujja. - **Hanyoyin auna na da iyaka.** Air displacement plethysmography ingantacciya ce, amma canje‑canjen rabi kilo na iya kasancewa kusa da kuskuren auna; canjin ruwa a jiki na iya shafar sakamakon. - **Wanene aka yi wa gwaji?** Manyan marasa lafiya, ba masu kiba ba ko ‘yan wasa masu horo mai tsanani. Sakamakon ba ya magana kan waɗanda ke son rage kiba ko masu horo na ƙwarai. ## Me Wannan Ke Nufi A Gashinka? **Adadin da aka gwada:** 4 g a rana na man kifin, wadda ke ba da **2.4 g na EPA + DHA** (1.6 g EPA, 0.8 g DHA). Wannan ne kawai adadin da nazarin ya gwada; duk wani ƙari da ka yi shi ne ƙara a hankali. **Karanta alamar sosai.** “1,000 mg man kifin” ba yana nufin 1,000 mg na EPA/DHA ba. Yawanci 1 g na man kifin yana ɗauke da kusan 300 mg na omega‑3s. Duba takardar sinadarai don sanin adadin EPA da DHA, sa’an nan ka ƙirga. Samun gram 2.4 na iya buƙatar kusan ƙwayoyi **8 na al'ada** ko ƙasa da haka idan kana amfani da samfur mai ƙarfi. **Lokaci na sha:** Takardar ba ta gwada yadda za a raba adadin ba. Hanya mafi sauƙi ita ce **a ci tare da abinci**, domin kitse a abinci na taimaka wa sha da rage ƙamshi na kifin. Raba adadin a cikin abinci daban‑daban na iya zama hanya mai sauƙi. **Tsawon lokaci:** Gwajin ya ɗauki makonni 6. Ba a san ko fa’idodin za su ci gaba, su daidaita, ko su ragu bayan wannan lokacin ba. **Waɗanda za su amfana:** - Manyan marasa lafiya da ba su cika cin kifi ba, kuma suke buƙatar ƙaruwa da omega‑3s. - Mutanen da ke son **re‑composition** (sauya kitse da tsoka) amma suna sane da cewa tasirin zai zama ƙanana. **Waɗanda ya kamata su guje shi ko su tuntuɓi likita:** - Duk mai shan magungunan rage jini (anticoagulants) ko yana da matsalar zubar jini. - Mutanen da ke da **allergy** ga kifin ko ɓangaren ƙasa. - Masu fama da cututtukan zuciya, masu ciki, ko wasu yanayi na kiwon lafiya waɗanda ke buƙatar hayar likita kafin su ɗauki manyan adadi na omega‑3s. - Duk wanda ke tsammanin zai rage kitse nan take – wannan ba zai faru ba. ## Karshe A wannan **double‑blind trial**, makonni 6 na kusan gram 2.4 a rana na EPA + DHA sun haifar da kusan **0.5 kg ƙarin lean mass** da **0.5 kg ragin kitse** idan aka kwatanta da man safflower, yayin da nauyin jiki ya tsaya iri ɗaya. Raguwar cortisol ta biyo waɗannan canje‑canje, amma alaka ce kawai, ba dalili ba. Metabolic rate bai canza ba. Don haka, man kifin na da tsaro, tasiri ƙanana, kuma ya fi dacewa a hadashi da abinci mai kyau da horo, ba a matsayin hanyar maye gurbin su ba.

Kofi Mai Caffeine Ƙanana Ba Ya Ba 'Yan Wasan Ƙwararru Ƙarfin Sprint

Dr. Gymbro — Fri, 23 Oct 2026 07:14:49 GMT

# Kofi Mai Caffeine Ƙanana Ba Ya Ba 'Yan Wasan Ƙwararru Ƙarfin Sprint Kana tunanin cewa kofi da ka sha kafin horo zai ƙara maka saurin sprint? A wani sabon gwaji da aka gudanar kan 'yan wasa 15 na matakin ƙasa a fannin dambe, kofi guda ɗaya zuwa biyu da ke ɗauke da caffeine ba su inganta aikin sprint mai maimaitawa kwata-kwata. Kafin ka rungumi injin espresso, akwai muhimman abubuwa da ya kamata ka sani. ## Babban Sakamako: Babu Canji Wata ƙungiya da Birol da abokan aikin sa suka jagoranta, kuma suka wallafa a *Scientific Reports* (DOI: 10.1038/s41598-026-72577-w, rajistar gwaji NCT07596511), sun binciki ko caffeine ƙanana a cikin kofi na yau da kullum zai iya canza aikin sprint mai maimaitawa da kuma yadda tsarin makamashi ke aiki a jiki. Sakamakon: **babu bambanci mai ma'ana na ƙididdiga tsakanin yanayi (duk p > 0.05)**. Wannan ya shafi kololuwar ƙarfi, matsakaicin ƙarfi, matakan gajiya, jin ƙoƙari, canjin lactate da kololuwar bugun zuciya. Haka kuma, ƙididdigar gudummawar tsarin aerobic, glycolytic da phosphagen ba su bambanta sosai ba. ## Yadda Gwajin Ya Gudana Tsarin gwajin ya kasance mai ƙarfi, kuma yana da kyau a fahimci ainihin abin da aka yi: - **Masu halarta:** 'yan wasa maza 15 na matakin ƙasa a wasannin gwagwarmaya (shekara 20.4 a matsakaici, nauyin jiki kilogram 68.1) - **Tsari:** double‑blind, placebo‑controlled, randomized crossover - **Zaman gwaji:** uku, a tazara na awanni 48 - **Yanayi:** kofi da ke ba da 1.5 mg/kg caffeine, kofi da ke ba da 3 mg/kg caffeine, da kofi mara caffeine a matsayin placebo - **Gwaji:** sprint mai maimaitawa a kan cycle ergometer, an fara sa'o'i ɗaya bayan shan kofi Ba a haɗa yanayin capsule ba, saboda haka ba a kwatanta kofi da capsule ba. An tambayi tambaya kai tsaye: menene low‑dose kofi mai caffeine yake yi idan aka kwatanta da kofi mara caffeine? ## Lissafin Ƙima: Menene “Low Dose” a Cikin Kofin Ka? Ga ɗan wasa da nauyin kilogram 68.1, adadin caffeine yana kusan: - **1.5 mg/kg ≈ 100 mg caffeine** - **3 mg/kg ≈ 200 mg caffeine** Wannan na nufin kofi ɗaya zuwa biyu, gwargwadon yadda ake sarrafa shi. A kalmar yau da kullum, wannan shine adadin da za a iya ɗauka a safiya ko a gaba da horo, ba wani tsari na dakin bincike ba, hakan ya sa sakamakon ya fi dacewa da ‘yan wasa na gari. ## Me Ya Sa Sauran Bincike Ke Nuna Sakamako Gaba Daban? Yawancin adabin da ke nazarin caffeine da aiki ya dogara ne kan capsules na caffeine anhydrous, a yawanci tsakanin **3–13 mg/kg**, inda ƙima daga 3 mg/kg sama ke nuna tasirin ergogenic. Capsules suna ba da daidaito da ƙima tabbatacce. Kofi kuwa yana da bambancin ƙima, kuma marubutan sun nuna cewa ba a san yadda ƙananan adadi (≤3 mg/kg) ke aiki a matsayin kofi ba, ko da yake haka yake a aikace ga ‘yan wasa. Saboda haka, binciken nan ba ya sabawa adadin capsule. Yana cike gibin da ake da shi: **ƙananan dose a cikin hanyar da mutane ke amfani da ita a kullum**. ## Lambar Da Ta Bayyana Babu Sakamako Effect size ga nau'ikan aikin ya kasance ƙanana (partial eta squared ≤ 0.01). Wannan na nufin caffeine ba ta ba da wani ƙarin gudunmawa ga bambancin sakamakon sprint a wannan ƙungiya ba. Effect size ga tsarin makamashi ya nuna matsakaici‑zuwa‑babba, amma ba su kai ga bambanci na ƙididdiga ba. Da ‘yan wasa 15 kawai, samun ƙarfin ƙididdiga ya zama ƙalubale. Zai iya kasancewa hayaniya ne ko kuma alamar wani tasiri da zai bayyana a gwajin da ya fi girma. Ba za a iya ɗauka a matsayin tasiri tabbatacce ba. ## Ƙuntatawa: Ba Huƙuma Caffeine Ba Ce Wannan sakamakon ƙanƙanta ne, kuma akwai wasu iyakoki da ya kamata a yi la’akari da su: - **Adadin samfur:** ‘yan wasa 15 kawai suna rage ƙarfin ƙididdiga. Sakamakon babu tasiri a nan ba ya nufin babu tasiri gaba ɗaya. - **Siffofin masu halarta:** duka maza ne, matasa, a matakin ƙasa na wasannin gwagwarmaya. Marubutan sun buƙaci ƙarin samfur da ya haɗa da mata da sauran matakan horo. - **Tsarin gwaji guda:** sprint a kan keke, a lokaci guda (sa'a ɗaya bayan shan caffeine). - **Dose:** 3 mg/kg yana a ƙasan iyakar da yawancin binciken capsule ke nuna fa'ida. ## Menene Wannan Ke Nufi A Gaban Ka? **Idan kana neman tasirin aiki:** mafi yawan hujjoji suna goyon bayan **3–6 mg/kg caffeine** da aka sha mintuna **30–60** kafin motsa jiki. Ga ɗan wasa kilogram 68, wannan na nufin **200–400 mg caffeine**. Dose na 3 mg/kg a wannan binciken ya kasance a ƙasan wannan tazara, kuma ba ya haifar da canji a sakamakon. **Dose da lokaci:** - Ka lissafta adadi bisa ga nauyin jikinka, ba bisa ga "kofi" ba, domin ƙimar caffeine a kofi na bambanta sosai. - Idan ka dogara da kofi, ka tuna cewa adadin caffeine a cikin kofi ba a iya tantancewa daidai kamar capsule ko tablet da aka rubuta adadi. - Ka gwada kowane dose a horo kafin ka yi amfani da shi a gasar. **Waɗanda za su amfana:** - ‘Yan wasa da ke son auna tasirin ergogenic tabbatacce kuma suke shirye su ɗauki dose gwargwadon nauyi. - Kowa da ke son kofi don ƙara farkawa da mayar da hankali. Wannan fa'ida ba a auna a wannan binciken ba, don haka ba ta hana amfani da shi ba. **Waɗanda ya kamata su yi taka tsantsa ko su guje:** - **Masu shan caffeine da yawa:** waɗanda ke yawan shan caffeine na iya lura cewa dose ƙanana ba ya tasiri sosai, kuma ya kamata su fahimci abin da kofi ke yi musu. - **Masu matsalar barci ko masu horo da dare:** fa'ida ta aiki ba ta cancanta rasa barci, wanda ke lalata murmurewa da horo na gaba. Caffeine da aka sha da dare na iya shafar yanayin barcin da kuke buƙata. - **Masu jin damuwa, jiri ko matsalar bugun zuciya:** manyan dose na ƙara yiyuwar samun illa. ## Ƙarshe A cikin ‘yan wasa 15 na ƙwararru, gram 100 da 200 na caffeine daga kofi ba su inganta aikin sprint mai maimaitawa ko canza ƙididdigar tsarin makamashi idan aka kwatanta da kofi mara caffeine. Wannan yana nuni da cewa **ba duk kofi ba ne zai ƙara maka gudu**, amma sakamakon ba zai zama hukunci na ƙarshe kan caffeine ba. Idan kana neman tasirin ergogenic na gaskiya, hujjojin da suka fi ƙarfi suna nuna bukatar dose mafi girma da aka ɗauka da nauyin jiki, mintuna 30–60 kafin motsa jiki. Idan kawai kana son kofi don farkawa da al'ada, wannan bincike ba ya ba da wani dalili da ya hana ka ci gaba da shan sa.

Katin Creatine Na Gina Tsoka Ga Masu Fara Hawa—Amma Ba Ya Kara Karfi. Me Ya Sa?

Dr. Gymbro — Fri, 23 Oct 2026 07:13:28 GMT

#### Hudu makonni – Mutane arba’in masu farawa a ɗaukar nauyi A wannan gwaji, ƙungiyar ta ba waɗanda suka ɗauki creatine haɗi tare da horon juriya. Sakamakon ya nuna ƙaruwa a girman tsoka da jin daɗin dawowa, amma **ba a samu ƙarin ƙarfin leg‑press 1RM ba** idan aka kwatanta da placebo. Wani sabon nazari da aka wallafa a *BMC Sports Science, Medicine and Rehabilitation* ya ba da wasu dalilai da ke bayyana wannan yanayi. ## Binciken a taƙaice Chen da abokan aikinsa sun gudanar da **gwajin bazuwar mai amfani da maganin wucin gadi a matsayin placebo**. An horar da maza masu farawa guda 50 a wani shirin juriya na makonni huɗu, inda aka raba su zuwa ƙungiyar da ke sha creatine‑mahadin (CR) da ƙungiyar da ke sha placebo (PL). **Maza 40 ne suka kammala gwajin**. Masu binciken sun auna abubuwa da dama: - **Siffofin jiki**: adadin tsoka da faɗin ƙafafu - **Matsayin ƙarfin leg‑press 1RM** - **Dangantakar hormone**: testosterone/cortisol (T/C), creatine kinase (CK), da 3‑methylhistidine/creatinine - **Alamomin aikin koda**: serum creatinine da eGFR - **Alamomin gajiya da dawowa** na mutum Gwajin yana da lamba a rijista (ChiCTR2500114236) kuma takardar da aka wallafa na da damar buɗewa. ## Abubuwan da suka ƙaru Idan aka kwatanta da placebo, ƙungiyar da ta sha creatine ta nuna: - **Ƙaruwa mai ma’ana a adadin tsoka da faɗin ƙafafu** - **T/C ratio mai inganci** – alamar da ke nuni da yanayin anabolic vs. catabolic - **Matsakaicin CK** da ya tsaya a mataki mai kyau, alamar damuwar tsoka ƙasa da al'ada - **Alamomin dawowa** da suka fi na placebo kyau Maza da suka sha creatine sun ce suna jin dawowa da sauri kuma sun lura da yanayin hormone da ke tallafawa gina tsoka yayin da suke kara girma. ## Abin da bai tasiri ba: Karfi Leg‑press 1RM ya inganta a dukkan kungiyoyi, amma **creatine ba ta kawo ƙarin haɓaka ba** a wannan fasali, haka kuma ba a sami bambanci a juriya ba. Idan kana zaton cewa wani “stack” zai tashi maka ɓangaren lambobi a cikin wata guda, wannan gwaji ya nuna ba haka ba ne. ## Me ke haifar da girma amma ba ƙarfi? Takardar ta ba da jerin hasashe, amma babu tabbataccen dalili da aka tabbatar da su. Ga wasu sababbin tunani: 1. **“New‑bie gains”** – Masu farawa kan samu saurin cigaba a dukkan fannoni saboda daidaituwar tsarin jijiyoyi, ƙaruwa a rarraba ƙwayoyin tsoka, da ƙwarewar motsi. Ma placebo ma suna ƙara karfi, don haka tasirin creatine a ƙarfin 1RM na iya zama ƙarami. 2. **Lokacin gwaji mai gajere** – Canjin ƙwayar tsoka yana buƙatar lokaci. A cikin wata guda, mafi yawan ƙaruwa a 1RM yawanci na faruwa ne saboda tsarin jijiyoyi, ba saboda ƙwayoyin tsoka ba. 3. **Ruwa a cikin ƙwayoyin tsoka** – Creatine na jawo ruwa zuwa cikin ƙwayoyin tsoka. Hanyoyin tantance girman tsoka na iya ɗaukar wannan ruwa a matsayin ƙarin tsoka, don haka faɗin ƙafa zai iya zama alamar ruwa ne, ba sabon tsoka ba. 4. **Dawowa mai ɗorewa** – Jin dawowa da sauri ba yana nufin ƙarin ƙarfi a makonni huɗu ba. Zai iya taimakawa wajen horo da ƙarfi mafi tsawo a watanni masu zuwa, amma wannan ba a tabbatar da shi a cikin wannan binciken ba. Masu binciken sun kuma lura da cewa **canjin T/C ratio yana da alaƙa mai kyau da canjin dawowa da leg‑press 1RM**. Wannan alaka ce mai ban sha’awa, amma ba ta nuna dalili ba. ## Alamar koda: Gamsasshe amma da iyaka Serum creatinine da eGFR **sun kasance a cikin al’ada ga duk mahalarta**. Don matasa maza masu lafiya na tsawon makonni huɗu, wannan ya nuna cewa creatine ba ta da illa a kan aikin koda. Sai dai ba a yi magana kan dogon lokaci, manyan ƙima, ko mutanen da ke da matsalar koda ba. ## Abubuwan Da Ya Kamata Ku Sani - **Samarwa ƙanana:** mutum 40 da suka kammala, **maza kawai**, kuma sabbin masu horo. Sakamakon na iya wucewa ga mata, ƙwararrun masu ɗaukar nauyi, ko tsofaffi. - **Lokaci gajere:** makonni 4. - **Haɗin gwiwa, ba creatine tsaf ba:** takardar ba ta bayyana cikakken sinadaran haɗin ba, don haka ba mu san wane sinadari ne ya haifar da tasiri ba. - **Tallafin masana’anta:** Hunan Deyang Nutrition Biotechnology da Hunan FoYes Sports Nutrition. Marubuta biyu suna da alaƙa da kamfanonin. Duk da cewa kamfanonin sun ce ba su shiga aikin bincike ba, ya kamata masu karatu su yi la’akari da wannan. - **Ba a wallafa a PubMed ba tukuna:** Wannan shi ne ɗaya daga cikin wallafe‑wallafen farko da ba su da cikakken nazarin bayan‑bayan. ## Mene ne ya kamata ku yi? **Idan kai sabon ɗaukar nauyi ne:** - **Abin da ya fi ƙarfi bisa hujja shi ne creatine monohydrate a 3–5 g a rana.** Wannan shawara ta samo asali ne daga manyan nazarce‑nazarce, ba daga wannan gwaji ba. Farashinsa ƙanƙanta, an yi masa bincike sosai, kuma ba ya buƙatar haɗin sinadarai na musamman. - **Lokacin shan ba shi da muhimmanci sosai.** Daidaitaccen amfani kullum ya fi muhimmanci fiye da lokacin. Sha shi tare da abinci ko a lokacin horo, duk abin da ya fi maka sauƙi. - **Kada ka yi tsammanin haɓaka mai sauri a 1RM.** Wannan gwaji ya nuna cewa a cikin wata guda, ci gaban ka zai fito ne daga horon da kake yi, ba daga creatine ba. - **Stacks ba dole ba ne.** Babu hujja da ke nuna cewa haɗin sinadarai da yawa ya fi creatine ɗaya amfani, domin ba a kwatanta su ba. Idan har kana son haɗi don sauƙi, ka duba alamar kuma ka tabbata cewa adadin creatine ya wuce 3 g a rana. **Wanda zai amfana:** matasa maza masu lafiya da ke farawa, masu neman hanyar da ta araha da sauƙi don tallafa wa horo, kuma waɗanda ke kula da ci gaba a cikin watanni, ba makonni ba. **Wanda ya kamata ya guje ko ya tuntuɓi likita a farko:** mutanen da ke da cutar koda, masu shan magungunan da ke tasiri kan koda, ko duk wani da ke da wata damuwa da ke buƙatar shawarwarin likita. Haka kuma a yi hankali da samfuran da ba su bayyana cikakken sinadarai ba. ## Kammalawa Wannan gwaji ya nuna cewa **haɗin creatine na iya inganta girman tsoka da jin dawowa a farkon horo**, amma ba ya ƙara ƙarfin leg‑press 1RM a cikin makonni huɗu. Haɓakar girma na iya zama sakamakon ruwa a cikin ƙwayoyin tsoka, kuma ba a fayyace hanyoyin da suka haifar da hakan ba. Don haka ka sanya tsammanin ka a hankali, ci gaba da horo a kai a kai, kuma idan kana son ƙara, fara da **creatine monohydrate** a cikin tsafta.

Wannan Nau'in Carnitine Ya Kara Karfin Sprint Har Zuwa 15% Kuma Ya Rage Lactate

Dr. Gymbro — Fri, 23 Oct 2026 07:12:24 GMT

## Carnitine da ake tunani za su rage kitse amma ba su da tasiri sosai A wani bincike da aka wallafa a 2009 a *Journal of the International Society of Sports Nutrition* an gwada wani nau'i daban na carnitine, **glycine propionyl‑L‑carnitine (GPLC)**, akan abin da mafi yawan ‘yan wasa ke bukata: **sprints masu ƙarfi da ake maimaitawa**. Sakamakon ya nuna ƙaruwa a ƙarfin sprint da kuma raguwar matakin lactate a jini. Lambar da aka miƙa a rubuce tana da ma'ana, amma dole ne a ba da cikakken yanayi. ## Binciken: Menene a hakikanin gaskiya? Masana a **Florida Atlantic University**, ƙarƙashin jagorancin Prof. Jacobs, sun gudanar da **gwajin double‑blind, placebo‑controlled, crossover** a kan **maza 24 masu horon ƙarfi** (shekaru 25.2 ± 3.6). Kowanne mahalarta ya halarci zaman gwaji biyu, a nesa mako guda. Minti 90 kafin kowanne zaman, an ba su **gram 4.5 na GPLC** ko **gram 4.5 na selulosa** (placebo) a tsari na jujjuya. Gwajin ya ƙunshi **sprints guda biyar na dakiku 10‑kawai a kan na'urar Wingate**, tare da hutu na dakiku 1 tsakanin su. An auna: - ƙarfin daka mafi girma (peak power) - ƙarfin matsakaici (mean power) - raguwar ƙarfin daga farkon zuwa ƙarshen sprint - bugun zuciya (HR) - matakin lactate a jini kafin, lokacin, da bayan sprints An daidaita ƙimar karfi da nauyin jiki na mahalarta. ## Yadda “15 %” aka samu Da GPLC, **ƙarfin mafi girma da matsakaici ya ƙaru tsakanin 2.6 % zuwa 15 % a cikin lokuta biyar** (p < 0.05). Wannan 15 % shine mafi girma da aka samu a wani sprint, ba matsakaicin ƙaruwa ba a duk sprints ɗin. Masu binciken sun kuma gano alaka mai ƙarfi tsakanin tsarin sprint da shigar GPLC (p < 0.05), wato amfanin yana iya bambanta daga sprint ɗaya zuwa wani. ### Lactate - **Minti 4 bayan motsa jiki:** lactate ya ragu **15.7 %** tare da GPLC, amma p = 0.09 (ba ƙarfi sosai). - **Minti 14 bayan motsa jiki:** lactate ya ragu **16.2 %** (p < 0.05). Saboda haka sakamakon mafi tabbatacce shine na minti 14. ## GPLC vs. L‑carnitine na al'ada vs. ALCAR Dukansu suna da asalin **carnitine**, wadda ke taimakawa kai fatty acids zuwa mitochondria. Bambancin su yakan fito daga abin da aka haɗa da su: - **L‑carnitine**: tsantsa, ana amfani da shi don rage kitse da inganta metabolism gaba ɗaya. - **Acetyl‑L‑carnitine (ALCAR)**: an ƙara acetyl, yana taimakawa kwakwalwa da tsarin jijiyoyi. - **GPLC**: propionyl‑L‑carnitine da aka haɗa da glycine. An fi nazarin propionyl‑L‑carnitine a fannin jijiyoyi, inda ake danganta shi da **nitric oxide**. Wasu bincike sun nuna GPLC na ƙara yawan metabolites na nitric oxide a lokacin hutu da kuma lokacin da jini ya yi zafi (reactive hyperaemia). Nitric oxide na buɗe manyan jijiyoyi, don haka ana tsammanin rage ƙarar ƙaura da inganta isar da sinadarai a lokacin sprint‑sprints masu maimaitawa. Sai dai a wannan binciken ba a auna nitric oxide ko yawan jini ba; abin da aka auna shine ƙarfin aiki da lactate, ba dalilin da ke bayan su ba. ## Iyakoki da ya kamata a sani - **Sampula ɗaya kawai:** maza 24 masu horon ƙarfi. Ba a wakilta mata, tsofaffi, ‘yan wasa masu juriya ko masu farawa ba. - **Adadin da aka gwada:** gram 4.5 guda ɗaya, ba a gwada shan a kai a kai ba. - **Nau’in motsa jiki:** sprint a na'urar Wingate. Ba a san ko zai yi aiki a horon barbell, gudu ko wasannin ƙungiya ba. - **Wurin bincike guda:** ƙungiyar bincike ɗaya ce kawai, ba a sami maimaitawa da yawa ba. Duba takardar don ganin ko akwai goyon bayan kuɗi da rikice‑rikice. - **Lactate:** daga gwaje‑gwajen biyu, ɗaya kawai ya wuce ka'ida ta p < 0.05. - **Rage lactate ba yana nufin ingantaccen aiki kai tsaye ba.** Zai iya nufin ƙarancin damuwa a glycolysis ko saurin tsabtace lactate. Binciken ba ya iya tantance menene ainihin dalilin. ## Menene wannan ke nufi a gare ka? ### Adadi da lokaci (kamar yadda aka gwada) - **Gram 4.5 na GPLC** a kusan minti 90 kafin horo. Wannan shi ne kadai tsari da ke da hujja a wannan bincike. Kada ka ɗauka ƙananan adadi ko canjin lokaci zai ba da irin wannan sakamako. ### Waɗanda za su iya amfana - ‘Yan wasa masu HIIT, sprint intervals ko ayyuka masu maimaitawa da hutu kaɗan. - Masu horon ƙarfi da ke son gwada wani pre‑workout don ranakun conditioning. - Kowane mutum da ke tunanin hujjar ba ta cika ba kuma yana son gwada shi a hankali. ### Waɗanda ya kamata su guje shi - Duk wanda ke neman maganin rage kitse ko kariya ga lafiya gaba ɗaya – binciken bai magance wannan ba. - Mutanen da ke da cutar koda, matsalolin thyroid, epilepsy, ko masu shan magungunan da ke da tasiri mai ƙarfi – su tuntuɓi likita kafin su sha wani nau’in carnitine. - Mata masu juna biyu ko masu shayarwa. - Masu kasafin kuɗi ƙanana: gram 4.5 na GPLC yakan fi tsada fiye da sauran nau’o’in carnitine. Kula da farashi kuma ka tabbatar lakabin ya ƙunshi **GPLC**. ### Gwaji na kai (self‑experiment) A ranar da kake yin tsauraran intervals, sha GPLC a minti 90 kafin horo, sannan a rubuta ƙarfin sprint da yadda kake ji bayan kowane zagaye. Ka kwatanta da ranar da ba ka sha ba. Tabbatar da cewa komai ya kasance iri ɗaya – abinci, caffeine, bacci. Gwaji na kai ba zai maye gurbin bincike ba, amma zai ba ka fahimtar yadda jikinka ke amsawa. ## Kammalawa A cikin wannan gwajin crossover, **gram 4.5 na GPLC** ya ƙara ƙarfin sprint tsakanin **2.6 % zuwa 15 %** a lokuta biyar, kuma ya rage matakin lactate a jini bayan minti 14 da **16.2 %**. Wannan na da amfani ga ‘yan wasa masu sprint da interval. Amma ya kasance gwaji guda ɗaya, ƙanƙanta, da na lokaci‑gajere a kan na'urar Wingate, kuma ba a tantance tasirin nitric oxide ba. GPLC na bukatar ƙarin bincike; kada a ba shi amincewa ba tare da cikakkiyar hujja ba.

Kadarar da aka ba Kre‑Alkalyn ba ta haɓaka matakin creatine a tsoka, binciken biopsies ya nuna

Dr. Gymbro — Fri, 23 Oct 2026 07:10:57 GMT

# Creatine mai ruɓutewa yana da tsada, yana ɗaukar ƙara, kuma yana ikirarin rage kumburi. To me ya faru lokacin da masana kimiyya suka ɗauki yankuna na ainihin tsoka don duba? **A ƙimar da kamfani ya ba da shawara, wato 1.5 g a rana, Kre‑Alkalyn bai ƙara matakin creatine a tsoka da wani ma'ana ba, yayinda creatine monohydrate ya ƙara shi sosai.** Ga abin da binciken Texas A&M ya gano, da abin da ke nufin walat ɗinka. ## Binciken: Wa, Me, Da Tsawon Lokaci Takardar da aka buga a *Journal of the International Society of Sports Nutrition* a 2012 ta Jagim, Kreider da abokan aiki, ita ce **bincike double‑blind, randomized controlled trial** kan **mutane 36 masu horo na ƙarfi** (kimanin shekaru 20, 82 kg, 14.7 % mai jiki). An gudanar da shi na **kwanaki 28**. An raba mahalarta zuwa rukuni uku: - **CrM:** creatine monohydrate (Creapure) a 20 g a rana (4 × 5 g) na kwanaki 7, sannan 5 g a rana na kwanaki 21. - **KA‑L:** Kre‑Alkalyn a ƙimar da kamfani ya ba da shawara, 1.5 g a rana na kwanaki 28. - **KA‑H:** Kre‑Alkalyn a ƙimar da ta dace da rukunin monohydrate (dosa 5 g a rana). Kowa ya ci gaba da horonsa na yau da kullum. Masana kimiyya sun ɗauki **biopsies na tsoka na vastus lateralis**, samfurin jini a lokacin azumi, DEXA scans, da gwajin Wingate anaerobic a ranaku 0, 7 da 28. Suka kuma gwada bench press da leg press 1RM a ranaku 0 da 28. ## Babban Sakamako: Matakin Creatine a Tsoka Biopsies na tsoka su ne ma'aunin da ya fi sahihi don amsa tambaya guda: Shin creatine ta shiga tsoka da gaske? Bayanai daga biopsies sun fito daga mahalarta 25 daga cikin 36. Creatine ta ƙaru a duk rukunoni da lokaci, amma bambance‑bambancen rukuni ba su da muhimmanci a kimiyyar (p = 0.46). Duk da haka, alamar ta nuna fifiko ga monohydrate. Canjin matsakaicin creatine a tsoka a kwanaki 7 da 28 ya kasance: - **KA‑L:** -7.9 da +4.7 mmol/kg nauyin bushe (NW) - **KA‑H:** +1.0 da +9.1 mmol/kg NW - **CrM:** +11.3 da +22.3 mmol/kg NW A gwajin ma‑mafi, canjin a rukuni mai ƙimar ruɓutewa ya kasance **-1.1 mmol/kg NW**, yayin da monohydrate ya samu **+11.2 mmol/kg NW** (mean ± SEM; p = 0.053). Wannan alamar ba ta wuce ma'aunin ƙididdiga ba, kuma bambance‑bambancen tsakanin mutane sun yi girma. Amma babban batu ya tsaya: babu hujja da ke nuna cewa ruɓutewar da aka lakaba ta fi ɗora creatine a tsoka, kuma a ƙimar 1.5 g a rana ba ta haifar da wani tasiri ba. ## Ƙarfi, Girma da Ƙarfin Jiki: Babu Fa'ida ga Creatine Mai Ruɓutewa Tallan creatine mai ruɓutewa yana cewa yana riƙe da kyau kuma yana inganta sakamakon horo. Bayanai ba su goyi bayan wannan ikirari ba. Babu bambance‑bambancen rukuni‑da‑lokaci a: - Nauyin jiki, nauyin ba‑mai, kitsen jiki, kaso na kitsen jiki ko jimillar ruwan jiki - Bench press da leg press 1RM - Wingate mean power, peak power ko total work Wasu ma'auni sun canza da lokaci, kamar yadda ake tsammani yayin horo, amma ba a sami rukuni da ya wuce sauran ba. Rukuni mai ƙananan ƙima na ruɓutewa ba shi da nasara kan monohydrate, haka kuma rukuni da aka daidaita da monohydrate ba shi da nasara. ## Ikirarin Kumburi: An Huutawa Wani muhimmin abu da Kre‑Alkalyn ke tallatawa shi ne ƙarancin tasirin gefe. Marubutan sun gano **babu wata shaida** na hakan. A zahiri, **babu wani tasirin gefe da aka bayar a kowane rukuni**, har ma da rukunin monohydrate da ke shan 20 g a rana a lokacin lodin. Ruwan jiki ba ya nuna bambanci tsakanin rukunoni, don haka ba za a iya zargin monohydrate da kumburi ba. Alamomin lafiyar sun kasance cikin yanayi mai kyau: - **Serum creatinine** ya ƙaru a duk rukunoni, mafi girma a ƙimar lodin (p = 0.03). Ƙaruwa ta kasance tsakanin 0.1 zuwa 0.2 mg/dL, wanda ke cikin ƙimar al'ada ga masu motsa jiki. - **LDL cholesterol** ya sauka sosai a rukunin monohydrate a lokacin lodin, sannan ya dawo ga asali a lokacin kulawa. - Lipids na jini, alamomin ƙashi, catabolism, electrolytes, da ƙididdigar lymphocyte da jan sel ba su nuna bambanci mai muhimmanci tsakanin rukunoni. ## Ƙuntatawa da Ya Kamata a Sani Wannan karamin bincike ne na kwanaki 28 a tsakanin matasa masu horo. Sakamakon biopsies sun fito ne daga mutane 25 cikin 36, kuma bambance‑bambancen ya yi girma, shi ya sa muhimmin gwaji ya tsaya a p = 0.053 maimakon ƙasa da 0.05. Bayanai ba za su iya ba da haske kan tasirin dogon lokaci, manya, mata musamman, ko ƙungiyoyin da ke da buƙatar kulawa ba. Abin da binciken ya nuna shine creatine mai ruɓutewa ba ta doke zaɓin da ya fi araha kuma da aka fi bincika a kowanne sakamako ba. ## Menene Wannan Ke Nufi A Gare Ka **Matsakaici:** Ka ɗauki **3 zuwa 5 g a rana na creatine monohydrate**. Binciken ya yi amfani da 5 g a rana a lokacin kulawa, wanda ke nuna wannan adadi ya isa. Idan kana son samun cikakken cika da sauri, za ka iya ƙara lodin kusan 20 g a rana (rabawa kashi huɗu na 5 g) na kwanaki 5 zuwa 7 – wannan shine tsarin da ya haɓaka matakin creatine a tsoka a wannan gwaji. Lodin na zaɓi ne, domin amfani da ƙananan ƙima a kullum zai kai ka ga irin wannan sakamako a cikin makonni kaɗan. **Lokaci:** Binciken bai gwada lokutan shan creatine ba, kuma shaidu masu yawa suna nuna cewa yana fi muhimmanci a ci gaba da amfani fiye da lokacin da aka ɗauka. Ka sha a kowane lokaci da ka iya tuna, tare da abinci idan hakan yafi sauƙi a gare ka. **Me Za Ka Saya:** Zaɓi monohydrate na asali, musamman samfurin da ke amfani da **Creapure** ko wani monohydrate da aka tantance daga ƙungiya ta uku. Wannan ne irin na rukuni na gwajin, kuma yana da araha. **Waɗanda Ya Dace Da Su:** Masu ɗaga nauyi, sprinters, da ‘yan wasa na ƙungiya da ke neman ƙara ƙarfin aiki da horon ƙarfi. **Waɗanda Ya Kamata Su Guje Shi Ko Su Tattauna Da Likita:** Duk wanda ke da cutar koda, ko ƙarancin aikin koda, ko ke shan magunguna da ke shafar koda, ya kamata ya tuntuɓi likita. Creatine kan ɗan ƙara serum creatinine, wanda zai iya rikitar da fassarar sakamakon gwaje‑gwaje. Mata masu juna biyu, masu shayarwa, da yara ƙanana su kuma nemi shawarar likita. ## Karshe Binciken ya nuna babu fa'ida ga creatine mai ruɓutewa a kan matakin creatine a tsoka, tsarin jiki, ƙarfi ko ƙarfin aiki, kuma babu rage tasirin gefe. A ƙimar 1.5 g a rana, bayanan biopsies sun nuna kusan babu wani ƙaruwa a creatine na tsoka, yayin da monohydrate ya ƙaru sosai. Sai dai idan sabbin shaidu masu ƙarfi suka zo da wani bambanci, farashin da ya fi na al'ada yana sayar da talla ne, ba aiki ba.

Sinadarin Taurine da ke Kara Juriya da Kansa

Dr. Gymbro — Thu, 22 Oct 2026 08:05:32 GMT

# Ka watsar da caffeine na ɗan lokaci Sinadarin da ake bayarwa a cikin manyan ƙwayoyin abin sha na ƙarfi, wanda yawanci mutane kan watsar, na iya yin tasiri mai amfani a kan jiki. Binciken meta na 2018 da aka buga a *Sports Medicine* ya gano cewa **taurine mai tsabta yana inganta aikin juriya, kuma ƙwayar guda ɗaya kaɗai ta isa**. Ba kwa buƙatar wani tsari na “loading” ko makonni na shan magani. Ga abin da masu bincike suka yi, abin da suka samu, da yadda za ku fassara su. ## Abin da Binciken Ya Aiki Da Gaske Takardar da Waldron, Patterson, Tallent da Jeffries suka wallafa, nazari ce ta tsarin meta‑analysis. Ƙungiyar ta tattara manyan bayanai a watan Satumba 2017 sannan ta tace karatu bisa ƙa’idojin cancanta. Suka samu **karatu 10 da aka buga a mujallar** waɗanda suka gwada taurine a baki, ba tare da haɗa shi da caffeine ko sukari ba. Biyu daga cikin waɗannan karatun sun yi amfani da gwajin “lokaci‑zuwa‑ƙarshen” (TTE), inda ‘yan wasa ke motsa jiki har sai sun gaji. Masu rubutu sun gudanar da ƙarin nazari a kan waɗannan gwaje‑gwajen. Suka kuma yi amfani da meta‑regression don amsa tambayoyi biyu masu mahimmanci: 1. Shin **adadin dosage** yana canza yadda taurine ke aiki? 2. Shin tasirin yana kan **shakawa ɗaya (acute)** ko **shakawa na tsawon lokaci (chronic)**? Dosages a cikin karatun sun kai **1 zuwa 6 g a rana**. An ba da su a matsayin ƙwayar guda ɗaya ko har zuwa **kwana biyu**, a cikin ƙungiyoyi daban‑daban na mahalarta. ## Abin Da Ya Nuna: Lissafi Siffofin farko shine taurine ya inganta aikin juriya gaba ɗaya tare da **Hedges' g = 0.40 (95 % CI 0.12–0.67, P = 0.004)**. Wannan ya nuna tasiri na ƙanana zuwa matsakaici, wanda ke nuni da sakamako mai daraja ga wani ƙari da ba ya tsada. Gwajin lokaci‑zuwa‑ƙarshen ya ba da sakamako iri ɗaya: **g = 0.43 (95 % CI 0.12–0.75, P = 0.007)**. Tambayoyi biyu na ƙarshe sun ba da amsoshi masu ban mamaki: - **Acute vs. chronic:** Babu bambanci. P = 0.897 ga dukan samfurin da P = 0.896 ga rukunin TTE. Shan taurine na tsawon kwanaki ba ya wuce ƙwayar guda ɗaya. - **Dose:** Dose ba ta tasiri tasirin ba (P > 0.05). A cikin kewayon 1‑6 g, ƙara yawan ba a ga ƙarin fa’ida ba. Masu rubutu sun kammala da cewa aikin juriya na iya ingantuwa ta hanyar **sha ƙwayar taurine guda ɗaya a baki (1‑6 g)**. ## Abin Da Ya Kamata Ku Kula Da Shi Kafin Ku Sayi Wannan al’amari mai ƙarfafa ne, amma ba a kammala ba. Ku tuna da waɗannan ƙuntatawa: - **Ƙaramin tushe na hujja.** Karatu 10 ba su da yawa, kuma gwaje‑gwajen ɗaya‑ɗaya ƙanana ne. Ƙididdigar da aka haɗa na iya sauyawa idan manyan gwaje‑gwajen sun bayyana. - **Faɗin interval na amincewa.** Jimillar interval (0.12 zuwa 0.67) na nufin tasiri zai iya zama ƙanana ƙwarai ko kuma mai girma sosai. - **“Babu tasirin dosage” ba nufin ba wani tasiri a tsakanin 1 g da 6 g.** Da ƙarancin karatu, meta‑regression ba shi da ƙarfi sosai don gano alakar dose‑response. Sakamakon ya nuna ba a ga bambanci mai ma’ana ba, amma ba ya nufin adadin 1 g da 6 g suna da tasiri iri ɗaya. - **Rukunin mahalarta da hanyoyi daban‑daban.** Karatun sun haɗa da mutane da nau’o’in gwaje‑gwaje daban‑daban, don haka sakamakon na iya bambanta da ƙwarewar ku ko matakin ku. - **Ba binciken abin sha na ƙarfi ba ne.** An yi nazarin taurine mai tsabta kawai. Ba ya nufin gajimare‑gajimare na Red Bull ko makamantansu zai ba da irin wannan fa’ida, tunda waɗannan kayan suna haɗa taurine da caffeine da sauran sinadarai. Saboda haka, karanta wannan a matsayin alamar da ke da ƙananan haɗari amma ba tabbataccen sihiri ba. ## Yadda Za Ku Yi Amfani Da Shi Takardar ta nuna taurine ya yi aiki a tsakanin 1‑6 g, a matsayin ƙwayar guda ɗaya ko har zuwa makonni biyu. Ga yadda za ku iya amfani da shi bisa ga mafi yawan tsarin da aka yi amfani da su a wannan fannin: **Yawan dosage:** Fara a ƙananan mataki, kusan **1‑3 g**. Mafi yawancin karatu a wannan fannin sun yi amfani da wannan adadi. Meta‑analysis ya nuna babu fa’ida mai ma’ana idan an ƙara dosage, duk da cewa an gwada har zuwa 6 g. **Lokaci:** Sha **ƙwayar guda ɗaya kusan awanni 1‑2 kafin** aikin juriya. Wannan ya dace da yadda mafi yawan gwaje‑gwaje suka gudanar. **Loading:** Ba a buƙata. Binciken ya nuna babu bambanci tsakanin acute da chronic supplementation, don haka ba sai kun tsara wani tsari na makonni ba. **Siffa:** Fure‑furen taurine na foda ko capsules su ne zaɓi mafi sauƙi, kuma su ne abin da aka gwada. Foda yawanci ba ya da tsada sosai a kowane serving kuma yana da sauƙin haɗawa cikin abin sha na pre‑workout. **Waɗanda ya dace da su:** ‘Yan gudu, masu keken hawa, masu rowing, masu ninkaya da duk wanda ke yin horon juriya mai tsawo kuma yana son gwada wani abu mai araha. Yana da amfani musamman idan kuna son gwada shi a manyan zaman horo ko ranar gasar ba tare da wani tsari na loading ba. **Waɗanda ya kamata su guje shi (ko su tattauna da likita):** - Kowa da ke da wata cuta ko ke shan magani, ya kamata ya tuntubi likita ko dietitian kafin ƙara ƙari. - Mata masu ciki ko masu shayarwa su nemi shawarar likita da farko. - ‘Yan wasa a wasanni masu buƙatar ƙarfi mai tsanani ko “explosive” ba su da tsammani wannan fa’ida, tunda binciken ya mai da hankali kan juriya. - Kowa da ke tunanin zai maye gurbin shirin horo da abinci na yau da kullum. Tasirin g = 0.40 yana taimako, ba sihiri ba. ## Babban Saƙo Taurine ba kawai cike‑cike ne a kan alamun abin sha na ƙarfi ba. A cikin wannan meta‑analysis na karatu 10, taurine mai tsabta da aka sha a baki ya samar da ƙaramin‑zuwa‑matsakaicin inganta aikin juriya (g = 0.40), kuma ƙwayar guda ɗaya ta isa. Tushe na hujja ƙanana ne, don haka ku ɗauke shi a matsayin gwaji mai araha, ba tabbataccen magani ba. Ku gwada shi a horo da farko, ku riƙa dosage a hankali, ku kuma auna tasirin da kanku.

Farin Cikin Barci da Ya Sa Masu Matsalar Barci su Fita da Wuri

Dr. Gymbro — Thu, 22 Oct 2026 08:04:39 GMT

# Ka ga tallan: wani ɓangare na whey da ke ɗauke da tryptophan, ana sha shi kafin kwanciya, an ce yana sa ka sauka cikin barci, ka kwanta lafiya, kuma ka tashi cikin ƙoshin lafiya. Sun kira shi **alpha‑lactalbumin (ALAC)** kuma ana kiran sa “fari na barci”. Gwajin bazuwar da aka wallafa a shekarar 2025 a *Nutrients* ya gwada ALAC a cikin mutanen da za su amfana da shi fiye da kowa – ‘yan wasa da ke fama da rashin barci. Sakamakon bai cika da’idai da abin da talla ke ikirari ba. --- ## Menene Gwajin Ya Gudu da Hakika? Masana da Barnard jagoranta – Roberts, Lastella, Aisbett da Condo – sun gudanar da **gwajin ƙaura‑ƙaura biyu (crossover trial)**. Kowanne mahalarta ya gwada duka ALAC da wani abu na ma’auni, don haka kowane mutum ya zama gwajin kansa. - **Wanene:** Mutane 24 masu horo na wasanni da ke da matsalar barci ta gaske. Matsakaicin maki a *Athlete Sleep Screening Questionnaire* ya kasance **8.6**, kuma a *Pittsburgh Sleep Quality Index* ya kasance **10.0**. PSQI da ya wuce 5 alamar barci marar kyau ne, don haka ba masu “zai yi kyau idan na barci” ba ne. - **Yawan da Lokaci:** 40 g na ALAC ko na ma’auni, an sha su awanni 2 kafin kwanciya, na kwana 7 a jere. - **Wurin Gwaji:** Mahalarta sun yi barci a gidajensu, ba a dakin gwaji ba, kuma an bi sawun barcinsu da *actigraphy* (na’urar da ke auna motsi a ƙwanƙwasa). - **Gwajin Aiki:** Bayan makon ciyarwa, an yi gwajin tsalle na 30‑seconds countermovement, Gwajin Yo‑Yo Intermittent Recovery Level 1, da gwajin lokacin amsa, duk a yanayin da aka sarrafa sosai. Wannan tsari yana da muhimmanci saboda wasu bincike na baya sun nuna cewa **cikin gajeren lokaci** na shan ALAC na iya inganta barci da aiki a ‘yan wasa. Gwajin nan ya tambayi ko mako guda na shan yau da kullum a yanayi na yau da kullum zai yi tasiri iri ɗaya. --- ## Abin da Ya Nuna: Lambobi Sakamakon da ya fi jan hankali shi ne “fari na barci” bai inganta barci ko aikin jiki ba. A wasu ma’auni, al’amari ya ƙara ɗan tabarbarewa. - **Ƙarin Tashin Farkawa:** Yawan tashin farkawa da na’ura ta auna ya tashi daga **10.25 ± 5.28** a lokacin da ba a sha ALAC ba zuwa **11.01 ± 5.79** da ALAC (p = 0.031). Wato kusan rabi na ƙarin tashin farkawa a kowace dare. - **Raguwar Tsayin Tsalle:** Matsakaicin tsayin countermovement jump ya sauko daga **28.58 ± 5.53 cm** zuwa **27.68 ± 5.14 cm** (p = 0.037), wato kusan 0.9 cm ƙasa. - **Rashin Jin Daɗi a Yamma:** Kimar ƙwarin gwiwa da tunani a yamma ta ragu sosai (p < 0.001). - **Abu ɗaya Mai Kyau:** Yanayin damuwa a yamma ya ragu (p = 0.001). Masu rubutun sun kammala da cewa kwanaki bakwai na ALAC ba su inganta barci ko ƙwarewar jiki a mutanen da ke da matsalar barci mai tsanani ba. A takaitaccen bayanin, an jaddada canjin tsayin tsalle, yayin da ba a fayyace bambance‑bambancen a sauran gwaje‑gwajen ba. --- ## Me Ya Sa Wannan Ya Kaucewa Jita‑jita Game da “Fari na Barci”? Tryptophan yana da alaka da serotonin da melatonin; ALAC kuwa na ƙunshe da tryptophan da yawa, don haka an yi tsammanin ƙara ALAC zai haifar da barci mafi kyau. Amma ilimin kimiyya ba koyaushe ke haifar da sakamako iri ɗaya a cikin mutane ba. Binciken gajeren lokaci sun nuna alamar fa’ida, amma idan ‘yan wasa da ke fama da matsalar barci suka sha ALAC a kowace dare a gida na mako guda, babu fa’ida da ta bayyana. Canjin da aka samu ya tafi akasin: ƙarin tashin farkawa, ragin tsayin tsalle, da kuma ƙasa ƙwarin gwiwar yamma. Dole ne a yi taka tsantsan. Wadannan bambance‑bambancen ba manya ba ne, kuma “ɗan tabarbarewa” ba yana nufin “hadari mai tsanani” ba. Amma samfurin da ake sayarwa a matsayin maganin inganta barci ya kamata ya guji yin ikirari da ba su da tushe. --- ## Iyakokin Gwajin: Abubuwan Da Ba Za Su Iya Nuna Ba Kafin a watsar da ALAC gaba ɗaya, ga wasu iyakokin gwajin: - **Ƙananan ƙungiya:** Mutane 24 ne kawai, don haka yana da wahala a gano ƙaramin tasiri. Ƙimar *p‑value* masu muhimmanci ba su da ƙarfi sosai, kuma ba a nuna ko an yi gyara na yawan gwaje‑gwajen ba. - **Matsalolin Barci na Matsakaici:** Masu rubutu sun ba da shawarar a gaba a yi bincike a kan masu matsalar barci mafi tsanani, waɗanda za su iya amsa daban. - **Tsawon Lokaci Kaɗan:** Kwana bakwai watakila ba su isa ba don ganin tasiri da ke buƙatar lokaci mai tsawo. - **Babu Bayanai Kan Tsarin Barci:** *Actigraphy* tana auna motsi, ba za ta iya tantance matakai kamar REM ko matakin zurfi ba, don haka wata tasiri a kan waɗannan ba a auna ba. - **Matsakaicin ƙima:** 40 g babban adadi ne; sakamakon ya shafi wannan ƙima da wannan lokaci, ba lallai ya shafi ƙananan adadi ba. - **Damuwa vs Barci:** Ragin damuwa a yamma gaskiya ne, amma ba tare da ingantaccen barci ko aiki ba. Binciken da ya biyo baya a *Nutrition Journal* (2026) ya duba ALAC kafin kwanciya da alaƙarsa da sauran nau’ikan protein a ‘yan wasa masu matsalar barci, yana nuna cewa tambayar lokacin da abincin da aka ci tare da ALAC zai iya aiki har yanzu ana bincike. --- ## Yadda Za Ka Amfani da Wannan Bayani - **Matsakaicin da Lokaci da Aka Gwada:** 40 g, awanni 2 kafin kwanciya, na kwana 7. Wannan ba ya haifar da ingantaccen barci ko aiki a wannan rukunin. - **Nau’in:** ALAC, ɓangaren whey mai ɗauke da tryptophan, an ba shi a matsayin kari, ba a matsayin madadin whey na kullum ba. - **Waɗanda Za Su Iya Gwada da Kansu:** ‘Yan wasa da ba su da matsalar lafiya za su iya ɗaukar shi a matsayin gwaji na ɗan haɗari. Idan ka yi haka, ka rubuta ainihin barcinka da kuma yadda kake jin ƙarfinka a safe maimakon ka dogara da talla. - **Waɗanda Ya Kamata Su Guje Shi:** - ‘Yan wasa da ke da matsalar barci kuma suna tunanin wannan zai magance su. Gwajin ya nuna babu fa’ida a wannan rukuni. - Duk wanda ke da babban gasa ko gwajin aiki a gobe, ganin ƙaramar ragin tsayin tsalle. - Duk wanda ke yawan tashi a dare, domin ƙara yawan tashin farkawa kaɗan. Darasin gabaɗaya shi ne: rashin barci na dindindin ya fi amsawa ga abubuwa na asali – irin su jadawalin kwanciya mai ɗorewa, dakin kwanciya mai kyau, da kuma halayen horo da caffeine masu hankali – ko kuma zuwa ga kwararren likita, fiye da dogaro da ƙari guda ɗaya. Kar ka jingina duka nauyin da ɗan ƙara ke ɗauka. --- ## Kammalawa A cikin ‘yan wasa masu matsalar barci, mako guda na 40 g ALAC kafin kwanciya ba ya inganta barci ko aikin jiki. Ya ƙara ɗan tashin farkawa, ya rage tsayin tsalle, kuma ya ƙara raguwar ƙwarin gwiwa a yamma. Fa’idar da ta rage shi ne ƙananan damuwa a yamma. “Fari na barci” na iya samun amfani a wasu ƙungiyoyi ko hanyoyin amfani, amma ga ‘yan wasa da ke fama da barci mara kyau, wannan gwaji ya nuna ba shi da dalilin siyan samfurin da aka talla.

Creatine Pyruvate vs Citrate: Wanne Tsari Ne Ya Riƙe Ƙarfi Na Dogon Lokaci

Dr. Gymbro — Thu, 22 Oct 2026 08:03:34 GMT

# Creatine Pyruvate vs Citrate: Wanne Tsari Ne Ya Riƙe Ƙarfi Na Dogon Lokaci **Bayanin taƙaice:** A gwajin kwanaki 28, nau’ukan creatine guda biyu sun yi kyau fiye da placebo, amma ɗaya kaɗai ne ya ci gaba da ƙara ƙarfafa tsoka a dukkan zagayen gwajin. Creatine pyruvate ya ƙaru a kowanne zagaye (p < 0.001), yayin da tasirin creatine citrate ya ƙare bayan zagaye na shida. Pyruvate shi ne kawai ya inganta saurin sassauta tsoka da kuma haɗa iskar oxygen a lokacin hutu. Kafin ka yanke shawarar canza creatine ɗinka, ka lura da muhimmiyar ƙuntatawa: ba a ƙara ƙungiyar creatine monohydrate ba a wannan bincike. --- ## Menene Gwajin Ya Kunna Wannan takarda da aka buga a 2008 a *Journal of the International Society of Sports Nutrition* (Jäger da abokan aiki) ta gabatar da gwaji mai maƙale biyu, an sarrafa placebo, kuma an raba mahalarta ba tare da sanin wanene a kowanne rukuni ba. An raba mahalarta 49 zuwa rukuni uku: - **Creatine pyruvate (Cr‑Pyr):** 5 g a rana, n = 16 - **Creatine citrate (Cr‑Cit):** 5 g a rana, n = 16 - **Placebo:** 5 g a rana, n = 17 Kowane mahalarta ya sha ƙarin sinadarin na tsawon kwanaki 28. Kafin da bayan gwaji, an auna ƙarfi da ƙwarewa na hannu ta hanyar maimaita ɗaukar hannu na minti 15 a ƙarfin matsakaici: zagaye 10 na ƙoƙari ba tare da tsayawa ba, kowannensu yana da hutu na minti 0.75. Masu bincike sun auna: - ƙarfi (peak torque) - saurin motsi (rate of force development) - saurin sassauƙa (relaxation rate) - amfani da iskar oxygen a lokacin hutu (oxygen consumption recovery) --- ## Abin Da Aka Samu: Sakamakon Gaskiya Duk nau’ukan biyu sun yi nasara fiye da placebo. Ga sakamakon da aka bayar: - **Matsakaicin ƙarfi a dukkan zagaye:** ya ƙaru tare da Cr‑Pyr (p < 0.001) da Cr‑Cit (p < 0.01). - **Saurin motsi:** ya ƙaru tare da Cr‑Pyr (p < 0.001) da Cr‑Cit (p < 0.01). - **Ƙarfi tare da Cr‑Cit:** ya fi placebo a zagaye na farko da na biyu (p < 0.01), amma tasirin ya ragu da lokaci kuma ba a ga bambanci mai ma'ana a zagaye na shida da na tara ba. - **Ƙarfi tare da Cr‑Pyr:** ya ƙaru a *kowane* zagaye (p < 0.001). - **Saurin sassauƙa:** Cr‑Pyr ne kaɗai ya haifar da ƙaruwa mai ma'ana (p < 0.01). - **Amfani da iskar oxygen a lokacin hutu:** Cr‑Pyr ya ƙaru sosai (p < 0.05). Cr‑Cit da placebo ba su nuna wani ci gaba mai ma'ana ba. Wannan na nuni da cewa citrate yana ba da ƙarfi a farkon gwaji amma tasirinsa ya ƙare, yayin da pyruvate ya ci gaba da riƙe ƙarfi har zuwa ƙarshen gwajin kuma ya ƙara yadda tsoka ke sassauta bayan matsawa. Masu rubutu sun hasashen cewa pyruvate na iya taimakawa juriya ta hanyar ƙara aikin aerobic, amma wannan kiran ya dogara ne kan bayanan iskar oxygen, ba kan auna juriya kai tsaye ba. --- ## Ƙuntatawa: Abubuwan Da Binciken Ba Ya Iya Bayyana **Babu ƙungiyar creatine monohydrate.** Wannan shi ne babban iyaka. Binciken ya nuna pyruvate da citrate sun yi kyau fiye da placebo, amma ba ya tabbatar ko ɗaya daga cikinsu ya fi monohydrate, wanda shi ne mafi shahara kuma mafi arha. Sauran ƙuntatawa sun haɗa da: - **Daban‑daban na adadin creatine a cikin kowane gram.** Gram 5 na Cr‑Pyr na dauke da kusan 60 % na creatine, yayin da Cr‑Cit ke da kusan 40 %. Saboda haka, ba a ba da daidai adadin creatine a kowanne rukuni ba kamar yadda ake samu a monohydrate. - **Gwaji na ƙaramin tsoka kawai.** Auna hannun ba ya wakilta aikin ƙafafu kamar squats ko gudu, ko cikakken shirin motsa jiki. - **Ƙananan rukunai.** Kashi 16 a kowane rukuni ya yi ƙanƙanta, kuma rahoton ya fi maida hankali kan p‑values ba tare da nuna girman tasiri (effect size) ba. - **Dangantaka da masana'anta.** Wasu marubuta suna da alaƙa da kamfanonin ƙari (ciki har da Jäger da Purpura). Wannan ba ya cutar da sahihancin bayanai, amma gwaji mai maimaitawa ba tare da tsangwama ba zai ƙara tabbatar da sakamakon. - **Lokaci kaɗan.** Kwanaki 28 ba su ba da haske kan tasirin dogon lokaci ba. --- ## Wanne Nau'in Creatine Ya Dace Ka Zaɓa? **Monohydrate har yanzu shine zaɓi da ya fi ƙarfi a kan hujjoji.** Shi ne ke da mafi yawan bincike, kuma farashinsa ya fi sauƙi. Babu abin da wannan takarda ke ba da hujja don canza wannan fahimta. Creatine pyruvate da citrate za a iya la’akari da su ne kawai idan kana da dalili na musamman, kamar rashin son samfurin monohydrate ko akwai buƙatar takamaiman amfani ga yanayin tsare-tsarenka. Idan ka yanke shawarar gwada su, ga abubuwan da binciken ya nuna: - **Adadin da aka yi amfani da shi:** gram 5 a rana na haɗin, an sha shi kowace rana na tsawon kwanaki 28. - **Lokacin sha:** binciken bai gwada bambancin lokaci ba, don haka babu “lokaci mafi kyau” da aka nuna. Ka sha a kai a kai a lokacin horo. - **Tsari:** Pyruvate ya fi citrate riƙe ƙarfi a cikin jerin ƙoƙari masu maimaitawa, amma wannan sakamakon ya fito ne daga gwaji guda ɗaya. - **Lura da adadi:** Saboda adadin creatine a cikin kowane gram ya bambanta, kada ka ɗauka gram 5 na Cr‑Pyr ko Cr‑Cit daidai da gram 5 na monohydrate. --- ## Wa Ya Dace Ya Yi Amfani, Wa Ya Dole Ya Guje Shi **Wa ya kamata ya yi la’akari:** - ‘Yan wasa da ke yin motsa jiki na maimaituwa (intervals, sets da hutu gajere) wadanda ke son gwada madadin kuma suna fahimtar iyakokin binciken. - Mutanen da suka riga sun yi amfani da monohydrate kuma suna da dalilin canza samfur (misali rashin jituwa da sinadarin ko neman ɗanɗano daban). **Wa ya kamata ya guje:** - Duk wanda ke neman zaɓi mafi tabbatacce kuma ba zai yi tsada ba – monohydrate ya fi dacewa. - Mutanen da ke tunanin cewa tsadar samfur mafi girma na nufin sakamako mafi kyau – binciken bai nuna hakan ba. - Masu fama da cutar koda, matsalolin zuciya, ko masu shan magunguna – su tuntubi likita kafin su fara amfani da wani nau'in creatine. --- ## Kammalawa A wannan gwaji, duka creatine pyruvate da creatine citrate sun inganta aikin hannu fiye da placebo. Pyruvate ya nuna fa'ida mai ɗorewa a ƙarfi, saurin sassauƙa, da kuma amfani da iskar oxygen a lokacin hutu. Duk da hakan, gwaji guda ɗaya, gajere, da ke da alaƙa da masana'anta ba zai iya bayyana wane nau'in creatine ne ya fi dacewa ba. Har sai an samu ƙarin ƙididdiga masu zurfi da suka kwatanta su da juna, monohydrate zai ci gaba da zama ma’auni mafi aminci ga mafi yawan masu horo.

Guarana da Caffeine: Daidaitaccen Kwaya, Guarana Kaɗai Ta Ɗaga Ƙarfin Matsakaici

Dr. Gymbro — Thu, 22 Oct 2026 08:02:31 GMT

# Guarana da Caffeine: Daidaitaccen Kwaya, Guarana Kaɗai Ta Ɗaga Ƙarfin Matsakaici **Takaitaccen Bayani:** Daidaitaccen caffeine a cikin guarana da caffeine, amma guarana ce kaɗai da ta haifar da ƙaruwa mai ma’ana a ƙarfin matsakaici. A gwajin da aka gudanar kan maza matasa 18 masu motsa jiki, guarana ta ƙara ƙarfin matsakaici da kashi 4 % akan placebo, yayin da caffeine ba ta kai wani matakin ƙididdiga ba. Duk da haka, bambanci tsakanin guarana da caffeine ba shi da ƙarfi; bambance‑bambancen su na lamba ne kawai. Anan za mu bayyana lissafin da aka samu, iyakokin binciken, da yadda za a ƙididdige adadin caffeine a cikin guarana idan kana son gwadawa. ## Menene Gwajin Ya Kunna Masu bincike – Rocha Rodrigues da abokan aikinsa – sun zaɓi maza matasa goma sha takwas (shekaru 21.8 ± 2.5). Tsarin gwajin ya kasance **na bazuwar, marasa sani, dangan‑bangare** kuma an yi shi a yanayin **crossover**, wato kowa ya gwada yanayi uku: - **Guarana** (*Paullinia cupana*) a cikin kwaya - **Anhydrous caffeine** a cikin kwaya - **Placebo** a cikin kwaya Kwayoyin biyu an daidaita su daidai da **mg 5 na caffeine a kowace kilogram na jiki**; wato babu wani bambanci a adadin caffeine da aka samu. Maharta ta sha kwayar minti 60 kafin a fara **gwajin tsalle na dakika 30 mai ci gaba (30CJ)** – wani gwaji na ƙarfi anaerobic da aka fi amfani da shi a ƙungiyoyin wasanni. Masu bincike sun rubuta ma’aunin: - Tsayin tsalle mafi girma - Tsayin tsalle matsakaici - Ƙarfin matsakaici (PPO) - Ƙarfin ƙasa - Alamun gajiya - Jimillar adadin tsalle ## Sakamakon Da Aka Samu: Lambobi Mafi ƙayatarwa shine sakamakon a **ƙarfin matsakaici (PPO)**. Guarana ta fito a matsayin magani guda ɗaya da ya kai **ma’aunin ƙididdiga**: - **Guarana vs placebo:** PPO ya tashi kashi **4.0 %** (dz = 0.82, p = 0.022) - **Guarana vs ƙimar kafin gwaji:** PPO ya tashi kashi **4.4 %** (dz = 0.55, p = 0.041) - **Caffeine:** babu tasiri mai ƙididdiga a PPO (p > 0.05) A kan tsayin tsalle mafi girma, tsayin tsalle matsakaici da ƙarfin ƙasa ba a samu wani tasiri mai ma’ana ba. Sai dai **effect size** na guarana da placebo ya nuna alamar da ta fi kyau (dz = 0.73, 0.86 da 0.58). Marubuta sun kuma lura da rage adadin jimillar tsalle a manyan gwaje‑gwaje. ## Menene Ake Nufi Da Wannan **Babu bambanci mai ƙarfi tsakanin guarana da caffeine.** Guarana ba ta “fi” caffeine a wannan gwaji ba; abin da ya bambanta su kawai shi ne tazara a lamba. Ga wasu misalai na tazara: - Tsayin tsalle matsakaici: **+1.5 %** - Ƙarfin matsakaici: **+1.4 %** - Tsayin tsalle mafi girma: **+0.9 %** - Ƙarfin ƙasa: **+0.7 %** Wadannan ƙananan tazarar ba su wuce ƙarfin kuskure ba, don haka ba za a iya ɗauka a matsayin hujja ba. Sakamakon caffeine ya nuna alamar da ta yi kama, amma ba a tsallake matakin ƙarfafa ba. A taƙaice, **duka biyun na iya taimakawa, amma guarana ce kawai da ta nuna alamun ƙididdiga mafi tsabta a ƙarfin matsakaici**. ## Ƙuntatawa - **Ƙaramin samfur:** mutane 18 kawai – ba za a iya fitar da ƙarshe mai ƙarfi ba. - **Maza matasa ne kawai:** ba a tantance tasirin a kan mata, tsofaffi, masu horo na ƙwararru ko mutanen da ke da al’adar caffeine daban ba. - **Gwaji guda ɗaya:** ba a san yadda tasirin zai kasance a amfani na yau da kullum, juriya ko sakamako na dogon lokaci ba. - **Nau’in gwaji:** 30CJ na anaerobic ne kawai; ba zai iya wakiltar gudu, ɗagawa ko ƙwarewar wasa daban‑daban ba. - **Ra’ayin dalili:** tunanin cewa sinadaran guarana suna ba da “fa’ida ta musamman a metabolism” ba a tabbatar da shi a wannan bincike. ## Yadda Ake Amfani Da Guarana Da Caffeine ### Daidaita Daga Caffeine, Ba Daga Nauyin Guarana Ba Gwajin ya ba da **mg 5/kg** na caffeine a kowace kwaya. Saboda haka, idan kana son amfani da guarana, ka duba **caffeine per serving** a kan alamar samfur, ka yi lissafi bisa nauyin jikinka. Misali, mutum mai nauyin **80 kg** zai buƙaci kusan **400 mg** na caffeine – adadi ɗaya ne da ke kusan iyakar da hukumar lafiya ke ba da shawara a rana. ### Lokaci Kwayar an sha ta **mintuna 60 kafin** aikin. Wannan ya dace da mafi yawan lokutan “pre‑workout”. ### Salo An yi amfani da **kwaya** a gwajin. Foda, ‘ya’yan ƙwannan (energy drink) ko pre‑workout na kasuwa na iya bambanta a yawan caffeine da saurin sakin sa, don haka kada ka ɗauki sakamakon iri ɗaya. ### Waɗanda Zasu Amfana - ‘Yan wasa masu buƙatar ƙarfi a tsalle, sprints ko wasannin ƙungiya, waɗanda suka riga sun saba da caffeine kuma ke son gwada tushen tsirrai. ### Waɗanda Ya Kamata Su Yi Lura Ko Guje - Mutanen da ke da saurin amsa caffeine (caffeine‑sensitive), ko masu damuwa, bugun zuciya, ko matsalar barci. - Masu cutar zuciya, hawan jini ko masu ciki – su tuntubi likita kafin amfani. - ‘Yan wasa da ke horar da dare – dalilin da ya sa caffeine na ƙarshe zai iya shafar barci. - Duk wanda ke shan caffeine daga kofi, pre‑workout ko abin sha mai kuzari, domin guarana *caffeine ne* kuma zai ƙara adadin gaba ɗaya. **Shawara mafi kyau:** Ka gwada kowane dose a horo (ba a ranar gasar ba), ka lura da alamu, ka rage dose idan an sami tasiri mara kyau. ## Takaitaccen Bayani Idan an daidaita guarana da caffeine zuwa **≈5 mg/kg**, guarana ta ƙara **≈4 %** a ƙarfin matsakaici akan placebo, yayin da caffeine ba ta kai matakin ƙididdiga ba. Duk da haka, bambanci tsakanin su ba shi da ƙarfi, kuma tazara da guarana ke da ita ƙanana ne. Wannan sakamakon ne daga ƙaramin gwaji mai kulawa sosai, ba hujja ba ce da ke tabbatar da cewa guarana ya fi caffeine. Ka ɗauke guarana a matsayin tushen caffeine da za a gwada, ka ƙididdige adadin caffeine da ke cikinsa da hankali.

Ashwagandha da Rhodiola Sun Yi Aiki; Tsarin Barcin Dare Ba Ya Aiki

Dr. Gymbro — Thu, 22 Oct 2026 08:01:21 GMT

# Ashwagandha da Rhodiola Sun Yi Aiki; Tsarin Barcin Dare Ba Ya Aiki **Abin da ba kowa yake tsammani ba:** a cikin sabon gwaji mai rukunai huɗu, ƙwayoyin da suka kawo canji a kan damuwa da barci su ne na **safe** – ashwagandha da Rhodiola rosea. Shahararren ɗaurin barci na dare – magnesium L‑threonate, L‑theanine, da apigenin – ba shi da wani ƙari ga sakamakon, kuma haɗa su da ɗaurin safe ya haifar da sakamakon da bai dace ba a ma’aunin jin daɗi. Idan kana ɗaga nauyi, yin motsa jiki mai ƙarfi, ko kuma kana fuskantar damuwar aiki tare da rashin tabbas a barci, wannan sakamakon yana bukatar a duba shi sosai. ## Abin Da Binciken Ya Gano Masana a Jami'ar South Carolina da abokan aikinsu sun wallafa sakamakon gwaji *randomized, double‑blind, placebo‑controlled* a cikin *Journal of the International Society of Sports Nutrition* (2026). An gudanar da gwajin a kan **mutane 103 masu lafiya da motsa jiki** (mata 53, matsakaicin shekaru 34.8) waɗanda aka raba zuwa rukunai huɗu: - **AM kawai (n = 26):** 600 mg ashwagandha + 300 mg *Rhodiola rosea* a safe, placebo a dare. - **PM kawai (n = 25):** placebo a safe, sannan 2 g magnesium L‑threonate (da ke ba da 145 mg magnesium), 200 mg L‑theanine, da 50 mg apigenin a dare. - **AM + PM (n = 25):** duka rukunin safe da dare. - **Placebo (n = 27):** placebo a duk lokuta. Gwajin ya dauki makonni huɗu: mako ɗaya na rashin karɓa, **makonni biyu na ƙara ƙwaya**, sannan mako ɗaya na wankewa. Masu halarta sun cika tambayoyin damuwa da PROMIS a kowane mako, kuma sun amsa *Pittsburgh Sleep Quality Index* (PSQI) a farkon gwaji da bayan wankewa. An kuma bi diddigin barci da na’ura mai auna motsi a kowace dare. ## Abubuwan Da Aka Gano Rukunin da ya shaƙata da adaptogen a safe shi ne ya fito a gaba. Ga muhimman lambobin da takardar ta ba da: - **Raguwar damuwar mako‑mako** a rukunin AM (p = 0.034; η² = 0.020). Damuwar yau da kullum ba ta bambanta ba. - **Raguwar rashin ingancin barci** a rukunin AM (p = 0.032; d = 2.74). - **Rage lokacin farkawa bayan bacci** a rukunin AM (p = 0.047; η² = 0.020) – bisa ga bayanan na’ura. - **Ingantaccen sakamakon PSQI** a rukunin AM idan aka kwatanta da rukunin AM + PM (bambanci = 0.66 AU, p < 0.001, d = 1.45). - **Ƙaruwa a yanayin jin daɗi** a rukunin AM a karshen lokacin wankewa (p = 0.003; d = 1.68) kuma ya ci gaba da ƙaruwa. Rukunin AM + PM ya nuna akasin haka (p = 0.009; d = 0.16). Marubutan sun kammala da cewa haɗin ashwagandha da Rhodiola a safe yana haifar da raguwar damuwa da aka ji, ingantaccen barci, da yanayi mafi kyau bayan kwanaki 14 idan aka kwatanta da placebo. Ɗaurin barci na dare – ko shi kaɗai ko a haɗe da na safe – bai nuna wani fa'ida ba a cikin wannan bincike. Don haka, idan kana tunanin gina wani tsari mai tsada na ƙwayoyin kari na dare, wannan sakamakon na nuni da cewa hakan ba zai kawo sauran tasiri ba. ## Me Ya Sa Ƙarin Dare Ba Ya Aiki? Takardar ba ta ba da dalili kai tsaye ba kan dalilin da ya sa ƙarin dare bai yi tasiri ba; duk abin da ke ƙasa tunani ne kawai. Wataƙila mutane masu lafiya da motsa jiki ba su da isasshen matsa lamba don buƙatar ƙarin wannan nau'in ƙwayoyin. Ƙara kayan kari ba lallai ne ya nufin ƙara fa'ida ba. A zahiri, haɗa komai a lokaci guda na iya rage tasirin adaptogen na safe, kuma a maimakon haka ya iya jawo rashin jin daɗi. ## Kalubalen Da Ya Kamata A Lura Da Su Kafin ka canza ko ka ƙara ƙwayoyin kari, ka yi la’akari da waɗannan iyakoki: - **Tsawon lokacin gwaji:** an yi gwajin na makonni biyu kacal. - **Masu halarta su ne masu lafiya da matasa masu motsa jiki:** ba su da wata cuta ta damuwa ko matsalar barci. Wannan na iya rage ganin tasiri a wasu ma’auni. - **Ƙaramin girman rukuni:** kowane rukuni yana da kusan mutane 25, wanda ke nufin ƙarancin ƙarfin ƙididdiga. - **Ƙananan p‑values:** wasu muhimmancin p‑values suna nan a ƙarƙashin 0.05 (0.032, 0.034, 0.047), amma η² na 0.020 yana nuna tasiri ƙanana ne. - **Bambancin girman tasiri:** Cohen’s d ya tashi daga 0.16 zuwa 2.74; manyan ƙimomi na iya nuni da ƙara tasirin da ba a iya shawo kansa a cikin rukuni mai ƙarami. - **Sakamakon jin daɗi:** ya bayyana ne a ƙarshen lokacin wankewa, ba a lokacin ƙara ƙwaya ba. Marubutan sun ba da shawarar ci gaba da gudanar da gwaje‑gwaje masu tsawo da a kan al’ummomi masu damuwa da matsalolin barci. ## Yadda Za Ka Yi Amfani Da Sakamakon (A Praktika) - **Kimanin ƙwaya:** 600 mg ashwagandha + 300 mg *Rhodiola rosea* a kowace rana. - **Lokaci:** a safe – wancan ne rukuni ya nuna fa'ida. - **Tsawon amfani:** gwajin ya gudanar na kwanaki 14; ba a da hujja kan amfanin dogon lokaci ba. - **Tsarin ƙwaya:** takarda ba ta fayyace irin tsabarraki ba; ka nemi samfuran da ke bayyana irin tsabarraki da matakin tsafta da suka dace da ƙimomin da ke sama. - **Wanene ya dace da shi:** mutane masu lafiya da motsa jiki waɗanda ke fama da damuwa kuma ke son ƙara ingancin barci da yanayin ruhu. - **Waɗanda ya kamata su guje ko su nemi shawara:** mata masu juna biyu ko ke shayar da jarirai, mutanen da ke da cutar thyroid, hanta ko garkuwar jiki, masu shan magungunan barci, antidepressants, ko wasu magunguna, da kuma waɗanda aka gano da cutar barci – su tuntuɓi likita kafin fara amfani. ## Takaitaccen Bayani Ga Masu Ɗagawa Wannan gwaji ba ya tabbatar da cewa haɗin adaptogen a safe “sihrin” ba, kuma ba ya nuni da cewa magnesium L‑threonate, L‑theanine, ko apigenin ba su da amfani. Sai dai ya nuna cewa a cikin mutane 103 masu lafiya da motsa jiki na makonni biyu, safiyar ashwagandha da Rhodiola ce ke ba da sakamako mafi tabbatacce, yayin da ƙara ɗaurin dare ba ya ƙara wani fa'ida. Idan kana tunanin sayen ƙarin ƙwayoyi, bayanan na nuni da cewa hanyar mafi sauƙi – ɗaukar adaptogen a safe – na iya zama mafi inganci. Tsabtace barci, adadin horo, da dawowar jiki har yanzu su ne manyan abubuwan da ke tasiri ga ingancin barci da yanayin rai.